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Abstract  
 
Fetal Alcohol Spectrum Disorders (FASD) represent the largest preventable cause 
of cognitive deficits in the western world. The mechanism(s) of how prenatal alcohol 
exposure (PAE) results in FASD remain unknown. Towards this end, mouse models of 
PAE have successfully recreated endophenotypes that are characteristic of FASD. This 
doctoral thesis examines the long-term epigenomic alterations associated with PAE. I have 
examined both mice with PAE and human patients with FASD.  
In the first set of experiments, mice with PAE and matched controls were raised to 
adulthood and then their whole brains were examined for alterations to gene expression, 
non-coding RNA (ncRNA) expression, and DNA methylation. Long-term alterations were 
observed in genes related to neurodevelopment, cellular signaling, and immune processes. 
Furthermore, there was an enrichment for alterations to genomically imprinted clusters of 
ncRNA and genes related to PTEN/PI3K/AKT/mTOR signaling. 
In the second set of experiments, buccal epithelial swabs were collected from young 
children with FASD and matched controls. Children from a discovery cohort were 
examined for alterations to DNA methylation, which revealed changes to genes involved 
in neurodevelopment and synaptic signaling as well as hippo signaling. Select candidates 
(COLEC11 and HTT) were confirmed by sodium bisulfite pyrosequencing. Examination of 
a replication cohort revealed that while similar pathways are altered, the effect is not 
identical and that sex and age may alter the methylation profile. A larger group of children, 
representative of the general population, were then analyzed using a targeted sodium 
bisulfite next-generation sequencing panel and pyrosequencing. No single gene examined 
was found to be consistently affected in all FASD children.  
Finally, the mouse and human results were compared to identify alterations to 
shared loci, ontologies, and pathways. The clustered protocadherins, which are involved in 
generating individual neuronal identity, showed increased DNA methylation in both 
species. Together, the results suggest that a shared DNA methylation profile related to 
neurodevelopment is present in both the brains of adult mice and the buccal epithelial swabs 
of young children with PAE. These results may be used in future functional studies of 
candidate loci as well as towards the development of much needed diagnostics and 
precision medicine.  
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Epigraph 
 
 
 
 
 
 
 
 
 
 
“We might use the name ‘epigenetics’ for such studies, thus emphasizing their 
relation to the concepts, so strongly favourable to the classical theory of epigenesis, which 
have been reached by the experimental embryologists. We certainly need to remember that 
between genotype and phenotype, and connecting them to each other, there lies a whole 
complex of developmental processes. It is convenient to have a name for this complex: 
‘epigenotype’ seems suitable.” 
 
- Conrad Hal Waddington (The Epigenotype. Endeavour, 1942). 
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Chapter 1 
Introduction  
1.1. Prenatal Alcohol Exposure 
Alcohol consumption during pregnancy can result in the development of fetal 
alcohol spectrum disorders (FASD) (Williams et al. 2015). FASD is an umbrella term for 
a heterogeneous spectrum of related developmental disorders that are caused by prenatal 
alcohol exposure (PAE), with the worst possible outcome being fetal alcohol syndrome 
(FAS) (Lemoine et al. 1968; Jones et al. 1973; Williams et al. 2015). FAS shares 
commonalities with other psychiatric disorders including growth deficiency and central 
nervous system impairment. FAS is distinguished from other psychiatric disorders by a 
history of maternal alcohol consumption during pregnancy and three distinct facial 
features (Clarren & Smith 1978). First is a smooth philtrum: the vertical groove between 
the nose and upper lip is flattened. Second is a thin vermilion: a thin upper lip. Third are 
small palpebral fissures: a reduced width of the eye. However, these facial characteristics 
used to distinguish FAS and partial FAS (pFAS) do not typically apply to the lower part 
of the FASD spectrum, which is characterized by neurobehavioral and neuroanatomical 
alterations without the distinctive facial features.  
There are a total of 428 comorbidities related to FASD (Popova et al. 2016). 
FASD is associated with congenital malformations to the ocular, auditory, skeletal, 
cardiac, and renal systems. The clinical heterogeneity and uniqueness of each case 
appears to be driven by the combination of dosage and timing of PAE, other exposures, 
genetic background, sex, family history of PAE, as well as maternal genotype, nutrition 
and stress (Kleiber, Diehl, et al. 2014). In Canada, from 2003-2010, ~10% of pregnant 
women and ~20% of breast feeding women consumed alcohol (Lange et al. 2016). While  
no official record exists for Canada, FASD is typically diagnosed in only 2-5% of 
children (May et al. 2014). These numbers are comparable across many alcohol 
consuming nations and represent a multi-billion dollar public health issue.  
 2 
The Institute of Medicine (IOM) of the National Academies has four diagnostic 
categories for the disorders that constitute FASD: FAS, pFAS, alcohol-related 
neurodevelopmental disorder (ARND), and alcohol-related birth defects (ARBD) 
(Stratton et al. 1996; Chudley et al. 2005). The latest edition of the diagnostic and 
statistical manual of mental disorders (DSM–5) now includes the psychiatric diagnosis: 
Neurobehavioral Disorder Associated with Prenatal Alcohol Exposure (ND-PAE) 
(American Psychiatric Association 2013). ND-PAE considers the neurobehavioral 
alterations to be independent from the facial characteristics and is listed in the DSM–5 
appendix under “conditions for further study” (Doyle & Mattson 2015). 
Endophenotype is a psychiatric genetics concept that deconstructs a complex 
behavioural phenotype into components with a clearer genetic connection (Gottesman & 
Gould 2003). The endophenotypes of FASD overlap with other psychiatric disorders, 
particularly attention deficit hyperactivity disorder (ADHD). While an individual can be 
diagnosed with the two disorders, they are distinct disorders, and misdiagnosis of one can 
lead to inappropriate medication and therapy (O’Malley & Nanson 2002; Greenbaum et 
al. 2009; Peadon & Elliott 2010). Endophenotypes commonly associated with FASD 
include impairments in cognition, learning, executive function, judgment, attention, and 
social adaptation (Mattson & Riley 1998; Jirikowic et al. 2008; Green et al. 2014). The 
molecular mechanisms behind FASD endophenotypes have been difficult to ascertain in 
humans. However, animal models have greatly aided research into FASD 
endophenotypes (Gil-Mohapel et al. 2010; Kiecker 2016). The results suggest that FASD 
endophenotypes are a result of cellular and molecular aberrations to neurodevelopment 
that are caused by PAE (Resendiz et al. 2014).  
1.1.1. PAE Endophenotypes are Associated with Altered 
Neurodevelopment  
Human neurodevelopment is a complex process that takes a relatively long time to 
produce a mature brain. Once an oocyte is fertilized by a sperm, they form a zygote that 
undergoes the ~8-week process of embryonic development. During its voyage down the 
fallopian tube, the zygote undergoes cleavage, which is a series of rapid cell divisions that 
divide the large cytoplasm of the egg into a solid spherical mass of smaller nucleated cells 
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known as blastomeres (Gilbert 2013). The spherical structure then begins to form a cavity 
on the inside and results in a hollow ball of cells known as the blastocyst. The outer cells 
of the blastocyst form the trophoblast, which is the first embryonic epithelium, and the 
remaining cells are trapped inside and form the pluripotent inner cell mass (ICM). The 
blastocyst then arrives in the uterus after four days and implants into the endometrium of 
the uterine wall after a few more days to begin gastrulation. 
During gastrulation the embryo forms three distinct germ layers: endoderm, 
mesoderm, and ectoderm (Gilbert 2013). The endoderm forms into parts of the digestive 
system, liver, lungs, and thyroid. The mesoderm forms into a number of muscle types, 
bone, cartilage, dermis, gonads, circulatory system, and lymphatic system. The ectoderm 
forms into the surface ectoderm, neural tube, and neural crest. The surface ectoderm 
forms the epidermis, nails, hair, tooth enamel, parts of the eye, and buccal epithelium. 
The neural tube forms into the brain, spinal cord, retina, and part of the endocrine system. 
The neural crest forms into the peripheral nervous system, epinephrine-producing 
(medulla) cells in the adrenal gland, various pigment cells, and facial bone and cartilage. 
It also generates connective tissue in the eye, tooth, skin, fat, arteries as well as 
connective tissue the salivary, lachrymal, thymus, thyroid, and pituitary glands. The 
diversity of differentiated cell types has led to the neural crest being referred to as the 
fourth germ layer; however, these stem cells are in fact derived from the neural tube and 
the diverse fates are determined largely by where they migrate. In later embryonic 
development and differentiation, a strip of specialized cells in the endoderm known as the 
notchcord induces a portion of the ectoderm to become the neuroectoderm, which is also 
known as the neuroepithelium (Gilbert 2013). The neuroectoderm then transforms into 
the neural plate.  
During neurulation, the neural plate folds into the neural tube. As neurulation 
occurs, the neural plate border separates from the neuroectoderm and serves as boundary 
between the neuroectoderm and surface ectoderm. The neural plate borders, which are 
peripheral to the neural plate, then fold in on themselves and once connected are known 
as the neural crest. During this period, the neural tube may fail to close completely and 
result in neural tube defects. The closing of the neural tube is sensitive to certain 
environmental conditions with folate (Vitamin B9) and Vitamin B12 supplementation 
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greatly reducing the chances of a neural tube defect (Ray et al. 2002). In human PAE 
pregnancies, ethanol was found to impair the transfer of folate across the placenta 
(Hutson et al. 2012). Folate and B12 are involved in one-carbon metabolism, which is used 
to derive the methyl groups of the epigenome and also nucleic acid synthesis (Kobor & 
Weinberg 2011). After the neural plate closes, it becomes the neural tube. The neural 
crest cells will then migrate great distances, which leaves the neural tube disconnected 
from the epidermis. In order to migrate, neural crest cells must undergo an epithelial-
mesenchymal transition (EMT). During EMT, epithelial cells undergo morphological 
change, lose their current cell-to-cell adhesion, and become migratory multipotent 
mesenchymal stem cells. Inside the neural tube are neural stem cells that will differentiate 
into neurons and glia. Thus, in addition to the fetal stages of pregnancy, PAE can also 
alter embryonic development and produce a number of overlapping and distinct clinical 
outcomes. 
Embryonic development represents the first trimester of human pregnancy and 
results in a fetus just over 1 inch in size that continues to undergo slower cell divisions as 
it grows and refines existing structures (Gilbert 2013). The developing brain forms 
intermediate structures and refines a network of synaptic connections throughout the 
second and third trimester of pregnancy. Notably, throughout fetal development and into 
young adulthood DNA cytosine methylation in the developing brain continues to 
reconfigure itself during neurodevelopmental events (Lister et al. 2013). Any of the above 
developmental processes may be disrupted by PAE.  
A single occasion of PAE during the third trimester of pregnancy has been shown 
to trigger widespread but select acute apoptosis of neurons (Farber et al. 2010) and 
oligodendrocytes (Creeley et al. 2013) in the fetal macaque brain. Furthermore, PAE 
induced apoptosis in the fetal macaque brain is comparable to PAE induced apoptosis in 
the developing rodent brain (Young & Olney 2006).  The above observations suggest that 
PAE causes neurodevelopmental aberrations, which result in life long anomalies 
associated with FASD. The above conclusion, however, is too general and has provoked 
more refined studies on the mechanism behind the effect of PAE on neurodevelopment. 
These mechanistic studies have been greatly aided by more sensitive molecular 
technologies assessing the effect of PAE at the genomic level. Specifically, such studies 
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have focused on the effect of PAE on genome-wide gene expression and the epigenome, 
which are discussed below.  
1.1.2. PAE Alters Short-Term and Long-Term Gene Expression 
Insight into the effects of alcohol on the developing brain have been assessed 
using animal models, which typically include rats for neuroscience-based studies and the 
C57BL/6J (B6) strain of mice for molecular-biology-based studies (Valenzuela et al. 
2012; Zhou 2015). The most common in vivo PAE paradigm involves injecting acute 
doses of ethanol during different developmental time points and represents a binge 
exposure (Kleiber, Diehl, et al. 2014). Studies of PAE in mice have identified differential 
expression of diverse genes, many of which are involved in development.  
  Gene expression microarrays have been used to examine PAE in a B6 mouse 
model with binge injections (3.8 g/kg, twice a day) from gestational days (GD) six to 
eight (Lee et al. 2004). Craniofacial malformations were observed in both embryos 
(GD10) and fetuses (GD15). An alteration to “palate, lung, and nasal epithelium clone 
(plunc)”, which is involved in palate closure, was confirmed by polymerase chain 
reaction (PCR). These findings provided early evidence that PAE results in genome-wide 
alterations in both embryos and fetuses and that the altered genes are involved in 
processes related to the morphological abnormalities associated with FASD.  
Other studies have used gene expression microarrays to identify PAE induced 
alterations to genes with functions that include cellular division and proliferation, cell 
signaling, cell migration, apoptosis, cell-to-cell adhesion, metabolism, and protein 
synthesis and degradation. In 2004, Gutala et al. isolated cortical neurons from GD14 
C57BL/6J mouse fetuses and subjected them to 5 days of ethanol treatment in vivo 
(Gutala et al. 2004). They screened 638 genes and identified 56 down-regulated and 10 
up-regulated genes. Gene expression associated with “protein synthesis” (ribosome) and 
“ubiquitin-proteasome” was decreased by alcohol exposure. They also confirmed the 
genes involved in “ubiquitin-proteasome” by qPCR. Heat shock proteins and members of 
the PI3K/AKT/mTOR pathway (mTOR, Pten, and Marcks) were also altered. In 2005, 
Hard et al. examined a B6 model of binge injections on GD7 and GD9 and the fetal 
brains were examined for differential gene expression on GD18 (Hard et al. 2005). 
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Twenty-five PAE genes were identified, all of which were down-regulated. Notable 
candidates identified by the authors were Timp4, Bmp15, Rnf25, Akt1, Tulp4, and 
Dexras1. These identified genes have roles in cellular proliferation, differentiation, 
signaling, and apoptosis. In 2007, Green et al. examined two substrains of C57BL/6 mice 
and collected embryonic head folds 3 hours after binge injection on GD8 (Green et al. 
2007). The group observed alterations to 2,906 non-redundant genes, including several 
hub genes (Mapk1, Ald3a2, Cd13, Pfkm, Tnfrsf1a, Rps6, Igff1, Egfr, and Pten). There was 
a significant overall down-regulation of pathways related to the ribosome and 
proteasome. There was also a significant overall up-regulation of the pathways related to 
cell adhesion and regulation of actin cytoskeleton. Furthermore, experimentation with a 
mitochondrial GABAA receptor antagonist also uncovered a role for Akt1 and strain-
specific effects. Together, the results from Gutala et al., Green et al., and Hard et al. 
suggest that cellular signaling is altered by PAE, particularly the PI3K/AKT/mTOR 
pathway.   
In 2011, Zhou et al. examined the effects of ethanol on GD8 B6 whole embryo 
culture (Zhou, Zhao, et al. 2011). They found that 34 out of 127 (27%) alcohol treated 
embryos had neural tube defects while only 3 out 139 (2%) controls showed obvious 
defects. When comparing two array experiments, 87 probe sets were replicated. There 
were a total of 49 probe sets that had decreased expression, while 38 showed increased 
expression. The genes were functionally involved in neurodevelopment, chromatin, eye 
and heart development, retinol metabolism, cell cycle, and cell adhesion. Several genes 
were also observed to be turned on or off by alcohol exposure. The group also observed 
de novo expression of aldehyde dehydrogenase 1B1 (Aldh1B1), which catalyzes the 
conversion of retinaldehyde to retinoic acid. Retinoic acid is involved in cellular signaling 
for developmental events.  
A number of laboratories have reported on mouse models of PAE based on 
voluntary and moderate maternal consumption throughout gestation that produce peak 
blood alcohol concentrations of ~80–120 mg/dl (Allan et al. 2003; Boehm et al. 2008; 
Brady et al. 2012). Kaminen-Ahola et al. examined a B6 maternal voluntary exposure 
paradigm and found that PAE results in craniofacial changes and growth restriction 
(Kaminen-Ahola, Ahola, Flatscher-Bader, et al. 2010). It was found in this case that PAE 
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induced growth alterations were not observable prior to birth but were apparent in 
weanlings. Furthermore, they cross-fostered the weanlings to show that this observation 
was not the result of altered maternal care by alcohol consuming mothers. Gene 
expression related to the metabolism of exogenous and endogenous compounds, iron 
homeostasis, and lipid metabolism was altered in the liver of young PAE mice. In 2014, 
Dobson et al. used qPCR to examine a guinea pig model of voluntary maternal PAE and 
found it disrupts the expression of genes involved in insulin and insulin-like growth factor 
(IGF) signaling in the adult prefrontal cortex (Dobson et al. 2014). Insulin signaling is 
capable of activating the PI3K/AKT/mTOR pathway (Laplante & Sabatini 2009). In 2016 
Ramani et al. examined a moderate voluntary exposure paradigm and observed that PAE 
during the first trimester results in the upregulation of mRNA and protein for an 
astrocytic connexin (Cx30), which is involved in forming gap junctions in the 
hippocampus of young mice (Ramani et al. 2016). Together, these results show that 
rodents can be used to model a number of PAE paradigms, which include acute binge 
injections at different developmental time points or variations of a more continuous 
moderate exposure by voluntary maternal consumption.  
The laboratory of Shiva Singh established a B6 maternal continuous preference 
drinking (CPD) paradigm that resulted in offspring with mild developmental delays, 
anxiety-related traits, and deficits in learning and memory (Kleiber et al. 2011). Analysis 
by qPCR revealed a down-regulation of a glutamate receptor (Grin2c) and glycine 
receptor subunit (Glra1). This paradigm was extended by evaluating global gene 
expression changes that occurred in adult brains of CPD PAE mice (Kleiber et al. 2012). 
The results indicated that alcohol induces subtle but consistent changes to gene 
expression. Gene enrichment analysis showed overrepresented gene ontology 
classifications of cellular, embryonic, and nervous system development. A number of the 
identified genes were previously implicated in FASD-relevant neurobehavioral 
phenotypes such as cognitive function, anxiety, ADHD, and mood disorders. Ultimately, 
the above findings suggest that altered gene expression is detectable long after PAE and 
most likely represents altered gene regulation and a shift in cellular populations for life 
(Kleiber, Diehl, et al. 2014).  
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The Singh laboratory has also examined how the variability seen in FASD 
phenotypes relates to the timing of alcohol exposure. In these experiments a binge 
exposure paradigm was used, in which B6 mice were exposed to two acute doses of 
alcohol (5 g/kg of body weight) at neurodevelopmental times representing the human 
first, second, or third trimester equivalent (Kleiber et al. 2013; Mantha et al. 2014; 
Kleiber, Laufer, et al. 2014). This method has been previously reported to result in peak 
blood alcohol concentrations of over 300 mg/dl (for 4–5 hours following injection) and 
can induce the apoptosis of millions of neurons by both a blockade of NMDA glutamate 
receptors and excessive activation of GABAA receptors (Ikonomidou et al. 2007; 
Wozniak et al. 2004). The first set of experiments utilizing the binge injection models set 
out to examine physiological, developmental, and behavioural deficits associated with the 
paradigms examined (Mantha et al. 2013). The results showed that alcohol exposure at 
any time during gestation causes delays in motor skill and reflex development. Also, the 
results provided further support for long-term PAE induced deficits in learning and 
memory, as assessed by the Barnes maze. These same mice were also used to assess 
changes in the adult brain transcriptome (Kleiber et al. 2013). The results suggested that 
alcohol disrupts biological processes that are actively occurring at the time of exposure. 
These include cell proliferation during trimester one, cell migration and differentiation 
during trimester two, and cellular communication and neurotransmission during trimester 
three. Furthermore, although alcohol altered a distinct set of genes depending on 
developmental timing, many of these show interrelatedness and can be associated with 
one another via ‘hub’ molecules and pathways. However, the regulatory mechanism 
maintaining the long-term alterations to gene expression remained hypothetical.  
1.2. Epigenetic Mechanisms May Underlie the Altered Gene 
Expression of PAE 
In addition to gene expression, PAE alters epigenetic marks (Haycock 2009; 
Kobor & Weinberg 2011; Basavarajappa & Subbanna 2016). Epigenetic marks maintain 
gene expression profiles related to development and tissue specificity without altering 
DNA sequence and are heritable in dividing cells. Epigenetic marks are distinct from 
transcription factors, however, they influence each other as gene expression is initiated by 
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transcription factors recruiting RNA polymerase. Epigenetic marks include DNA cytosine 
methylation (Smith & Meissner 2013), select histone post-translational modifications 
(Gurard-Levin & Almouzni 2014), and a diverse array of non-coding RNA (ncRNA) 
species (Pauli et al. 2011; Rinn 2014). These marks enable spatial and temporal control of 
gene expression by acting together to create distinct states of variation that have unique 
functions in the brain (Sweatt et al. 2012). While each mammalian cell has a (nearly) 
identical genome, there are layers of diversity that give each cell type a unique epigenome 
that is reflective of ontogeny. Epigenetic experimentation has provided invaluable insight 
into the molecular mechanisms of inheritance and disease that lie outside genetic 
contribution. 
1.2.1. PAE Alters Histone Post-Translational Modifications 
There are five types of histone proteins found in the chromatin of mammalian 
cells: the four core histones (H2a, H2b, H3, and H4) and histone H1, which is bound to 
the linker DNA between nucleosomes (Marzluff et al. 2002). Each time a mammalian cell 
divides, it must rapidly synthesize large amounts of histones. The unique properties of the 
histone genes are critical for cell cycle regulation (Marzluff et al. 2002). There are 
approximately 10–20 genes encoding each of the core histone proteins in mammals. The 
bulk of the replication-dependent histone genes are found in two clusters in both mouse 
and human (Albig & Doenecke 1997; Albig et al. 1997). The largest cluster is termed 
HIST1, and there is an orthologous Hist1 cluster on mouse chromosome 13 (Wang et al. 
1996). The mouse Hist1 cluster contains 45 core histone genes with 6 histone H1 genes. 
A smaller number of histone genes are present in HIST2 on human chromosome 1, and 
this cluster is orthologous to the Hist2 cluster on mouse chromosome 3 (Wang et al. 
1996). In addition there is a second small cluster of histone genes on human chromosome 
1, termed HIST3, and the orthologous Hist3 cluster is located on mouse chromosome 11 
(Marzluff et al. 2002). 
A relatively large number of histone post-translational modifications (PTMs) exist 
(Gurard-Levin & Almouzni 2014) and a number of PTMs may act as epigenetic marks. 
Multiple PTMs are possible on the same histone. Mono-, di-, and tri- methylations (me1, 
me2, and me3) and acetylation (ac) are intensely studied PTMs. Histones H2A, H2B, H3, 
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and H4 represent the core nucleosome subunits. The core subunits are present in 
duplicate, where the octamer wraps around ~150 bp of DNA and interacts with the linker 
histone (H1). PTMs typically occur on the exposed N-terminus tail of the histone subunit 
that is accessible to chromatin modifying machinery. For instance, the exposed lysines 
(K) at the 4th, 9th, and 27th position in amino acid sequence on Histone H3 (H3K4, H3K9, 
and H3K27) and H4K20 are relatively well characterized for their function in regulating 
gene expression.  Histones bind to DNA and form chromatin, which also includes DNA 
methylation and some ncRNAs. PTMs are widely hypothesized to constitute a histone 
code at a specific locus that encodes gene regulatory information (Jenuwein & Allis 
2001). Ultimately, PTMs effect the recruitment of other proteins onto chromatin and can 
then functionally affect transcription.  
Histone PTMs have been shown to be altered by PAE. In 2011, Guo et al. 
examined a rat model of PAE that corresponds to the third trimester of human pregnancy. 
They found a reduction in a histone acetyltransferase (CREB binding protein) in the 
developing cerebellum along with a reduction in H3 and H4 acetylation levels (Guo et al. 
2011). In 2013, Veazey et al. examined the effect of alcohol exposure on GD12.5 B6 
cortical neuroepithelial cells maintained as neurosphere cultures (Veazey et al. 2013). The 
group found that promoters of genes involved in neurodevelopment were under-enriched 
for H3K4me3 and H3K27me3 after ethanol exposure. Notably, while the group observed 
large-scale change to chromatin structure, they only observed a few matching alterations 
to transcription. Together, the above studies demonstrate that more than one histone PTM 
is altered by PAE.  
PAE has also been shown to alter histone PTMs on genes coding for enzymes that 
establish histone PTMs. Subbanna et al. examined a human trimester 3 equivalent mouse 
model of binge PAE. They observed that PAE increased histone methyltransferase (G9a) 
activity and lead to an increase in H3K9me2 and H3K27me2 (Subbanna et al. 2013). 
Later, Subbanna et al. found increased H3K14ac in the first exon of G9a and also 
observed that G9a immunoprecipitates with DNA methylation machinery (DNMT3A and 
MeCP2) (Subbanna et al. 2014). These observations show that PAE alters cooperating 
epigenetic marks. In 2015, Veazey et al. examined in vitro and in vivo models where it 
was found that the specific alterations to histone PTMs appear to depend on alcohol 
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dosage, the specific gene, as well as the time elapsed since alcohol exposure (Veazey et 
al. 2015). Notable candidates included the Hox genes. The predicted regulatory 
correlation was not observed for individual PTMs and altered gene expression; however, 
they observed an increase in repressive chromatin modifications that was correlated with 
significant alterations to the transcripts coding for DNA and histone methyltransferase 
enzymes. Ultimately, the above studies demonstrate the combinatorial nature of the 
epigenome and show that epigenetic machinery is also deregulated by PAE. Furthermore, 
the alterations to histone PTMs may sometimes, but not always, lead to altered gene 
expression.  
1.2.2. PAE Alters Non-Coding RNA Expression  
Gene expression is not limited to coding RNA, as ncRNAs represent a variety of 
RNA species that can be altered by PAE. Small nucleolar RNAs (snoRNA) are a class of 
RNA that guide the methylation and pseudouridylation of ribosomal RNA (rRNA), 
transfer RNA (tRNA), and small nuclear RNA (snRNA) (Bachellerie et al. 2002). Also 
noteworthy are orphan snoRNAs, which have taken on novel functions in alternative 
splicing, growth, and neurodevelopment (Laufer & Singh 2012). 
Another class of ncRNA are microRNAs (miRNA) (Filipowicz et al. 2008). 
miRNAs are small (~23 bp) endogenous RNA molecules that canonically target the 3’ 
untranslated region (UTR) of messenger RNA (mRNA) and result in post-transcriptional 
repression (Bartel 2009). The targeting of a mature mammalian miRNA is dependent 
upon the seed region (six bp; nucleotides 2-7), which is where a nearly perfect match 
occurs between miRNA and mRNA. Furthermore, several nucleotides thereafter may 
tolerate some mismatches and hybridize as well. There are thousands of miRNAs in the 
mammalian genome and ~60% of protein coding genes may be regulated by miRNAs 
(Friedman et al. 2009). 
miRNAs exist in the genome as independent genes, polycistronic gene clusters, or 
introns. miRNAs are also present in the introns and/or exons of some large non-coding 
RNAs (lncRNA). miRNAs are processed from a larger pri-miRNA precursor that can 
have a 5’ cap, poly-A tail, and form a secondary structure with a hairpin loop (Filipowicz 
et al. 2008; Bartel 2009). A Drosha-DGCR8 complex, also known as the microprocessor 
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complex, processes the pri-miRNA and produces a ~70 bp stem loop known as pre-
miRNA. However, introns containing miRNAs do not undergo pri-miRNA processing as 
their splicing results in pre-miRNA. Exportin-5 recognizes pre-miRNA in the nucleus and 
exports it to the cytoplasm. Dicer recognizes the pre-miRNA, cleaves the stem loop, and 
leaves a ~20 bp RNA duplex. Afterwards, one strand (the guide strand) of the duplex is 
selected as mature RNA, while the other (passenger) strand is either degraded or is 
selected in some situations to carry out alternative targeting. Mature miRNAs are loaded 
into the RNA-induced silencing complex (RISC), which is a ribonucleoprotein complex 
that contains a number of proteins including DICER and AGO. The miRNA loaded RISC 
complex can then target transcripts, resulting in translational repression or mRNA 
destabilization. Imperfect matching at the seed region enables a single miRNA to target 
many genes and a single gene to be targeted by many miRNAs, which allows for the 
regulation of complex gene expression profiles. A number of miRNAs have been 
implicated in various abnormalities that often show co-morbidity with FASD, including 
anxiety, depression, and other psychiatric disorders (O’Connor et al. 2012).  
PAE has been shown to alter miRNA expression. In 2007, Sathayan et al. 
examined the effect of alcohol exposure on miRNA expression in GD12.5 B6 cortical 
neuroepithelial cells maintained as neurosphere cultures (Sathyan et al. 2007). The group 
found that both high and low ethanol doses alter different miRNAs that influence the cell 
cycle and apoptosis. One of the altered miRNAs was shown to be regulated by a GABA 
receptor, while another miRNA is genomically imprinted. Genomically imprinted genes 
are expressed in a parent-of-origin-specific manner that is based on differential DNA 
methylation of an imprinting control region (ICR). Thus, the ex vivo results of Sathayan et 
al. show that different PAE doses alter distinct miRNAs and that PAE responsive 
miRNAs are regulated by different mechanisms. In 2009, Wang et al. examined miRNA 
expression in fetal B6 brains exposed to a number of alcohol dosages and observed the 
deregulation of several miRNAs (Wang et al. 2009). Together the above results 
demonstrate that PAE induces altered miRNA expression.  
Studies of PAE induced miRNA expression have also revealed that the gene 
expression alterations are dynamic. In 2012, Guo et al. examined the effect of a chronic 
and intermittent exposure on B6 primary cortical neuronal cultures, and observed the 
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differential expression of 42 miRNAs after 10 days of exposure (Guo et al. 2012). The 
group also examined the effects of ethanol removal. Five days after removal of the 
chronic ethanol exposure, they observed a profile of 26 deregulated miRNAs – 20 of 
which were unique to the removal. The predicted target genes had functions related to 
transcription, protein phosphorylation, and neurodevelopment. Some of the miRNAs were 
predicted to target MeCP2, which showed both decreased mRNA and protein levels. 
These finding suggest that, in addition to the immediate effect of alcohol on the 
developing fetus, there may also be an alcohol removal effect that alters 
neurodevelopment as well.  
In addition to mice, zebrafish have proved to be a useful model for studying PAE 
induced alterations to miRNA expression. Soares et al. found that ethanol upregulates 
several miRNAs in embryos with putative targets involved in cell cycle control, 
apoptosis, and transcription (Soares et al. 2012). Tal et al. observed the reciprocal 
deregulation of miRNAs and predicted target mRNAs, which are involved in brain 
morphogenesis (Tal et al. 2012). Notably, a knockdown of mir-9 or mir-153c 
phenocopied the PAE induced alterations to larval and juvenile swimming behaviour. The 
above zebrafish experiments provide strong evidence that alterations to miRNAs can 
result in PAE endophenotypes.  
Finally, miRNAs themselves may be regulated by other epigenetic marks altered 
by PAE. In 2013, Pappalardo-Carter et al. examined the role of mir-9 and related target 
gene expression in zebrafish embryos and mouse cortical neuroepithelial cells maintained 
as neurosphere cultures (Pappalardo-Carter et al. 2013). The group observed that mir-9 
was suppressed by alcohol and that a mir-9 knockdown in the zebrafish embryos 
produced similar craniofacial defects to PAE. Furthermore, there was increased CpG 
methylation at a mir-9 locus in the mouse cell line, which suggests an association 
between alterations to DNA methylation and alterations to miRNA expression.    
1.2.3. PAE Alters DNA Methylation at Specific Genomic Loci 
One of the most examined mechanisms of the epigenome is DNA methylation: a 
highly dynamic modification that is used to store additional information on nucleotides. 
The most widely studied DNA methylation mark is 5-methylcytosine (5mC). During 
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embryonic development, there are two waves of genome-wide DNA de-methylation 
(Seisenberger et al. 2013). The first follows the fertilization of the preimplantation 
embryo, and the second is during the establishment of primordial germ cells in the 
embryo that will go on to form sperm and oocytes. The first wave of DNA de-methylation 
retains genomic imprinting, and the second resets it. After the waves of de-methylation, 
methylation is established de novo, maintained across cell division, and also locally 
modified throughout development as cells become committed to their lineage (Hemberger 
et al. 2009). DNA methyltransferases (DNMTs) are an enzyme family capable of 
establishing and maintaining DNA methylation. In vertebrates, DNMTs are involved in 
establishing methylation at CpG dinucleotides and other sequences in the genome. CpG 
islands are a regulatory feature composed of greater than 50% GC content and range from 
300 to 3000 bp (Gardiner-Garden & Frommer 1987; Fatemi et al. 2005). When 
methylated, CpG islands typically result in the repression of gene expression and are seen 
in promoters or the first exon of ~40% of mammalian genes (Fatemi et al. 2005; Brenet et 
al. 2011). Furthermore, ~70% of human gene promoters have a higher CpG content than 
is expected when compared to the rest of the genome (Saxonov et al. 2006). Intragenic, or 
gene body, CpG islands may have a role as alternative tissue-specific promoters 
(Maunakea et al. 2010). Finally, CpG islands are also mutational hotspots due to the 
tendency of 5mC to spontaneously undergo deamination and mutate to thymine. Genome-
wide scans of CpG sites have revealed that CpG island shores, rather than CpG islands, 
may be the primary sites of normal tissue-specific differentially methylated regions 
(DMRs) (Yasui et al. 2007; Irizarry et al. 2009; Doi et al. 2009). CpG island shores are 
~250 bp in size, up to 2 kb away from a CpG island, and typically outside of gene 
promoters. DMRs in CpG island shores often show a strong inverse relationship with 
gene expression. CpG island shores are associated with developmental genes and are 
conserved across mice and humans. Additionally, there are CpG island shelves that are 
located 2-4 kb from a CpG island and also the open sea, which refers to genomic regions 
that show no significant CpG enrichment (Sandoval et al. 2011). Overall, DNA 
methylation is a widely used epigenetic mark in mammals and occurs at a number of 
distinct genomic features. 
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DNA methylation is the most studied marker for PAE induced epigenomic 
dysregulation (Haycock 2009). In 1991, Garro et al. observed that binge PAE exposure in 
pregnant mice resulted in global hypomethylation of fetal DNA (Garro et al. 1991). The 
group also observed that low levels of acetaldehyde, a metabolite of ethanol, were able to 
interfere with DNA methyltransferase activity in vitro. In 1999, Maier et al. found that 
PAE can result in increased methylation and decreased expression of brain-derived 
neurotrophic factor (Bdnf) in the developing olfactory bulb of rats exposed during the 
equivalent of the first two trimesters of human pregnancy (Maier et al. 1999). Together, 
the above two studies suggested that PAE alters DNA methylation. 
In 2009 Haycock & Ramsay examined the effect of PAE on genomic imprinting 
in pre-implantation mouse embryos by examining the H19 differentially methylated 
region (DMR) (Haycock & Ramsay 2009). They observed that while PAE embryos were 
severely growth restricted, hypomethylation of the paternal allele at this specific region 
was only detectable in the placenta. Genomic imprinting is an epigenetic process that 
utilizes DNA methylation and other marks to enable parent-of-origin specific monoallelic 
expression of genes related to growth and development. Ouko et al. examined the sperm 
of alcohol-consuming adult human men and found hypomethylation at the imprinted H19 
and Dlk1-Dio3 DMRs (Ouko et al. 2009). Thus, the above studies suggest that genomic 
imprinting is deregulated by PAE.  
Later in 2009, Liu et al. examined the genome-wide effects of ethanol in a B6 
whole embryo culture (Liu et al. 2009). Gene expression arrays and methylated DNA 
immunoprecipitation (MeDIP) arrays (MeDIP-Chip) revealed that genes of promoters 
with a high CpG content had decreased methylation and increased expression from binge 
exposure with an enrichment for genes on chromosomes 7, 10, and X. A 10-fold increase 
of methylation was observed on chromosomes 10 and X in exposed embryos with neural 
tube defects when compared to those without. The alterations to methylation were seen in 
a large number of genes associated with olfaction as well as genes involved development, 
chromatin, and genomic imprinting. The altered methylation was associated with changes 
in the expression of 84 genes. This study suggests that PAE induced alterations to 
methylation are not random. The findings also demonstrate that most genes showing 
 16 
significantly altered methylation do not show significantly altered expression when 
examined. 
A number of studies have examined the mechanism behind PAE induced 
alterations to DNA methylation. In 2010, Kaminen-Ahola et al. used the Agouti viable 
yellow (Avy) B6 mouse model, which provides a visual phenotype when methylation is 
altered at a single gene (Kaminen-Ahola, Ahola, Maga, et al. 2010). This revealed that 
voluntary maternal consumption of 10% alcohol causes hypermethylation. This study 
showed that PAE at the embryonic stage can result in a long-lasting alteration to DNA 
methylation. In 2011, Downing et al. examined methylation of the imprinted Igf2 locus in 
mouse embryos and observed a subtle ~8% decrease to methylation at a single CpG site 
with associated transcripts showing a -1.5 fold change (Downing et al. 2011). Notably, 
placing mothers on a methyl-supplemented diet attenuated some of the PAE 
endophenotypes. Later in 2011, Zhou et al. examined the effects of alcohol exposure on 
rat neural stem cell culture and found altered migration, neuron formation, and growth 
that was similar in an effect to the DNA methyltransferase inhibitor 5-aza-cytidine (Zhou, 
Balaraman, et al. 2011). During differentiation, it was found that alcohol exposure 
prevented the reprogramming of genes related to neurodevelopment, neuronal receptors, 
and olfaction. The specific sites showing altered methylation were correlated with 
transcription factors related to neurodevelopment. Overall, these studies link PAE 
induced differential DNA methylation to birth defects.  
Continuous maternal preference drinking also produces offspring with altered 
DNA methylation. In 2013, Chen et al. used immunostaining to visualize altered DNA 
methylation programming in the developing C57BL/6J mouse hippocampus (Chen et al. 
2013). In 2015, Marjonen et al. examined a voluntary maternal preference drinking model 
of PAE and found that early gestational alcohol exposure results in alterations to gene 
expression in the adolescent post-natal day (PND) 28 hippocampus, bone marrow, and 
main olfactory epithelium (Marjonen et al. 2015). The group observed gene expression 
changes related to olfaction, immune response, epigenetics (miRNAs and a histone), and 
two keratin associated proteins in the hippocampus. Genes showing differential 
expression belonged to similar families reported by Kleiber et al. in 2012, which analyzed 
some arrays generated for this thesis (Kleiber et al. 2012). Marjonen et al. also used 
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bisulfite sequencing and found alterations to DNA methylation in CpG islands upstream 
of some of the genes. Furthermore, magnetic resonance imaging (MRI) of post-natal day 
60 PAE adult mice revealed an enlargement of the left hippocampus and decreased 
volume of the left olfactory bulb. While the differential expression in the hippocampus 
was low and not possible to confirm by quantitative reverse transcription PCR (qPCR), 
some of the gene expression alterations identified by the gene expression array of the 
hippocampus were also confirmed in the bone marrow or main olfactory epithelium by 
qPCR. These observations suggest that differences present in adults with PAE are a long-
term result of earlier alterations in embryonic stem cell populations, which differentiate 
into a number of tissues and maintain some signature of developmental alterations.  
DNA methylation alterations induced by PAE are also transmitted 
transgenerationally. In 2012, Govorko et al. examined a rat model of continuous maternal 
preference drinking from GD7 to GD21. The group examined Pomc, a gene that produces 
multiple peptide hormones, and found that adult (PND60-80) F1 offspring had alterations 
in the hypothalamus, which is involved in stress reaction (Govorko et al. 2012; Sarkar 
2016). The neurons showed increased CpG methylation at the Pomc promoter, suppressed 
gene expression, and a resulting phenotype of altered stress response. Alterations to DNA 
and histone methyltransferase gene expression levels were also seen. The alterations to 
the methylation, expression, and function of Pomc were also found to be transmitted to 
both the F2 and F3 generations by the male germ-line with sperm showing alterations to 
Pomc methylation. These findings show that the DNA methylation alterations induced by 
PAE can transmit not only through mitosis but also meiosis.  
1.2.4. PAE May Alter the Epigenetic Landscape of 
Neurodevelopment  
PAE appears to alter a number of epigenetic marks in overlapping and distinct 
regions. The altered genes are enriched for functions related to cellular fate commitment 
events that occur during neurodevelopment. Thus, it appears that PAE results not only in 
immediate toxicity, but also creates distinct epigenotypes that may influence later 
developmental events. Conrad Waddington proposed the concept of the epigenotype 
(Waddington 2012), which led to his theory of canalization and the epigenetic landscape 
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(Waddington 1942; Bird 2007; Reik 2007). The epigenetic landscape is an abstract 
concept that describes the dynamic epigenomic profiles of stem cells during development. 
As cells differentiate, they become increasingly committed to certain lineages and are 
poised (or primed) at the epigenetic level for later events and certain responses 
(Waddington 1942; Lesch et al. 2013). The brain is highly dependent on the epigenome 
for neurodevelopmental processes (LaSalle et al. 2013). Developmental trajectories are 
also sensitive to the environment, where exposures may alter quality of life long after the 
initial exposure and immediate toxicology (LaSalle 2013). This effect appears to be due 
to an altered epigenetic programming related to future development that is continuing to 
exert an effect as well as a shift in vulnerable cell populations. Therefore, early life 
exposures may continue to exert an effect on adult hippocampal neurogenesis. One third 
of neurons in the hippocampus are subject to exchange over a lifetime, with annual 
turnover rate of 1.75% in the renewing fraction of adult humans that is also similar in 
mice (Spalding et al. 2013). Ultimately, the above suggests that some PAE 
endophenotypes may be maintained by long-term alterations from the initial exposure. 
Studies examining one-carbon metabolism have provided insight into how PAE 
initiates disruptions to DNA methylation, while also demonstrating the preventable nature 
of some long-term alterations. Alcohol exposure during embryonic development affects 
the transfer of folate from the mother to the developing embryo (Hutson et al. 2012). This 
is of significance to the developing embryo because folate is a methyl donor and essential 
in establishing and maintaining DNA methylation. The lack of folate has the potential to 
cause aberrant epigenetic profiles. Treatments that contain methyl donors, such as 
choline, have been able to attenuate some of the effects of PAE (Zeisel 2011). Of 
particular interest to this thesis is the observation that co-incubation of alcohol-exposed 
mouse embryos with folic acid, a synthetic form of folate, was able to prevent altered 
expression of a miRNA and  target gene (Wang et al. 2009). Such results argue that the 
alcohol-induced molecular cascade might involve DNA methylation. In 2013, Bekdash et 
al. examined the hypothalamus of adult offspring of a voluntary maternal consumption rat 
model and found a decrease in activating histone and an increase in repressive histone 
marks and DNA methylation (Bekdash et al. 2013). Furthermore, they observed increased 
methylation of the Pomc promoter and a decrease in Pomc mRNA expression. Notably, 
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these alterations could be attenuated with choline supplementation during PAE. Using the 
same model in 2014, Gangisetty et al. demonstrated a mechanistic role for MeCP2 in 
altering Pomc expression upon PAE (Gangisetty et al. 2014). Overall, these studies 
suggest that altered DNA methylation is mechanistically responsible for some PAE 
induced differential gene expression and that the prevention, or even potentially the 
reversal, of these alterations can attenuate some of the endophenotypes.  
Given the above observations, it appears that PAE can alter DNA methylation in 
specific regulatory sequences. For example, CTCF is a highly conserved ubiquitous 11-
zinc-finger protein with multiple functions in 3D chromatin organization and gene 
regulation, including chromatin insulator activity as well as transcriptional activation and 
repression (Williams & Flavell 2008). CTCF binds to a set of signal sequences that are 
sensitive to methylation (Filippova 2007) and mediates chromosomal interactions (Ling et 
al. 2006). There are over 100 000 CTCF-binding sites in the mouse genome (Shen et al. 
2012). CTCF-binding sites involved in the DMR of H19 have shown significant 
differential methylation in PAE placental tissue (Haycock & Ramsay 2009) and in the 
sperm of alcohol-consuming mice (Knezovich & Ramsay 2012). These results argue that 
the observed affect of PAE on gene expression may be caused by the effect of PAE on 
DNA methylation at specific regulatory sequences, which include imprinted regions. 
1.2.4.1. Genomic Imprinting  
 A number of studies of PAE have observed methylation changes occurring in genes 
that are known to be genomically imprinted (Liu et al. 2009; Shukla et al. 2011; Sittig et 
al. 2011; Dietz et al. 2012). Genomic imprinting enables parent-of-origin specific 
monoallelic expression of a select set of genes that are important in early development, 
particularly neurodevelopment (Kernohan & Bérubé 2010). These genes are crucial 
during not only neurodevelopment but also the normal functioning of the brain (Davies et 
al. 2008). Interestingly, ~30% of imprinted genes are hypothesized to be ncRNAs, 
including miRNAs (Morison et al. 2005). The above observations suggest that PAE is 
best explained as a sequence of events in response to ethanol that may begin with 
differential methylation of imprinted genes encoding for ncRNAs, which regulate gene 
expression. For example, moderate and voluntary maternal PAE alters adult levels of a 
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vesicular glutamate transporter in the mouse hippocampus (Zhang et al. 2015). This 
glutamate transporter showed increased mRNA levels that were correlated with decreased 
DNA methylation and increased (activating) H3K4me3 at the transporter promoter. 
However, while mRNA levels of the transporter were increased, the protein levels were 
decreased, which suggested post-transcriptional regulation. The discrepancy between 
mRNA and protein was found to be caused by the increase of an imprinted miRNA from 
the Sfmbt2 cluster and further functional experimentation showed that the miRNA binds 
to the 3’UTR of the transporter mRNA. This observation highlights the complexity of the 
interactions that shape the epigenetic landscape as well as their potential for disruption by 
PAE. Ultimately, it appears that the epigenetic landscape is one of the prime 
mechanism(s) for the long-term deregulation of brain gene expression following PAE. 
Yet the genome-wide details of this mechanism, particularly DNA methylation and 
ncRNA, have not been assessed. Also, perhaps more importantly, there remains the 
possibility that some of the epigenetic alterations observed in animal models are also 
present in children born with the clinical diagnosis of FASD. 
1.2.4.2. Systems Biology Approaches  
Given the interactive nature of the epigenetic landscape, single gene approaches do 
not capture the full complexity of alterations to the epigenome. The genome-wide 
analyses presented in this thesis make use of systems biology approaches. The genes 
identified are grouped in three ways. First, gene ontologies allow for genes to be grouped 
according to annotations of known functions and relationships across three categories: 
biological process, cellular component, and molecular function. Second, gene lists can 
also be assembled into associative genetic interaction networks, which are based on gene 
ontologies and other annotated or computationally predicted relationships. Finally, gene 
lists can be assembled into canonical protein pathways, which represent a generalized, 
linear, and well-studied cellular signaling pathway.  
Systems biology approaches can be based on the principles of independent 
component analysis (Lee & Batzoglou 2003). These approaches offer added insight to a 
series of observations from single genes with low-fold changes and borderline statistical 
significance by grouping them according to modular functions that show a significant 
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enrichment. A 1.2-fold change in many genes of a pathway could produce a biologically 
significant result that is comparable to a 20-fold increase in a single gene (Barabási & 
Oltvai 2004; Subramanian et al. 2005). Nevertheless, in a network, certain genes serve as 
hubs where they connect a large number of genes and can also allow for cross-talk 
between different cellular signaling events. An alteration to a hub can theoretically be 
more catastrophic than many similar alterations to a number of lesser connected nodes in 
the network. Overall, systems biology allows for the analysis of complex and large-scale 
alterations, which are typical of PAE.  
 
Hypothesis: Alterations to DNA methylation and ncRNA expression are associated with 
the long-term effect of prenatal alcohol exposure in (i) mice and (ii) humans with FASD. 
 
Objectives: 
1. To examine the differential epigenetic landscape associated with the long-term effects 
of PAE in adult mouse C57BL/6J brains by comparing to matched controls and 
assessing alterations in: 
a. gene expression using the Affymetrix GeneChip® Mouse Gene 1.0 ST array.  
b. miRNA expression using the Affymetrix GeneChip® miRNA 2.0 array. 
c. DNA methylation using the NimbleGen MM9 2.1M deluxe promoter array v2. 
2. To examine the association of PAE with DNA methylation in buccal swab DNA 
from children born with a diagnosis of FASD and compare to matched controls using: 
a. Illumina Infinium HumanMethylation450 BeadChips (450K) to assess 
genome-wide methylation changes. 
b. pyrosequencing confirmations of gene-specific CpG methylation differences.  
c. a targeted NGS bisulfite sequencing panel to confirm gene-specific CpG 
methylation differences. 
 
Thesis Organization: 
The results of this thesis are organized into three chapters. Chapter 2 describes an 
exploration of long-term alterations in a mouse model. Chapter 3 characterizes alterations 
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present in young human children with FASD. Chapter 4 presents a comparison of the 
alterations to DNA methylation in PAE mice and human children.  
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Chapter 2 
Exploration of Long-Term Alterations to the 
Epigenome of a PAE Mouse Model 
2.1 Overview 
This chapter examines the mechanisms initiating and maintaining the long-term 
effect of prenatal alcohol exposure (PAE) in a mouse (C57BL/6J) model of fetal alcohol 
spectrum disorder (FASD). The results presented include the long-term in vivo effects of 
PAE on brain: 1) Gene Expression, 2) microRNA (miRNA) and small nucleolar RNA 
(snoRNA) expression, and 3) DNA Cytosine Methylation. The three data sets from 
different treatment paradigms were integrated to reveal alterations to the epigenetic 
landscape of the whole brain of adult mice. The results show that PAE causes long-term 
epigenomic alterations and identify a comprehensive set of affected genes that have been 
independently implicated in endophenotypes related to Fetal Alcohol Spectrum Disorders 
(FASD). Ultimately, this chapter highlights an epigenomic hypothesis that may be 
applied towards understanding the developmental course of the effect of PAE. Most, but 
not all, of the results included in this chapter are already published in Laufer et al. 2013 
and some are published in Kleiber et al. 2012.  
2.2 Introduction 
Understanding how PAE results in the development of FASD presents a number 
of biological as well as ethical challenges. As it stands, most of the relevant experiments 
cannot be undertaken on humans. In order to address these challenges, the laboratory of 
Shiva Singh has established a C57BL/6J (B6) mouse model to examine the long-term 
effects of PAE across a number of exposure paradigms. In the binge exposure paradigms, 
mice were exposed to ethanol at specific developmental stages to model the first, second, 
or third trimester of human pregnancy (T1, T2, and T3) (Kleiber et al. 2013; Mantha et al. 
2014; Kleiber, Laufer, et al. 2014). It was found that PAE at any time during 
embryonic/fetal development results in delays to developmental milestones as well as 
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deficits in learning and memory (Mantha et al. 2013). The aforementioned mice were also 
reared to adulthood and showed differential brain gene expression in genes related to 
developmental events disrupted by PAE (Kleiber et al. 2013). The changes to expression 
were observed primarily in genes involved in cell proliferation (T1), cell differentiation 
and migration (T2), and neurotransmission and cellular communication (T3) (Kleiber, 
Diehl, et al. 2014). Thus, PAE primarily alters the expression of genes in a manner that 
depends on the developmental timing of exposure. While few of the genes were shared 
across paradigms, a much larger number are associated by gene families, ontologies, 
‘hubs’ in associative gene networks, and/or by canonical protein pathways. These results 
follow Green et al. (2007) who found changes in the expression of 2,906 genes in 
embryonic head folds 3 hours after a single binge injection on gestational day (GD) 8 
(Green et al. 2007). There was a significant down-regulation of KEGG pathways related 
to the ribosome and proteasome and also a significant up-regulation of pathways related 
to focal adhesion, adherens junction, tight junction, and regulation of actin cytoskeleton. 
They also observed that PAE altered the expression of a number of hub genes, some of 
which are involved in the PI3K/AKT/mTOR signaling pathway. Furthermore, Zhou et al. 
examined the effects of ethanol in a whole embryo culture of GD8 B6 mice and found 
changes in the expression of genes for alcohol metabolism, retinol metabolism, 
hematopoiesis, neurodevelopment, cell cycle, histones, cell adhesion, homeobox genes, 
and oncogenes (Zhou, Zhao, et al. 2011).  
Chronic and moderate exposures have been examined in a voluntary maternal 
continuous preference drinking (CPD) paradigm in B6 mice. The resulting PAE mice 
display relatively mild developmental delays, anxiety-related traits, and deficits in spatial 
learning (Kleiber et al. 2011). This treatment protocol has been previously shown by 
others to produce peak maternal blood alcohol concentrations of ~80–120 mg/dl (Allan et 
al. 2003; Boehm et al. 2008; Brady et al. 2012). The brains of adult PAE mice were also 
analyzed by gene expression arrays (Kleiber et al. 2012). Genes involved in embryonic 
and nervous system development showed subtle but consistent changes in expression. 
Furthermore, some of the genes identified have previously been associated with FASD-
relevant endophenotypes. Such genome-wide gene expression results following different 
PAE paradigms are now common in the literature and pose the next logical question: 
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What maintains changes in brain gene expression caused by PAE in B6 mice? One of the 
most logical mechanisms that may account for long-term changes in gene expression are 
ethanol induced changes to epigenetic marks. Epigenetic marks maintain gene expression 
profiles without altering DNA sequence and are heritable in dividing cells. Epigenetic 
marks are involved in gene regulation at two distinct levels. The first occurs at the level 
of transcription, which is mainly accomplished by chromatin modifications, such as DNA 
methylation and histone post-translational modifications (Métivier et al. 2008). To this 
end DNA methylation has become among the most studied of such processes because of 
the relative ease and effectiveness of analytic technology. Furthermore, the second level 
of epigenetic regulation may be achieved post-transcriptionally by miRNAs and allows 
for the fine-tuning of gene expression (Moazed 2009). miRNAs are key regulators of 
eukaryotic gene expression that act via translational repression and mRNA decay 
(Friedman et al. 2009). The two aforementioned levels of epigenetic regulation are 
particularly crucial during embryonic development, where changes to the epigenome are 
critical in ongoing differentiation (Monk et al. 1987; Howlett & Reik 1991).  
It is logical to argue that epigenetic mechanisms may provide the foundation for 
long-term alterations in gene expression and behavioral outcomes by ethanol’s direct 
effect on epigenetic features, particularly DNA methylation (Garro et al. 1991; Haycock 
2009; Kobor & Weinberg 2011). Such a hypothesis is backed by a number of independent 
and unrelated reports. For example, Liu et al. examined a whole embryonic culture of B6 
mice at early neurulation (Liu et al. 2009). They observed alterations to methylation in 
genes involved in development and chromatin organization as well as in genes regulated 
by genomic imprinting (Igf2r and Ube3a). Furthermore, Kaminen-Ahola et al. examined 
the Agouti viable yellow (Avy) B6 mouse model and found that continuous maternal 
preference drinking of 10% alcohol from GD0.5 to GD8.5 results in hypermethylation of 
the metastable epiallele, as well as postnatal craniofacial and growth defects in congenic 
PAE siblings. (Kaminen-Ahola et al. 2010). This study demonstrated that PAE during 
embryogenesis results in a long-term alteration to DNA methylation at a specific locus.  
The transcriptional alterations induced by PAE are not limited to protein-coding 
genes. Interestingly, they also include miRNA expression (Miranda 2012). Sathayan et al. 
examined the effect of alcohol exposure on miRNA expression in GD12.5 B6 
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neurosphere cultures (Sathyan et al. 2007). It was observed that high and low ethanol 
doses alter different miRNAs. The target genes were generally involved in apoptosis and 
the cell cycle. Furthermore, Wang et al. showed that PAE induces altered expression of 
mir-10a and its target gene Hoxa1 (Wang et al. 2009). Co-incubation of alcohol-exposed 
mouse embryos in folic acid, which is involved in establishing DNA methylation, 
prevented the alteration to miRNA and target mRNA. Such observations suggest that 
altered DNA methylation has the potential to directly or indirectly alter the expression of 
a specific set of miRNAs underlying PAE induced alterations to gene expression.  
Genomically imprinted genes typically utilize differential DNA methylation at an 
imprinting control region (ICR) and studies have observed PAE induced alterations to 
imprinted genes (Liu et al. 2009; Shukla et al. 2011; Sittig et al. 2011; Dietz et al. 2012). 
Approximately 30% of genomically imprinted genes are hypothesized to be ncRNAs, 
including miRNAs (Morison et al. 2005). In the placenta, PAE was shown to induce 
alterations to DNA methylation at CTCF-binding sites within the differentially 
methylated region (DMR) of the imprinted gene H19 (Haycock & Ramsay 2009). 
Genomic imprinting has been further examined in mouse embryos, where Downing et al. 
observed a ~8% decrease to methylation at a single CpG site in the imprinted Igf2 DMR 
(Downing et al. 2011). Furthermore, associated transcripts showed a -1.5 fold change in 
gene expression. These observations were also extended mechanistically by placing 
mothers on a methyl-supplemented diet, which ameliorated some of the PAE 
endophenotypes. The above and related observations in the literature suggest that PAE 
may alter DNA methylation and thus suppress transcriptional machinery by altering the 
binding sites of a number of transcription factors. Based on these observations, I 
hypothesize that large-scale alterations to the epigenome, which may be initiated by PAE, 
occur in functional sites and maintain the observed long-term alterations to gene 
expression and behaviour that underlie FASD.  
In this chapter, I present comprehensive epigenomic results from four paradigms 
of PAE. These include continuous preference drinking (CPD) by pregnant B6 mothers as 
well as injections (binge) during the B6 equivalent of the first (T1), second (T2), or third 
(T3) trimester of human pregnancy. The results are used to develop a generalized 
mechanism for alterations to gene expression and behaviour associated with PAE/FASD. 
 37 
Specifically, the results identify long-term changes in DNA methylation, ncRNA, and 
mRNAs in the adult brain resulting from multiple PAE paradigms in B6 mice. The results 
of this chapter ultimately offer novel insights into the mechanisms maintaining FASD 
endophenotypes and may also be used towards translating rodent model research to 
human FASD studies. 
2.3 Materials & Methods 
The methodologies and workflow for the B6 mouse model are overviewed in 
Figure 2.1. The PAE paradigms utilized in this research relied on an established model 
for CPD (Kleiber et al. 2011) and three established binge injection paradigms (Mantha et 
al. 2013). The brains of the ethanol exposed and matched control animals were collected 
on post-natal day (PND) 70.   
2.3.1 Mice 
Male and female B6 mice were originally obtained from Jackson Laboratories 
(Bar Harbor, ME) and maintained at the Health Sciences Animal Care Facility at the 
University of Western Ontario (London, Ontario, Canada). The studies followed 
Canadian Council of Animal Care guidelines and approved by the Animal Use 
Subcommittee of the University of Western Ontario (Appendix K). All mice were 
housed in standard cages at 21–24°C with 40–60% humidity at a 14-hour light/10-hour 
dark cycle with access to food and water ad libitum. Virgin females of 8 weeks of age 
were time-mated and assessed for pregnancy based on the presence of vaginal plugs 
(GD0). Pregnant females were transferred to individual cages during gestation. The 
individual females were exposed to ethanol or control using different treatment paradigms 
involving binge injections or continuous preference drinking by pregnant females. The 
resulting offspring were weaned on PND21 and housed in cages with two to four same-
sex littermates. Only male offspring were used for all experimentation described in this 
research. 
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2.3.1.1 Chronic Alcohol Treatment of Pregnant Females by 
Continuous Preference Drinking (CPD) 
Female mice were placed in individual cages, where they were acclimated to 
increasing concentrations of ethanol (towards a final of 10%) diluted in water, alongside 
freely available drinking water, for 2 weeks to establish a stable drinking pattern 
previously described by Kleiber and Wright (Kleiber et al. 2011; Kleiber et al. 2012). The 
female mice were then time-mated, where they had only access to water, and once the 
male was removed the ethanol was replaced to ensure exposure from GD0 to PND10. 
Control dams had access to water only. Voluntary maternal alcohol consumption and 
water consumption were measured daily from GD0 to PND10 for each female at 10:00 
AM. Resulting pups, both alcohol-exposed and matched controls, were weaned at PND21 
and housed in same-sex colony cages of two to four mice until PND70. These mice were 
raised and assessed by Ben Laufer & Eric Diehl. 
2.3.1.2 Binge Alcohol Treatment of Pregnant Females by Acute 
Injections  
The binge exposure models used in this thesis were established by Kleiber and 
Mantha (Mantha et al. 2013; Kleiber et al. 2013). Pregnant dams were subcutaneously 
injected with two 2.5 g/kg body weight doses of ethanol in 0.15 M saline (alcohol-treated) 
spaced 2 hours apart (at 0 hours and 2 hours), or with saline alone (control), at GD8 and 
GD11 (trimester 1; T1) or GD14 and GD16 (trimester 2; T2) (Ikonomidou et al. 2007; 
Mantha et al. 2014). Control and alcohol-treated dams were age- and weight-matched. 
Given that the third trimester human equivalent occurs postnatally in mice (Dobbing & 
Sand 1979), a binge exposure during this neurodevelopmental period was modeled by 
treating pups on PND4 and PND7 via subcutaneous injection (trimester 3; T3) (Kleiber, 
Laufer, et al. 2014). In this model, pups from one litter were matched across treatment 
groups for sex and weight to control for litter effects. Injections represented two doses of 
2.5 g/kg body weight spaced 2 hours apart with matched controls receiving 0.15 M saline. 
All resulting offspring were weaned on PND21 and housed in cages with two to four 
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same-sex littermates. T1 & T2 mice were raised by Katarzyna Mantha and the T3 mice 
were raised by Morgan Kleiber.  
2.3.1.3 Tissue Collection and Nucleic Acid Isolation  
Alcohol-treated and matched control adult males (PD70) resulting from the four 
treatment paradigms (n=12 per paradigm with six alcohol-exposed and six matched 
controls) were sacrificed using CO2 and cervical dislocation. Whole brains were 
extracted, snap frozen in liquid nitrogen, and stored at −80°C until RNA and DNA 
isolation. Whole-brain total RNA was isolated from frozen tissues using TRIzol® 
Reagent (Invitrogen, Carlsbad, CA), purified using the RNeasy® Mini Kit (QIAGEN, 
Valencia, CA), and quantified using a NanoDrop ND-1000 spectrophotometer (Thermo 
Fisher Scientific Inc., Wilmington, DE). Total RNA quality was assessed using the 
Agilent 2001 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA). Further, whole 
brain DNA was isolated from the interphase layer of TRIzol using sodium citrate, 
followed by ethanol precipitation and purification using the QIAamp® DNA Micro Kit 
(QIAGEN, Valencia, CA). DNA was then quantified using a NanoDrop ND-1000 
spectrophotometer (Thermo Fisher Scientific Inc., Wilmington, DE) and all samples had 
OD260/OD280 nm ratios of 1.8–2.0 and OD260/OD230 nm ratios of 2.0–2.4.  
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Figure 2.1. Flowchart of workflow used to analyze different exposure paradigms.  
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2.3.2 RNA Analysis 
The RNA studies included in this thesis investigate both coding and non-coding 
RNAs. These studies relied on RNA isolated from the same mice and were used for 
hybridization on Affymetrix GeneChip® Mouse Gene 1.0 ST arrays and Affymetrix 
GeneChip® miRNA 2.0 arrays respectively. The RNA expression analysis primarily 
examined the CPD PAE paradigm (3 arrays with samples pooled in duplicate); however, 
the binge injection paradigms were also examined (2 arrays with samples pooled in 
triplicate). 
2.3.2.1 Gene Expression Arrays 
Affymetrix gene expression arrays are single channel arrays that have proved 
useful for the study of ethanol exposure in mice (Kerns & Miles 2008). The Affymetrix 
GeneChip® Mouse Gene 1.0 ST array (Affymetrix, Santa Clara, CA) consists of 770,317 
unique 25-mer perfect match probes that are targeted across 28,853 transcripts, with 
1,305 of those being ncRNA, and an average of 27 probes for a gene.  
The Affymetrix GeneChip® Mouse Gene 1.0 ST array was used to analyze PAE 
induced alterations to gene expression. Single-stranded complementary DNA (sscDNA) 
was prepared from 200 ng of total RNA as per the Ambion WT Expression Kit for 
Affymetrix GeneChip Whole Transcript WT Expression Arrays (Applied Biosystems, 
Carlsbad, CA) and the Affymetrix GeneChip WT Terminal Labeling kit and 
Hybridization User Manual (Affymetrix, Santa Clara, CA). Total RNA was first 
converted to complementary DNA (cDNA), followed by in vitro transcription to make 
cRNA. By subjecting the cDNA to a cRNA conversion, a biotinylated Uracil analogue is 
incorporated. The biotin molecules can then be used to attach fluorescent molecules to 
label the cRNA. Subsequently, 5.5 µg of sscDNA was synthesized, end-labeled, and 
hybridized for 16 hours at 45°C to Mouse Gene 1.0 ST arrays. GeneChip Fluidics Station 
450 performed all liquid handling steps, and GeneChips were scanned with the GeneChip 
Scanner 3000 7G using the Command Console v1.1 (Affymetrix, Santa Clara, CA). All 
hybridizations were performed at the London Regional Genomics Centre at the Robarts 
Research Institute, University of Western Ontario. Probe level (.CEL file) data were 
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generated using the Affymetrix Command Console v1.1. The .CEL files identify 
intensities of individual probes.  
Probes, which have multiple replicates and target exons, were assembled into 
probesets that represent single genes. This summarization of the .CEL files was done in 
Partek Genomics Suite v6.5 (Partek Inc., St Louis, MO) by quantile normalization using 
the RMA algorithm adjusted for GC content and log2-transformed (Irizarry et al. 2003). 
Partek software was then used to determine gene level one-way ANOVA p-values and 
fold changes. All arrays were analyzed by using a 1.2-fold cut-off with a significance 
threshold of p=0.05 to generate a list of genes of interest to be assessed further using 
bioinformatic analysis of gene ontologies and pathways. The gene expression array 
results for the T1, T2, T3, and CPD paradigms were deposited within the NCBI GEO 
database under accessions GSE34469 (T1 & T2), GSE34549 (T3) and GSE34305 (CPD, 
experiment 2). The data from CPD mice were generated by Ben Laufer, T1 & T2 mice by 
Katarzyna Mantha, and T3 mice by Morgan Kleiber.  
2.3.2.2 miRNA Expression Arrays 
The Affymetrix GeneChip® miRNA 2.0 array is based on a similar design as the 
Affymetrix GeneChip® Mouse Gene 1.0 ST array, and has probes that are 25-mer. 
However, smaller probes are used if the miRNA is less than 25 bases. The miRNA array 
targets 722 mouse mature miRNAs, 690 mouse pre-miRNA, and 2,334 small RNAs from 
humans that include snoRNAs. It also has 9 probes per a probe set for a miRNA. The 
workflow is also similar to Affymetrix GeneChip® Mouse Gene 1.0 ST arrays.  
In order to investigate the effect of PAE on miRNAs, all samples were analyzed at 
the London Regional Genomics Centre (Robarts Research Institute, London, Ontario) 
using Affymetrix miRNA 2.0 arrays. Briefly, 1 µg total RNA from each treatment 
paradigm was labeled using the Flash Tag Biotin HSR kit (Genisphere, Hatfield, PA) and 
hybridized to Affymetrix miRNA 2.0 arrays for 16 hours at 45°C. Probe level (.CEL file) 
data were generated using Affymetrix Command Console v1.1. Probes were summarized 
to gene level data in Partek Genomics Suite v6.6 (Partek Inc., St Louis, MO) by using the 
RMA algorithm (Irizarry et al. 2003). Partek software was used to determine differences 
between control and ethanol-treated samples by a one-way ANOVA and corresponding 
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P-values and fold changes. For each treatment model, the miRNAs present on this array 
were filtered using stringency criteria of 1.2-fold change (p<0.05) and subjected to a 
hierarchical clustering analysis by using Euclidean distance and average linkage to assess 
consistency in ethanol response between the arrays of different treatment paradigms. The 
miRNA expression array results for all treatment protocols were deposited within the 
NCBI Gene Expression Omnibus (GEO) database under accession GSE34413. Analyses 
of CPD mice were performed by Ben Laufer, T1 & T2 mice by Katarzyna Mantha and 
Ben Laufer, and T3 mice by Morgan Kleiber and Ben Laufer. 
2.3.2.3 Quantitative PCR Confirmation 
The quantitative polymerase chain reaction (qPCR) allows for real-time 
quantification of DNA amplification by optically measuring fluorescent dyes after laser 
excitation (Fraga et al. 2008). Taqman® is a methodology that utilizes sequence-specific 
oligonucleotide probes attached to both a fluorophore and a quencher molecule, which 
prevents fluorescence. During qPCR, the probe will hybridize to complementary DNA 
and will then be degraded by Taq polymerase, which releases the fluorophore from the 
quencher and allows it to be detected after excitation. qPCR technology can also be 
coupled with reverse transcription (RT) to enable the study of both coding and non-
coding RNA expression.  
In order to confirm gene expression results, cDNA was reverse transcribed from 
whole-brain RNA of the CPD paradigm (n=6) and matched controls (n=6). For mRNA 
expression, cDNA was created using Applied Biosystems High-Capacity cDNA Reverse 
Transcription Kit (Foster City, CA) and sequence specific TaqMan™ assays (Foster City, 
CA), which were used according to the manufacturer’s protocol. For miRNA expression, 
the Applied Biosystems TaqMan™ MicroRNA Reverse Transcription Kit (Foster City, 
CA), which uses stem-loop reverse transcription primers (Chen et al. 2005), and sequence 
specific TaqMan™ MicroRNA Assays (Foster City, CA) were used according to the 
manufacturer’s protocol. All TaqMan™ probes were selected using the Applied 
Biosystems (Carlsbad, CA) search engine to identify previously characterized TaqMan™ 
assays. GAPDH was chosen as an endogenous control for mRNA expression, while 
snoRNA 202 was chosen as an endogenous control for miRNA expression (Gao et al. 
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2010). The target and control reactions were run in separate tubes on the same plate for 
each sample as per the manufacturer’s protocol. Three technical replicates were averaged 
for both the endogenous control and gene of interest for each sample. qPCR reactions 
were performed on the Applied Biosystems StepOne™ Real-Time PCR System 2.0 
according to the manufacturer’s protocol. Fold change was calculated using the ΔΔCt 
method (Schmittgen & Livak 2008). The ΔΔCT method allows for relative quantification 
of gene expression from qPCR experimentation. CT is the threshold cycle, which is the 
PCR cycle where fluorescence exceeds a threshold value. The ΔΔCT method compares 
CT’s for an experimental gene to a reference gene across both the experimental and 
control group. The results were analyzed using Applied Biosystems DataAssist™ 
Software v3.0. Statistical significance was assessed by an unpaired Student’s t-test. 
2.3.2.4 Bioinformatic Analysis of Differentially Expressed Probe 
Sets (mRNAs and miRNAs) 
The chromosomal locations for all miRNAs were determined by using miRBase 
and Ensembl (Flicek et al. 2011; Kozomara & Griffiths-Jones 2011). Genomically 
imprinted regions were identified by the mouse imprinting catalog 
(www.mousebook.org).  
Data from the CPD paradigm were analyzed through the use of Ingenuity® 
microRNA target filter [Ingenuity® Systems (www.ingenuity.com)] to generate lists of 
interactions between genes and miRNAs of interest from the TargetScan Human database 
(mouse was not available at the time). Results were filtered based on a moderate or high 
confidence of interaction (Lewis et al. 2005; Vergoulis et al. 2012), brain specificity, and 
an inverse miRNA to target mRNA expression relationship. miRNAs were filtered based 
on a 1.15 fold change and a p<0.3 cut-off. This analysis is referred to as the original 
(2012) analysis. 
At a later date, updated (2016) annotations and improved software became 
available for the gene expression and miRNA arrays. These updates offered some 
improvement and thus were utilized for a re-analysis. Enrichr was used for biological, 
cellular, and molecular ontologies (Chen et al. 2013). Partek Pathways was used for 
canonical KEGG pathways. Gene annotations were obtained from UniProt (UniProt-
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Consortium 2014). An updated and more stringent (1.2 fold change, p<0.05) miRNA 
target filter analysis was done in Partek using Mouse TargetScan 6.2. This analysis is 
referred to as the updated (2016) analysis. 
2.3.3 DNA Analysis 
 The DNA studies included in this thesis investigate DNA cytosine methylation. 
These studies relied on DNA isolated from the same CPD mice used for RNA analysis.  
2.3.3.1 DNA Methylation (MeDIP-Chip) Arrays 
The DNA methylation analysis of the mice utilized MeDIP-Chip tiling arrays of 
promoter regions and analyzed the CPD PAE paradigm. The NimbleGen MM9 2.1M 
deluxe promoter array v2 is a two channel array that contains 2.1 million 50-75mer 
probes that utilize methylated DNA immunoprecipitation (MeDIP) and a tiling approach 
to examine DNA methylation. MeDIP involves enriching for 5mC with an antibody to 
immunoprecipitate ~500 bp fragments with the mark (Weber et al. 2005; Mohn et al. 
2009). In MeDIP-Chip, the MeDIP reaction is then coupled to a microarray chip, where 
the enriched DNA is labelled green with Cy3 and the input sample from before 
enrichment is labelled red with Cy5. The deluxe promoter array tiles approximately 8.2 
kb upstream and 3 kb downstream all 22,425 MM9 mouse gene promoters, 20 kb 
upstream of 510 mature miRNA transcripts, 16,002 CpG islands, and other biologically 
relevant sites identified from ENCODE. It also includes positive, negative, and non-CpG 
control sites. MeDIP-Chip allows for a relative level of methylated DNA enrichment to 
be analyzed by bioinformatic algorithms, which can determine differentially methylated 
regions (DMRs). However, MeDIP-Chip does not offer single nucleotide resolution, as 
the lower detection limit is 2 methylated CpG sites per a DNA fragment. Previous 
versions of this array have been used successfully in PAE rodents embryos and 
candidates were confirmed using Sequenom EpiTYPER DNA methylation analysis (Liu 
et al. 2009; Zhou, Balaraman, et al. 2011). 
In order to examine PAE-induced alterations to genome-wide DNA methylation 
by MeDIP-Chip, equal amounts of brain DNA from two non-littermate males from the 
CPD paradigm were pooled per biological replicate (n=3) to reduce potential litter effects. 
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All methylated DNA immunoprecipitation (MeDIP), sample labeling, hybridization and 
processing were performed at Arraystar Inc. (Rockville, MD). Briefly, genomic DNA was 
sonicated to 200- to 1000-bp fragments followed by immunoprecipitation of methylated 
DNA using Biomag™ magnetic beads coupled to mouse monoclonal antibody against 5-
methylcytidine (Diagenode). The DNA was eluted, whole genome amplified, and 
purified. The total input and immunoprecipitated DNA were labeled with Cy3- and Cy5-
labeled random 9-mers, respectively, and hybridized to the NimbleGen MM9 DNA 
Methylation 2.1M Deluxe array (Roche NimbleGen Inc., Madison, WI). Scanning was 
performed with the Axon GenePix 4000B microarray scanner. 
Raw data from three arrays were extracted as pair-files by NimbleScan software 
(Roche NimbleGen Inc.). Median-centering, quantile normalization, and linear smoothing 
by Bioconductor packages Ringo, limma and MEDME were performed to generate 
normalized log2-ratio data. From the normalized log2-ratio data, a sliding-window peak-
finding algorithm provided by NimbleScan v2.5 (Roche NimbleGen Inc.) was applied to 
find the enriched peaks with specified parameters (sliding window width: 750 bp; mini 
probes per peak: 2; maximum spacing between nearby probes within peak: 500 bp). The 
identified peaks were mapped to genomic features: transcripts and CpG Islands. The MA 
plots and box-plots were applied to assess the quality of raw data and effect of 
normalization. A correlation matrix was used to describe correlation among replicate 
experiments. 
To compare differentially enriched regions between ethanol-exposed (E) and 
matched control (C) mice, the log2-ratio values were averaged and then used to calculate 
the M′ value [M′=Average(log2 MeDIPE/InputE) – Average(log2 MeDIPC/InputC)] for 
each probe. The NimbleScan sliding-window peak-finding algorithm (Scacheri et al. 
2006) was run on the data to find the differential enrichment peaks (DEPs). The 
differential enrichment peaks, called by the NimbleScan algorithm, were filtered 
according to the following criteria: (i) at least one of the two groups had the median value 
of log2 MeDIP/Input ≥0.3 and a median value of M′ >0 within each peak region; (ii) at 
least half of the probes in a peak had the median value of coefficient of variability (CV) 
≤0.8 in both groups within each peak region. 
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Using an R script, a hierarchical clustering analysis was completed. The probe 
data matrix was obtained by using PeakScores from DMRs selected by DEP analysis. 
‘PeakScore’ is a measure calculated from the P-values of the probes within the peak and 
reflects the significance of the enrichment. This analysis used a ‘PeakScore’ ≥2 to define 
the DEPs by using the NimbleScan sliding-window peak-finding algorithm. The peak 
score is a –log10 transformed P-value, which is the average of the P-values for all probes 
within the peak. Therefore, a ‘PeakScore’ ≥2 means the average P-value was ≤0.01. This 
analysis is referred to as the original (2012) analysis.  
For the purpose of comparing more directly to the next chapter of this thesis an 
updated analysis of the methylation data was also later carried out using Partek Genomics 
Suite Version 6.6. While Partek had gained some capability to analyze the methylation 
array from raw scans in 2016, it was only under limited support and not fully featured. 
This analysis is referred to as the updated (2016) analysis.  
For the updated (2016) analysis, the 635 nm and 532 nm scans (.pair files) were 
analyzed in Partek Genomics Suite Version 6.6 and normalized using the default settings 
for the tiling workflow. An ANOVA was used to analyze each probe and then the model-
based analysis of tiling-arrays (MAT) algorithm (Johnson et al. 2006) was used to detect 
differentially methylated regions (DMRs). The DMRs were then annotated to genes if 
they occurred in the gene body or were 5000 bp to -3000 bp from the transcriptional start 
site. The list of genes overlapping DMRs with a MAT p-value of <0.005 was used for 
bioinformatic analysis. The software was not able to produce a proper principle 
components analysis, heatmaps, or fully present sequence annotations. Thus, the updated 
(2016) analysis is presented in addition and as complement to the original (2012) 
analysis. 
2.3.3.2 Bioinformatic Analysis of Differently Methylated Genes 
For the original (2012) analysis, the top gene promoters identified from the DNA 
methylation arrays were subjected to Ingenuity Pathway Analysis. The genes 
corresponding to all previously identified significantly affected promoters were subjected 
to an Ingenuity Core Analysis. The Ingenuity Knowledge Base (genes only) was used to 
examine direct and indirect relationships. Results were filtered to consider only molecules 
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and/or relationships specific to species (mouse, rat, or human) and tissues (nervous 
system). From the identified ‘Behavior, Neurological Disease, and Psychological 
Disorders’ network, 30 significantly differentially methylated peaks belonging to 
different regions of the promoters of hub genes were examined for CTCF-binding sites 
using the CTCFBS prediction tool (Bao et al. 2008). The genes identified as having 
CTCF-binding sites were then subjected to a pathway analysis using GeneMANIA 
(Warde-Farley et al. 2010). Gene annotations were obtained from UniProt (UniProt-
Consortium 2014). For the updated (2016) analysis, Enrichr (Chen et al. 2013) was used 
for ontologies and Partek Pathways for canonical pathways.  
2.4 Results 
2.4.1 Differential Gene (mRNA) Expression  
The first set of experiments in this chapter identified alterations to gene expression 
in CPD PAE brains at PND70 using Affymetrix GeneChip® Mouse Gene 1.0 ST arrays. 
Principle component analysis (PCA), which examines total signal from the arrays, 
correctly distinguishes CPD PAE mice from matched controls (Figure 2.2). After 
filtering, there were 783 significantly (p<0.05) altered (fold-change cut-off of 1.2) 
transcripts. A heatmap of the significant alterations distinguishes CPD from matched 
controls and illustrates that the majority of differentially expressed transcripts are up-
regulated by PAE at this level of filtering (Figure 2.3). Notably, 456 of the differentially 
expressed transcripts were ‘housekeeping’ internal control exons and introns that did not 
have available annotations. Furthermore, 31 of the differentially expressed transcripts 
were miRNAs and 116 transcripts were largely unannotated expressed sequences 
identified by consortiums, with most having no predicted protein function. The top 
differentially expressed transcripts with a gene symbol are presented in Table 2.1. The 
269 genes annotated with symbols were analyzed with Enrichr for gene ontologies and 
Partek pathways identified several altered canonical pathways (Table 2.2).  
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Figure 2.2. PCA analysis of gene expression arrays from CPD PAE (red) and matched 
control (blue) adult brains. Each point represents a single array and ellipsoids have been 
placed around groups to allow for visual clustering. 
 
-250-204-159
PC #3 17.2%
-69-252065110155
-250
200-230
-114
-206
-163
-120
-77
PC
 #2
 22
.2%
-35
137
180
8
51
94
Attribute
Alcohol
Control
190148106
PCA Mapping (71.6%)
-187 -145 -103 -61
PC #1 32.2%
-20 22 64
 50 
 
Figure 2.3. Heatmap of significant (p<0.05) differential (fold change cut-off 1.2) gene 
expression in CPD PAE and matched control adult brains. The expression (intensity) of 
each gene (probe set) is normalized by being standardized to a mean of 0 and a standard 
deviation of 1. Genes with no change are displayed with a value of zero (grey), 
upregulated genes have a positive value (red), and down-regulated genes have negative 
values (blue).  
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Table 2.1. Top differentially-expressed transcripts in CPD adult mouse brains that were annotated with a gene symbol. 
PAE Upregulated 
  Fold Change p-value Symbol Gene Name Gene Function 
1.9 0.002 Gm26315 Unknown Unknown 
1.8 0.027 Gm10115 Unknown Unknown 
1.6 0.022 AY512949 Unknown Unknown 
1.6 0.004 Gm16498 Unknown Unknown 
1.6 0.002 Gm22260 Unknown ncRNA 
1.6 0.010 Gm10304 Unknown Expressed in adult male diencephalon 
1.5 0.014 Gm23422 Unknown ncRNA 
1.5 0.038 Gm22951 Unknown ncRNA 
1.5 0.009 9330155M09Rik Unknown Expressed in adult male hypothalamus 
1.5 0.017 Prp2 Proline rich protein 2 Secreted Protein 
PAE Downregulated   
Fold Change p-value Symbol Gene Name Gene Function 
-1.4 0.0126 Mrpl46 39S ribosomal protein L46, mitochondrial Mitochondrial translational regulation 
-1.3 0.0386 Prg4 Proteoglycan 4 Skeletal and cartilage development 
-1.3 0.0002 Nuak1 NUAK family SNF1-like kinase 1 Cell Adhesion and DNA Damage 
-1.3 0.0377 Vmn1r-ps77 Vomeronasal 1 receptor, pseudogene 77 Pheromone receptor pseudogene  
-1.3 0.0031 Zfp518a Zinc finger protein 518A Transcriptional Regulation 
-1.3 0.0427 Ucma Unique cartilage matrix-associated protein Skeletal and cartilage development 
-1.3 0.0035 Ssna1 Sjoegren syndrome nuclear autoantigen 1 Cytoskeleton and Cell Cycle 
-1.3 0.0087 Phkg2 Phosphorylase b kinase gamma catalytic chain Neural and hormonal regulation of glycogen breakdown 
-1.3 0.0080 Cldn1 Claudin-1 Cell Adhesion 
-1.3 0.0002 Serping1 Plasma protease C1 inhibitor Complement and coagulation cascade [Immune Process]  
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Table 2.2. Ontologies and pathways for differentially-expressed genes (p<0.05, and a 
fold-change cut-off of 1.2) from CPD adult mouse brains. 
Enrichr GO Biological Processes  Overlap p-value 
Regulation of complement activation  3/27 2.6E-04 
Regulation of protein activation cascade  3/29 3.2E-04 
Dendritic spine morphogenesis  2/8 7.6E-04 
Regulation of humoral immune response  3/45 1.1E-03 
Regulation of cell communication by electrical coupling  2/10 1.1E-03 
Dendritic spine organization  2/13 1.7E-03 
Aging  5/204 1.8E-03 
Enrichr GO Cellular Location Overlap p-value 
Extracellular space  15/1120 1.7E-04 
Blood microparticle  4/161 7.3E-03 
Voltage-gated calcium channel complex  2/38 1.5E-02 
Platelet alpha granule lumen  2/48 2.3E-02 
Chloride channel complex  2/50 2.4E-02 
Outer membrane  3/137 2.8E-02 
Serine/threonine protein kinase complex  2/56 3.0E-02 
Enrichr GO Molecular Function Overlap p-value 
Solute:cation antiporter activity  2/28 6.8E-03 
Peptidase activator activity  2/37 1.1E-02 
Peptidase regulator activity  4/209 1.2E-02 
Hormone activity  3/122 1.5E-02 
Growth factor binding  3/123 1.5E-02 
Nucleotidyltransferase activity  3/140 2.1E-02 
Antiporter activity  2/62 2.9E-02 
Partek KEGG Pathways Overlap  p-value 
Complement and coagulation cascades 5/71 3.2E-03 
Purine metabolism 7/171 9.1E-03 
Taste transduction 4/59 9.5E-03 
Prion diseases 3/31 1.0E-02 
Pyrimidine metabolism 5/99 1.2E-02 
Antigen processing and presentation 4/72 1.8E-02 
Ribosome 5/133 3.6E-02 
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Prenatal ethanol induced mRNA (Pnet-ps) was the most significant (p=0.0001) 
differentially expressed (1.2 fold increase) gene in the CPD model. Pnet-ps was also 
significantly up-regulated in the T1 model (1.3 fold change, p=0.003) (Kleiber et al. 
2013). Pnet-ps is a pseudogene that appears to be a lncRNA. However, the biological 
function and genomic properties remain a mystery as there is only one report that used 
subtractive hybridization, which is a technique able to detect novel transcripts. In that 
report four transcripts were examined in the neural tube of mouse embryos 1 hour after 
ethanol treatment (Du & Hamre 2003). While three of the genes detected were previously 
annotated, one novel transcript (Pnet-ps) was detected and showed a seven-fold increase 
in expression in ethanol-treated embryos. This expression was found to be induced in 
PAE embryonic brains and also possibly present at a low level in control hearts. In this 
chapter, both the CPD and T1 models showed a subtler increase; however, the 
observation demonstrates that a transcript which shows highly increased expression 1 
hour after PAE is still altered in the same direction 70 days later in the adult brain.  
Trdn was the only protein coding gene to be altered across all exposure 
paradigms. It showed a significant (p<0.05) 1.3, -1.6, -2.2, and 1.2 fold change in the T1, 
T2, T3, and CPD paradigms respectively. Trdn is involved in the release of calcium ions 
from the sarcoplasmic reticulum, which is a key step in the contraction of cardiac and 
skeletal muscle (Roux-buisson et al. 2012). Notably, Trdn showed a significant (p<0.05) 
1.5 fold change in PND7 hippocampus from a rat model that was developmentally 
exposed to a polychlorinated biphenyl (PCB), which acts as a teratogen (Royland & 
Kodavanti 2008).  
2.4.2 Differential ncRNA Expression  
The second set of experiments in this chapter identified differences related to 
ncRNA expression by utilizing Affymetrix GeneChip® miRNA 2.0 arrays and 
Affymetrix GeneChip® Mouse Gene 1.0 ST arrays. The differential ncRNA expression is 
represented by two sets of observations. The first set of observations is of the reciprocal 
differential expression of miRNAs and target genes in CPD PAE mice at PND70. The 
second set of observations is of miRNA and snoRNA expression in multiple exposure 
paradigms at PND70. In addition to CPD, binge PAE (injection) at the first (T1), second 
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(T2) and third (T3) trimester equivalents of human development were analyzed to 
confirm and expand on the CPD results in the second set of observations. The long-term 
gene expression alterations from the binge injection models have been compared (Kleiber 
et al. 2013; Kleiber, Diehl, et al. 2014) and detailed ncRNA expression analysis is 
available for the T2 (Mantha et al. 2014) and T3 (Stringer et al. 2013; Kleiber, Laufer, et 
al. 2014) binge exposure paradigms.  
2.4.2.1 Reciprocal Differential miRNA and Target Gene 
Expression  
For the original (2012) analysis, IPA’s miRNA Target Filter® was used to 
analyze all possible miRNA and target-gene interactions from the miRNA and gene 
expression array data sets for the CPD PAE paradigm. The results were filtered based on 
the confidence of interaction, brain specificity, and an inverse miRNA to target mRNA 
relationship (Appendix A). The miRNA analysis was also updated in 2016 (Table 2.3). 
An updated (2016) target filter analysis was carried in Partek out under more stringent 
conditions using the mouse-specific TargetScan database and updated annotations for 
both arrays (Table 2.4). 
The Partek miRNA target filter revealed two mRNAs (Slitrk2 and Otx2) that had a 
reciprocal alteration with a shared miRNA (mir-130b, 1.2 fold increase) (Table 2.4). 
Slitrk2 was downregulated (–1.2), whereas one of the IPA target filter predicted miRNAs 
(mir-17*) was upregulated (Appendix A). Slitrk2 is expressed in the developing embryo 
and adult neurons, where it has an inhibitory effect on neurite outgrowth (Aruga & 
Mikoshiba 2003). Otx2 was downregulated (–1.3) along with one of its IPA target filter 
predicted miRNAs (mir-152) being upregulated (Appendix A). Otx2 is a homeobox gene 
that is involved in embryonic head development as well as in the neuroplasticity of 
GABAergic interneurons in the visual cortex and has been implicated in mood disorders 
(Acampora et al. 1995; Sabunciyan et al. 2007; Sugiyama et al. 2009). Interestingly, both 
of the above genes are involved in neurodevelopmental processes and were predicted by 
the Partek target filter to be targeted by a single miRNA.  
Aak1 (1.2 fold change, p=0.007) showed increased expression, while a number of 
miRNAs predicted to target it by both IPA and Partek being downregulated (Table 2.4 
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and Appendix A). In the T2 binge PAE model, Aak1 (1.2 fold change, p=0.027) showed 
an increase in expression and two miRNAs predicted to target it, mir-10b (-1.5 fold 
change, p=0.002) mir-342-5p (-1.3 fold change, p=0.025), showed decreased expression 
(Mantha et al. 2014; Kleiber, Diehl, et al. 2014). AAK1 is a kinase that regulates clathrin-
mediated endocytosis, which is a process that recycles synaptic vesicles at presynaptic 
terminals (Conner & Schmid 2002; Saheki & De Camilli 2012). Furthermore, AAK1 is a 
positive regulator of the Notch signaling pathway and directly interacts with an active and 
membrane-tethered form of Notch that results in part from metalloprotease cleavage by 
the ADAM gene family (Gupta-Rossi et al. 2011). Other notable candidates identified by 
the Partek miRNA target filter include Rnf165 and Nlrc5 (Table 2.4). RNF165 was 
shown to mediate motor axon extension by BMP-Smad signaling (Kelly et al. 2013). 
NLRC5 has a role in immune response, where it is a negative regulator of the NF-kappaB 
and type I interferon signaling pathways (Cui et al. 2010). Finally, both the original 
(2012) and updated (2016) analysis of altered miRNAs found that let-7 miRNA(s) were 
down-regulated (Table 2.4). Notably, let-7 miRNAs promote differentiation over 
pluripotency and are involved in neurodevelopment (Mayr et al. 2007; Worringer et al. 
2014; Ivakhnitskaia et al. 2016) 
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Table 2.3. Updated (2016) analysis of significant differentially-expressed mouse 
miRNAs in CPD adult brains (p<0.05 and 1.2-fold change cut-off). 
miRNA p-value Fold Change 
mmu-miR-466d-3p 0.023 1.6 
mmu-miR-181c 0.040 1.6 
hp_mmu-mir-686 0.020 1.3 
hp_mmu-mir-147 0.018 1.3 
hp_mmu-mir-708 0.044 1.3 
hp_mmu-mir-28 0.028 1.3 
mmu-miR-130b 0.017 1.2 
mmu-miR-322* 0.023 1.2 
hp_mmu-mir-291a 0.015 1.2 
hp_mmu-mir-146b 0.011 1.2 
mmu-miR-151-5p 0.017 1.2 
hp_mmu-mir-181b-2 0.046 1.2 
mmu-miR-291a-5p 0.037 1.2 
mmu-miR-669o 0.039 -1.2 
hp_mmu-mir-491 0.005 -1.2 
mmu-miR-27b* 0.010 -1.2 
mmu-miR-488 0.048 -1.2 
hp_mmu-mir-22 0.032 -1.3 
hp_mmu-mir-707 0.045 -1.3 
hp_mmu-mir-325 0.046 -1.3 
mmu-miR-683 0.002 -1.3 
hp_mmu-mir-193 0.016 -1.3 
mmu-let-7g 0.012 -1.3 
hp_mmu-mir-340 0.024 -1.3 
mmu-let-7f 0.041 -1.3 
hp_mmu-mir-98 0.001 -1.3 
mmu-miR-1306 0.025 -1.3 
mmu-miR-146a 0.042 -1.4 
mmu-miR-93* 0.007 -1.4 
mmu-let-7f* 0.039 -1.4 
mmu-miR-122 0.026 -1.5 
mmu-miR-150* 0.034 -1.5 
mmu-miR-369-5p 0.025 -1.7 
mmu-miR-299* 0.029 -1.8 
Note: hp = hairpin precursor and * = star 
  
 57 
Table 2.4. Updated (2016) Partek miRNA target filter analysis (p<0.05 and 1.2-fold 
change cut-off) of differentially expressed genes and associated miRNAs identified in 
CPD adult brains.  
miRNA p-value Fold Change Gene  p-value Fold Change 
mmu-miR-146a 0.0424 -1.4 Trp53rka 0.0196 1.2 
mmu-miR-683 0.0022 -1.3 Aak1 0.0007 1.2 
mmu-let-7g 0.0116 -1.3 Aak1 0.0007 1.2 
mmu-let-7f 0.0410 -1.3 Aak1 0.0007 1.2 
mmu-let-7g 0.0116 -1.3 Nlrc5 0.0103 1.3 
mmu-let-7f 0.0410 -1.3 Nlrc5 0.0103 1.3 
mmu-miR-130b 0.0170 1.2 Otx2 0.0162 -1.3 
mmu-miR-683 0.0022 -1.3 Rnf165 0.0128 1.2 
mmu-let-7g 0.0116 -1.3 Rnf165 0.0128 1.2 
mmu-let-7f 0.0410 -1.3 Rnf165 0.0128 1.2 
mmu-miR-488 0.0476 -1.2 Rnf165 0.0128 1.2 
mmu-miR-130b 0.0170 1.2 Slitrk2 0.0002 -1.2 
Results were obtained from the 2016 analysis of gene and miRNA expression arrays 
respectively. 
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2.4.2.2 Confirmations of Differential Expression 
The results observed on the two independent array platforms for the CPD PAE 
mice were then examined by quantitative PCR (qPCR). Although the qPCR results 
showed similar fold changes to the arrays for all genes of interest examined (Pten, 
Nmnat1, Slitrk2 and Otx2), they were not statistically significant (p=0.122, p=0.129, 
p=0.452 and p=0.078, respectively). 
However, it is worth noting that the gene expression and miRNA arrays used were 
independent platforms that contained different probes for the same snoRNAs and 
miRNAs. The results showed that some ncRNAs are similarly affected on the two 
(miRNA and gene expression) arrays. For example, the MBII-52 snoRNA (Snord115) 
belonging to Snrpn-Ube3a is upregulated (Appendix D). 
Despite difficulties with confirming gene expression, a miRNA identified in the 
CPD model by the original (2012) IPA analysis was confirmed by qPCR. mir-679-5p, 
which is located in the Dlk1-Dio3 region, showed a 1.45-fold increase (p=0.019) in mice 
that were treated with ethanol during neurodevelopment via maternal CPD (Figure 2.4). 
The results provide support for the two independent (miRNA and gene expression) array 
platforms that showed 1.2 (p=0.03)- and 1.4 (p=0.04)-fold increases, respectively. 
Notably, this miRNA was not identified as significant in the updated (2016) miRNA 
analysis.  
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Figure 2.4. A bar graph depicting the quantitation of mmu-mir-679-5p expression in 
control and CPD PAE adult brains. This miRNA was identified in the original (2012) 
analysis. The y-axis depicts the relative mir-679 expression normalized to snoRNA 202, 
expressed as a mean ± s.e.m. of both biological (n=6) and technical (n=3) replicates. 
*p<0.05. 
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2.4.2.3 Differential ncRNA Expression in All Exposure 
Paradigms 
The original (2012) analysis of the mouse miRNA arrays shows that all PAE 
paradigms resulted in changes to global miRNA expression. The effect of each treatment 
paradigm was relatively consistent between biological replicates. Consequently, alcohol-
treated and matched control ncRNA expression patterns consistently group together when 
hierarchically clustered (Appendix B), however, they do not represent the same 
transcripts across paradigms.  
The pattern of expression between alcohol-exposed and matched control brains is 
quite distinct. Notably, the miRNAs that were affected were primarily specific to the 
developmental timing of alcohol treatment (Appendix C). Treatment during T1, T2, or 
T3 resulted in the unique expression for 21/24 (88%), 38/45 (84%) and 60/68 (88%) of 
the affected miRNAs for each of the three trimesters, respectively. This number for the 
CPD paradigm was also comparable [28/32 (88%)]. 
Finally, the altered miRNAs from the four exposure paradigms map to 
genomically imprinted regions in the mouse genome. Interestingly, 8/32 (25%) of 
identified miRNA transcripts in the CPD treatment paradigm, 2/24 (8%) in the T1 
paradigm, 13/45 (29%) in the T2 paradigm, and 13/68 (19%) in the T3 paradigm mapped 
to three known imprinted regions of the mouse genome. The genomic locations include 
the Snrpn-Ube3a region of chromosome 7 (Appendix D), the Dik1-Dio3 region of 
chromosome 12 (Appendix E), and the Sfmbt2 region of mouse chromosome 2 
(Appendix E).  
Ultimately, these results suggest that the long-term changes in ncRNA expression 
following PAE are subtle and treatment specific, with the relative exception of Snord115 
(H/MBII-52). 
 
 
 61 
2.4.3 Differential DNA Methylation  
The third experiment in this chapter examines genome-wide as well as specific 
differences in DNA methylation in CPD PAE adult brains by utilizing NimbleGen MM9 
2.1M deluxe promoter arrays (v2). 
The original (2012) analysis revealed that the differences across individuals, 
although variable, show a significant (p<0.01) effect of PAE on genome-wide DNA 
methylation. Upon hierarchal clustering analysis, it was observed that experimental and 
control mice group together according to exposure (Figure 2.5). Furthermore, the results 
reveal significant differentially methylated regions (DMRs) in 6660 regions that are 
associated with PAE. A total of 16% of transcripts and 18% of the miRNAs that showed 
significant (p<0.05) differential expression (fold change > ±1.2) also showed significant 
(p<0.01) differential methylation in their gene promoters. Furthermore, ~50% of 
imprinted regions showed significant differences in methylation.  
Next, all the promoters identified were subjected to Ingenuity Pathway Analysis® 
(IPA®). After filtering, this analysis revealed that a large number of genes associated 
with cell death as well as nervous system development and function are significantly 
enriched (Table 2.5). An IPA associative genetic interaction network analysis revealed 
that the ‘Behavior, Neurological Disease, and Psychological Disorders’ network was the 
most significantly affected network, with an IPA® score of 65. From this network a 
number of highly connected ‘hub genes’ were identified. 
Among the most prominent hub genes was App: its promoter is less methylated in 
the treated mice. Furthermore, the promoters of a set of interacting genes (Akt1, Ghr, 
ApoE, Ntrk1) within this hub are also differentially methylated following PAE. Finally, 
IPA’s canonical pathway analysis showed that the top two pathways were Cdk5 signaling 
(p=9.01E–7), with 47/78 molecules affected (Figure 2.6), and Pten signaling (p=1.9E–
06), with 54/95 molecules affected (Figure 2.7). 
 
 
 
 
 62 
 
 
 
Figure 2.5. Hierarchical clustering of significant (p<0.01) differential methylation in 
CPD PAE adult mouse brains identified by the original (2012) analysis. The heatmap was 
plotted based on the log2 ratio of probes within the peak regions of each sample. 
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Table 2.5. Top ontologies identified by the original (2012) Ingenuity analysis of 
significantly (p<0.01) differentially methylated gene promoters.  
Molecular and Cellular Functions     
Name p-value # Genes 
Cell Death 4.06E-04 - 4.97E-02  224 
Cellular Development 6.24E-04 - 4.52E-02  166 
Cellular Function and Maintenance 9.57E-04 - 4.97E-02  86 
Cellular Movement 4.12E-03 - 4.52E-02  41 
Cell Signaling 8.43E-03 - 4.97E-02  26 
Physiological System Development and Function     
Name p-value # Genes 
Nervous System Development and Function 3.86E-05 - 4.97E-02  273 
Tissue Morphology 1.64E-04 - 4.23E-02  97 
Behavior 1.62E-03 - 1.58E-02  24 
Embryonic Development 1.23E-02 - 4.23E-02  29 
Organismal Development 1.23E-03 - 4.23E-02  25 
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Figure 2.6. Ingenuity pathway analysis of the CDK5 signaling pathway. Genes identified 
by the original (2012) analysis as showing significant (p<0.01) differential methylation in 
CPD PAE mice are highlighted. The legend for symbols is in Appendix F. 
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Figure 2.7. Ingenuity pathway analysis of the PTEN signaling pathway. Genes identified by the original (2012) analysis as showing 
significant (p<0.01) differential methylation in CPD PAE mice are highlighted. The legend for symbols is in Appendix F.
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In addition to the genome-wide results, ontologies, and pathways, a functional 
examination of the results was also undertaken. The original (2012) DNA methylation 
data were integrated with the gene expression data to reveal gene families that showed 
significant differential methylation and some corresponding alterations in gene 
expression. Furthermore, an analysis of CTCF binding sites was also carried out on the 
promoter sequences of a critical gene network identified in the original (2012) analysis.  
2.4.3.1 Gene Families  
The replication-dependent histone gene clusters showed significant (p<0.01) 
increases in methylation following CPD, including Hist1h1e, Hist1h2aa, Hist1h2ak, 
Hist1h2ba, Hist1h2be, Hist1h2be, Hist2h2bb, Hist2h3b, Hist2h4, and Hist3h2ba. 
Notably, Hist1h2ab showed a significant (p=0.007) 1.2 fold decrease in expression in the 
CPD model. Finally, members of the histone gene family typically showed a similar 
decrease in expression in all binge exposure paradigms (Kleiber et al. 2013).  
Genes from the HoxA, HoxC, and HoxD clusters showed significant (p<0.01) 
decreases in methylation. The genes altered by CPD were Hoxa3, Hoxa4, Hoxa6, Hoxa7, 
Hoxa13, Hoxc8, Hoxc13, Hoxd1, Hoxd3, Hoxd8, and Hoxd11. These altered Hox genes 
have promoters with high CpG content. Hoxc8 showed a significant (p=0.01) 1.2 fold 
increase in expression in the CPD model and Hoxd10 showed a significant (p=0.04) 1.3 
fold increase in expression in the T1 model (Kleiber et al. 2013). Significant increases in 
methylation by PAE were also observed for Rhox2a, Rhox2c, Rhox2e, Rhox2h, Rhox3a, 
Rhox3h, Rhox9, Rhox10, and Rhox11. These genes have promoters with low to 
intermediate CpG content. Furthermore, Rhox1 showed a significant (p<0.02) 1.2 fold 
increase in expression in the CPD model. 
In the CPD model, significant (p<0.01) alterations to methylation in both 
directions were seen in Adam1a, Adam1b, Adam3, Adam4, Adam10, Adam12, Adam23, 
Adam30, Adam32, Adam33, Adamts8, Adamts14, Adamts15, Adamts17, Adamtsl2, 
Adamtsl5, and Adamtsl5. Adamts9 showed a significant (p<0.008) 1.2 fold increase in the 
CPD model and several miRNAs predicted to target it by IPA were significantly (p<0.05) 
down-regulated ~1.2 fold (Appendix A). In the T3 model Adamts9 showed a significant 
(p=0.00001) 1.2 fold decrease, while Adam9 showed a 1.1 fold decrease and a miRNA 
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(mir-26b) predicted to target it showed a 1.3 fold increase (Kleiber et al. 2013; Kleiber, 
Diehl, et al. 2014; Kleiber, Laufer, et al. 2014).  
The Keratin associated proteins Krtap4-13, Krtap4-16, Krtap5-1, Krtap5-4, 
Krtap8-2, Krtap10-10, Krtap26-1, and Krtap31-2 showed a significant increase in 
methylation. Krtap17-1 showed a significant decrease in methylation. Both Krtap10-10 
and Krtap31-2 showed a significant (p<0.03) 1.2 fold increase in gene expression in the 
CPD model. Promoters for these genes had low to intermediate CpG content. Krtap’s are 
clusters of genes unique to mammals that are undergoing rapid evolution and are 
expressed during the terminal differentiation of hair cells (Shimomura & Ito 2005; Wu et 
al. 2008). Twenty-eight kertain genes, of both the cytoskeletal and cuticular type, showed 
significant differential methylation that was typically an increase. Keratinocyte 
differentiation-associated protein (Krtdap) also showed a significant increase in 
methylation. Furthermore, 64 transmembrane (Tmem) family genes showed significant 
(p<0.01) altered methylation in the CPD model. Notably, in the CPD model none of the 
genes with altered methylation showed altered expression. However, Tmem19, Tmem60, 
Tmem150b, and Tmem235 showed significant (p<0.03) 1.2 fold decreases in expression 
while Tmem217 showed a significant (p<0.02) 1.2 fold increase in expression. The 
original (2012) target filter analysis also identified two miRNAs with increased 
expression that were predicted to target Tmem19 (Appendix A).  
2.4.3.2 CTCF Binding Sites  
The results included in this chapter suggest that PAE causes significant changes in 
DNA methylation in the developing brain that last to adulthood (Figure 2.5). The DMRs 
of the original (2012) analysis cover a relatively large number (6610) of gene promoters 
(6131 unique) that are related to molecular, functional, and phenotypic abnormalities 
implicated in FASD (Table 2.5). The most significant network identified by IPA (score 
65) is that of ‘Behavior, Neurological Disease, and Psychological Disorders’, which has a 
distinct set of ‘hub genes’. Among the most prominent hub genes affected is App 
(amyloid precursor protein), which is a protein that helps direct the migration of neurons 
during early development (Priller et al. 2006). These results suggest that the hub genes 
identified (Akt1, Ghr, ApoE, Ntrk1) are involved in FASD endophenotypes.  
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The results also suggest a gene regulatory mechanism underlies some FASD 
endophenotypes. The alterations in promoter methylation might interfere with 
transcriptional machinery as demonstrated by the role of differential methylation of H19 
(Hark et al. 2000). Notably, altered methylation was seen in the H19 promoter, which is 
involved in CTCF binding and imprinting (Figure 2.8A) (Lin et al. 2011). This specific 
peak has previously been identified as showing significant differential methylation in 
FASD placental tissue (Haycock & Ramsay 2009). CTCF binds to the H19/Igf2 ICR in a 
DNA-methylation-sensitive manner, where it acts as insulator activity for the 
unmethylated maternal ICR by blocking the Igf2 promoter from engaging enhancers 
downstream of H19 that are shared by H19 and Igf2 (Figure 2.8C) (Hark et al. 2000). 
The deletion or mutation of the four CTCF-binding sites within the ICR causes a 
paternalization of the maternal allele that results in biallelic Igf2 expression and H19 
repression (Engel et al. 2006). 
In addition to the H19 locus, CTCF binds to DMRs at a number of other imprinted 
loci. One of these is the secondary DMR of Gtl2 (Meg3) (Figure 2.7 and Table 2.6), 
which also relies on differential methylation at a CTCF-binding site (Nowak et al. 2011) 
and showed a significant (p<0.009) 1.2 fold decrease in expression in the T3 injection 
paradigm (Kleiber, Laufer, et al. 2014). Given the role of CTCF in imprinted regions 
implicated in FASD, other important genes that were affected were examined for CTCF 
binding sites in their promoters. From the ‘Behavior, Neurological Disease, and 
Psychological Disorders’ network, 30 significantly altered DMRs were examined for 
CTCF-binding sites using the CTCFBS prediction tool (Bao et al. 2008). Of these 30 
regions, 12 (40%) showed sequences that represented predicted CTCF-binding motifs 
(Figure 2.7). Eight of these promoter regions showed increased methylation and four 
showed decreased methylation. The results on H19 and App are similar to previous 
research (Liu et al. 2009). However, these results show that the changes are present in 
adult brain tissue long after PAE. The 12 DMRs with CTCF binding sites were then 
subjected to a pathway analysis (Figure 2.9) using GeneMANIA (Warde-Farley et al. 
2010), with the results supporting those of IPA. However, it is worth noting that other 
methylation-sensitive regulatory proteins are likely to be involved in the altered 
transcriptomics resulting from PAE.  
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Figure 2.8. The functional potential of altered CTCF-binding-site methylation after PAE in significant (p<0.01) differentially 
methylated regions identified by the original (2012) analysis. Increased (A) and decreased (B) methylation after PAE at select gene 
promoters (‘P’) with CTCF sites. (C) Schematic of H19/IGF2 imprinting regulation and the effects of PAE. The black rectangle 
represents the H19/Igf2 ICR. On the maternal allele, CTCF binds to the ICR and blocks the Igf2 promoter from accessing the 3′ shared 
enhancers (E). On the paternal allele, the ICR is methylated and H19 transcription is repressed. White lollipops represent non-
methylated DNA and black lollipops represent methylated DNA.    
Igf2 H19ICR E
Igf2 H19ICR E
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GeneP
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Gene	Name Protein	Name Chr. Peak	Length Peak	To	TSS Motif	Score(s)
H19 N/A	(ncRNA) 7 1544 -3262 8.5*
Gtl2	(Meg3) N/A	(ncRNA) 12 542 -3894 1.5*
Npy Pro-neuropeptide	Y 6 657 -2146 2.7
Akt1 RAC-alpha	serine/threonine-protein	
kinase
12 1349 -6960 8.6	and	8.1
Ghr Growth	hormone	receptor 15 234 1338 10.4
Ntrk1 High	affinity	nerve	growth	factor	
receptor
3 2221 -4868 9.1,	4.6,	and	5.4
Apoe ApolipoproteinE 7 1374 2605 7.5	and	4.6
Grin2c Glutamate	[NMDA]	receptor	subunit	
epsilon-3
11 359 -6161 2.8
B
GeneP
CTCF
EtOH
GeneP
Gene	
Name Protein	Name Chr.
Peak	
Length
Peak	To	
TSS Motif	Score
App Amyloid	beta	A4	protein 16 1235 261 5.3
Mbp Myelin	basic	protein 18 649 322 5.3
Atp1a2 Sodium/potassium-transporting	
ATPase	subunit	alpha-2
1 534 -6515 13.5
Grin1 G	protein-regulated	inducer	of	
neurite outgrowth	1
2 155 -4995 13.2
C
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Figure 2.9. GeneMANIA network analysis of significant (p<0.01) differentially 
methylated genes containing CTCF-binding sites from the top associative network 
identified in the original (2012) analysis by Ingenuity Pathway Analysis (“Behavior, 
Neurological Disease, and Psychological Disorders”). 
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Finally, the updated (2016) analysis identified significant (p<0.005) alterations to 
DNA methylation in 4304 gene promoters and/or CpG islands that belonged to 2898 
unique annotated genes. The top differentially methylated genes are presented in Table 
2.6. The analysis also revealed significant (p<0.002) alterations in methylation to 
Snord116 and Ipw, which are ncRNAs within Snrpn-Ube3a. A larger amount of 
significant alterations were seen in gene ontologies and canonical pathways. The updated 
ontologies and pathways indicate alterations to ion transport across the membrane, cell-
to-cell adhesion events, proliferation and differentiation (cancers) as well as 
developmental, cellular, immune, and synaptic signaling events (Tables 2.7 & 2.8). 
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Table 2.6. Updated (2016) analysis of genes in CPD adult brains with the greatest differential DNA methylation (p=0.0001). 
PAE Hypermethylated 
 Score Symbol Gene Name Gene Function 
36 Ntm Neurotrimin Cell Adhesion and Neuron Recognition 
29 Mroh2a Maestro heat-like repeat-containing protein family member 2A Unknown 
27 Slc22a5 Solute carrier family 22 member 5 Sodium-ion dependent carnitine transporter 
27 Arhgap26 Rho GTPase-activating protein 26 Actin cytoskeleton and nervous system development 
25 Bcl11b B-cell lymphoma/leukemia 11B Tumor-suppressor  
24 Syn3 Synapsin-3 Neurotransmission and synaptogenesis 
20 Foxp4 Forkhead box protein P4 Transcriptional repressor 
18 Pisd-ps Phosphatidylserine decarboxylase, pseudogene Unknown pseudogene 
17 Gnas Guanine nucleotide-binding protein G(s) Alpha Subunit GPCR signal transduction [Imprinted Gene] 
17 Meg3 Maternally expressed 3 [Also known as Gtl2] lncRNA [Imprinted: Dlk1-Dio3] 
PAE Hypomethylated 
 Score Symbol Gene Name Gene Function 
-14 Xiap X-linked inhibitor of apoptosis E3 ubiquitin protein ligase [Regulated by Akt] 
-10 Map2k1 Dual specificity mitogen-activated protein kinase kinase 1 MAPK signal transduction  
-10 Pmfbp1 Polyamine-modulated factor 1-binding protein 1 Organization of cytoskeleton  
-9 Clcn5 H(+)/Cl(-) exchange transporter 5 Proton-coupled chloride transporter 
-9 Mir188 MicroRNA 188 Post-transcriptional regulation 
-9 Mir532 MicroRNA 523 Post-transcriptional regulation 
-9 Eif3e Eukaryotic translation initiation factor 3 subunit E Translational regulation 
-9 Izumo4 Izumo sperm-egg fusion protein 4 Reproduction [immunoglobulin superfamily protein] 
-9 Mob3a MOB kinase activator 3A Metal ion binding 
-9 Gldc Glycine dehydrogenase (decarboxylating), mitochondrial Glycine degradation 
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Table 2.7. Ontologies for the updated (2016) analysis of significant (p<0.005) differential 
DNA methylation in CPD mice.   
Enrichr GO Biological Processes  Overlap p-value 
Calcium ion transmembrane transport  33/128 1.9E-04 
Inorganic cation transmembrane transport  82/440 2.5E-04 
Response to steroid hormone  71/369 2.9E-04 
Response to mechanical stimulus  40/176 4.1E-04 
Divalent inorganic cation transport  50/238 4.2E-04 
Gland development  47/220 4.5E-04 
Divalent metal ion transport  49/234 5.0E-04 
Cellular response to lipid  61/315 6.6E-04 
Epithelial cell development  27/107 9.2E-04 
Regulation of ion transmembrane transport  60/314 9.7E-04 
Enrichr GO Cellular Location Overlap p-value 
Cell-cell junction  65/335 3.6E-04 
Postsynaptic membrane  42/195 6.7E-04 
Synaptic membrane  46/228 1.3E-03 
Cell cortex  22/83 1.4E-03 
Integral component of plasma membrane  162/1066 2.1E-03 
Contractile fiber part  35/167 2.7E-03 
Lamellipodium  25/111 4.7E-03 
Centrosome  62/360 5.7E-03 
Perinuclear region of cytoplasm  69/411 6.2E-03 
Golgi membrane  54/308 7.0E-03 
Enrichr GO Molecular Function Overlap p-value 
Channel activity  85/427 3.9E-05 
Passive transmembrane transporter activity  85/427 3.9E-05 
Metal ion transmembrane transporter activity  78/400 1.4E-04 
Substrate-specific channel activity  79/406 1.4E-04 
Inorganic cation transmembrane transporter activity  92/497 1.9E-04 
Divalent inorganic cation transmembrane transporter activity  39/154 9.0E-05 
Calcium ion transmembrane transporter activity  34/127 1.0E-04 
Ion channel activity  76/396 2.7E-04 
Cation channel activity  58/285 4.0E-04 
Calcium channel activity  28/108 6.2E-04 
Gated channel activity  60/323 2.2E-03 
RNA polymerase II regulatory region DNA binding  55/288 2.0E-03 
SH3 domain binding  28/119 2.1E-03 
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Table 2.8. Pathways for the updated (2016) analysis of significant (p<0.005) differential 
DNA methylation in CPD mice.   
Partek KEGG Pathways Overlap  p-value 
Pathways in cancer 94/234 6.2E-05 
Focal adhesion 60/148 1.1E-03 
Arrhythmogenic right ventricular cardiomyopathy  26/48 1.5E-03 
Melanogenesis 31/70 6.2E-03 
Prostate cancer 28/61 6.2E-03 
ECM-receptor interaction 27/60 8.7E-03 
Renin-angiotensin system 9/11 9.5E-03 
Acute myeloid leukemia 19/38 1.2E-02 
Calcium signaling pathway 50/136 1.2E-02 
TNF signaling pathway 32/78 1.3E-02 
Phosphatidylinositol signaling system 25/57 1.4E-02 
Glycosphingolipid biosynthesis - globo series 7/8 1.7E-02 
Basal cell carcinoma 18/38 2.0E-02 
Colorectal cancer 20/44 2.0E-02 
HTLV-I infection 69/208 2.2E-02 
Regulation of actin cytoskeleton 55/160 2.3E-02 
Proteoglycans in cancer 57/167 2.3E-02 
Protein digestion and absorption 26/64 2.5E-02 
Dilated cardiomyopathy 26/64 2.5E-02 
Fc gamma R-mediated phagocytosis 25/61 2.6E-02 
Amphetamine addiction 20/47 3.3E-02 
Estrogen signaling pathway 27/70 3.6E-02 
Adherens junction 22/54 3.7E-02 
Endometrial cancer 16/36 4.1E-02 
Vasopressin-regulated water reabsorption 14/30 4.1E-02 
Hippo signaling pathway 40/115 4.2E-02 
Bacterial invasion of epithelial cells 22/55 4.2E-02 
Wnt signaling pathway 37/105 4.3E-02 
Pertussis 21/52 4.3E-02 
Prolactin signaling pathway 21/53 5.0E-02 
Osteoclast differentiation 33/93 5.0E-02 
Neurotrophin signaling pathway 32/90 5.2E-02 
Renal cell carcinoma 19/47 5.3E-02 
FoxO signaling pathway 35/101 5.6E-02 
Hedgehog signaling pathway 15/35 5.8E-02 
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2.5 Discussion 
The experimentation in this chapter has resulted in a number of observations 
based on three key experiments (Figure 2.1). The first set of experiments are related to 
gene (mRNA) expression. PAE, an early life exposure, was associated with long-term 
alterations to the adult brain (Figures 2.2 & 2.3 and Table 2.1). Overall, the top up-
regulated genes were primarily uncharacterized while the top down-regulated reflected a 
variety of functions (Table 2.1). The genes with long-term alterations share ontologies 
and pathways related to immune processes, synaptic events, nucleotide metabolism, 
protein synthesis, ion transport, and the cell membrane (Table 2.2). The observation of 
such long-term alterations to gene expression in adult PAE mice raises two questions. The 
first question is are they contributing to FASD related behaviours? The results suggest the 
possibility that some alterations may be playing an active role, but require gene specific 
functional confirmation. The second question is what is initiating and maintaining the 
long-term alterations gene expression? To this end, the next two experiments of this 
chapter tested the hypothesis that miRNAs and DNA methylation are involved in 
maintaining the long-term alterations and may contain a footprint that is informative of 
the events initiating these alterations.  
In the second set of experiments different ncRNA species were examined. First, 
the CPD PAE model was examined for reciprocal alterations to the expression of 
miRNAs and predicted target genes (Table 2.4). These results revealed several 
interactions and aided in the identification of candidate biomarkers by providing 
additional layers of support for their deregulation (Figure 2.4). Second, alterations to 
ncRNA in the CPD paradigm, which represents moderate exposure were compared to 
ncRNA alterations in binge exposure paradigms that represent different developmental 
time points. The results show that PAE by any of the paradigms alters the expression of a 
number of ncRNAs in the adult brain (Appendix B). The results also show that long-term 
changes in miRNA expression are dependent on the treatment paradigm (Appendix C). 
The exception to this pattern is Snord115 (MBII-52) snoRNA expression, which is 
affected regardless of the timing of exposure (Appendix D). The connection of the 
ncRNA expression to loci of genomic imprinting then raised the question: are alterations 
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to methylation responsible for maintaining the long-term alterations to ncRNA and 
mRNA expression? 
In the third set of experiments, long-term alterations to DNA methylation were 
examined. At the general level, the examination revealed a genome-wide scale of change 
(Figure 2.5). However, the alterations were non-random. The ontologies (Tables 2.5 & 
2.7) and pathways (Figures 2.6 & 2.7 and Table 2.8) altered are related to calcium 
signaling, ion transport, stem cell signaling, cell adhesion, synaptic events, immune 
processes, and the cell membrane. The alterations were seen in predicted and known 
CTCF binding sites (Figure 2.8) including those of H19, which was previously shown to 
be deregulated by PAE (Haycock & Ramsay 2009) and provides further evidence for the 
sensitivity of genomic imprinting to PAE.  
Finally, because gene expression, miRNA expression, and DNA methylation were 
all examined in the CPD paradigm, the different datasets were integrated to observe any 
biological relationships. Notably, a larger scale of alteration was seen to DNA 
methylation as compared to gene and ncRNA expression. Furthermore, few genes and 
ncRNAs showing altered expression also showed altered DNA methylation. This lack of 
correlation between altered epigenetic marks and transcription has been reported in the 
literature (Veazey et al. 2015). The lack of correlation presumably reflects on the 
combinatorial nature of the epigenome, where multiple modifications are needed for 
effect. Furthermore, the lack of correlation also reflects on the fact that the gene 
expression tested is from mice in a resting steady state and that differential expression 
could be seen under other activating conditions (Lussier et al. 2015). However, despite 
the complexity of the relationship of the epigenome to transcription, three key 
observations that warrant further examination for both biomarker and therapeutic 
development have emerged. First, are imprinted clusters of ncRNA, second are select 
gene clusters, and third is cellular signaling. 
2.5.1 Imprinted ncRNA Clusters  
Approximately 20% of the miRNAs and some snoRNAs showing differential 
expression are encoded by one of three imprinted regions of the mouse genome: Snrpn-
Ube3a (murine 7qC/human 15q11-q13), Dlk1-Dio3 (murine 12qF1/human 14q32.2), and 
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Sfmbt2 (murine 2qA1) regions. Genes within these regions displayed differential 
methylation. The Sfmbt2, Snrpn-Ube3a, and Dik1-Dio3 regions are of special interest to 
PAE because they are also known to affect a range of endophenotypes seen in FASD. 
These include impaired growth, craniofacial abnormalities, and a range of cognitive and 
behavioral deficits (May & Gossage 2001). The detailed biological consequences and 
evolutionary relationship of these imprinted clusters have been previously reviewed 
(Laufer & Singh 2012); however, their connection to FASD endophenotypes is briefly 
described below.  
Snrpn-Ube3a expresses a neuron-specific polycistronic transcript. The Snrpn-
Ube3a transcript is processed into two clusters of snoRNAs, H/MBII-52 (Snord115) and 
H/MBII-85 (Snord116) (de los Santos et al. 2000; Runte et al. 2001; Le Meur et al. 2005) 
that were deregulated by PAE. This transcript also codes for a number of alternative 
ncRNA species (Kishore et al. 2010; Bortolin-Cavaille & Cavaille 2012; Falaleeva & 
Stamm 2012). For example, a long non-coding RNA (lncRNA) transcribed from Snrpn-
Ube3a undergoes alternative splicing where the introns are processed into SNORD116 
snoRNAs, while the spliced exons form a functional lncRNA (116HG) (Powell, Coulson, 
Crary, et al. 2013; Powell, Coulson, Gonzales, et al. 2013). 116HG forms a lncRNA 
cloud that modulates genes involved in circadian rhythm and energy expenditure, which 
notably includes mTOR, (imprinted) Ifg2r, and Crebbp. Notably, Snord116 and Ipw, both 
of which are in the Snrpn-Ube3a locus, showed significant (p<0.002) alterations to 
methylation in the updated (2016) analysis. 
Furthermore, the array results from this chapter follow those of Liu et al., who 
have reported that PAE causes differential methylation at Ube3a, which also has an 
antisense transcript (Liu et al. 2009). The Snrpn-Ube3a locus is involved in the classic 
sister imprinting disorders Prader-Willi syndrome (OMIM: 176270) and Angelman 
syndrome (OMIM: 105830), both of which display developmental delay and deficits in 
cognitive function (Knoll et al. 1989; Wagstaff et al. 1992). Interestingly, H/MBII-52 
(Snord115) and H/MBII-85 (Snord116), are believed to be key players in these disorders 
(Buiting 2010; Bieth et al. 2015). Furthermore, overexpression of Snord115 in a paternal 
duplication mouse model results in poor social interaction, behavioral inflexibility, 
abnormal ultrasonic vocalizations, and anxiety (Nakatani et al. 2009). SNORD115 
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changes the alternative splicing of the serotonin receptor 5HTR2C (Kishore & Stamm 
2006; Glatt-Deeley et al. 2010), which is a G-protein coupled receptor involved in 
calcium signaling (Nakatani et al. 2009). Snord115 also regulates the splicing of genes 
(Dpm2, Taf1, Ralgps1, Pbrm1, and Crhr1) involved in the cell cycle, chromatin 
modification, and development (Kishore et al. 2010). Further investigation has also 
revealed that SNORD115 and SNORD116 can regulate a large number of genes, as well 
as modify each other’s activity (Falaleeva et al. 2015).  
The Dlk1-Dio3 locus expresses over 40 miRNAs contained in two clusters, 
including a cluster of snoRNAs that contains Snord113 and Snord114 that were 
deregulated by PAE (Appendix E) (Seitz et al. 2004). Notably, Meg3 (also known as 
Gtl2) showed significant differences in methylation in both the original (2012) and 
updated (2016) analyses (Figure 2.8 & Table 2.6). Altering the dosage of the imprinted 
genes at the Dlk1-Dio3 region has also been shown to cause a range of endophenotypes, 
from growth deficiencies and developmental defects in the embryo and placenta, to 
defects in adult metabolism and brain function (Rocha et al. 2008). Some of the Dlk1-
Dio3 miRNAs are involved in activity dependent dendritic outgrowth of hippocampal 
neurons (Fiore et al. 2009). A rat model has also shown that PAE alters the expression of 
Dio3 and antisense Dio3os in the hippocampus, as well as altering related behaviors and 
physiology (Sittig et al. 2011; Dietz et al. 2012).  
SFMBT2 is a polycomb binding protein that interacts with, or ‘reads’, histones 
and transcriptionally represses HOXB13 (Lee et al. 2013). Sfmbt2 contains a rodent-
specific large cluster of miRNAs that has led to it becoming genomically imprinted 
(Wang et al. 2011). Sfmbt2 showed decreased methylation in the updated (2016) analysis 
and its miRNAs were deregulated by PAE (Appendix E).  Maternal disomy of the Sfmbt2 
region results in fetal and placental growth retardation, whereas paternal disomy was 
shown to result in normal fetal growth and placental overgrowth (Kuzmin et al. 2008). 
Recently, another moderate and voluntary maternal PAE paradigm was shown to alter 
adult levels of a vesicular glutamate transporter in the mouse hippocampus (Zhang et al. 
2015). The glutamate transporter showed increased mRNA levels that were correlated 
with decreased DNA methylation and increased (activating) H3K4me3 at the transporter 
promoter. Notably, while mRNA (Slc17a6) levels of the transporter were increased, the 
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protein (VGLUT2) levels were decreased by an imprinted miRNA (miR-467b-5p) from 
the Sfmbt2 cluster, which was functionally confirmed to bind to the transporter mRNA.  
Both the Snrpn-Ube3a and Dlk1-Dio3 regions undergo allele-specific chromatin 
decondensation (or ‘unwinding’) during neuronal maturation (Leung et al. 2009; Leung et 
al. 2011). These clusters are also shared between mice and humans and expressed in 
embryo, placenta, and in the adult, in which their expression is confined mostly to the 
brain (Seitz et al. 2004). The Snrpn-Ube3a and Dlk1-Dio3 regions have also been 
associated with several neurodevelopmental disorders (Leung et al. 2009). Furthermore, 
all three imprinted ncRNA clusters contain polycistronic transcripts, with some processed 
transcripts initially showing similar levels of expression that then change as a result of 
unequal stability (Seitz et al. 2004; Le Meur et al. 2005; Fiore et al. 2009; Wang et al. 
2011).  
The observations suggest that PAE might alter the regulation of not only 
individual miRNAs or snoRNAs, but entire clusters of co-regulated ncRNAs. More 
importantly, this process could involve differences in DNA methylation as DNA 
methylation is a functional mark at imprinting control regions. The nature of imprinted 
ncRNAs creates the potential for an environmentally responsive mechanism in the 
regulation of neurodevelopmental gene expression. Ultimately, given the observation of 
upregulated Snord115 in all four paradigms examined, the confirmation of results across 
two independent array technologies, and the similar endophenotypes associated with 
alterations to it, Snord115 may serve as an ideal candidate for future functional 
experiments investigating PAE. Thus, the above observations suggest that the similarity 
and variability in the manifestation of FASD could be in part attributed to the common 
(Snord115) and different ncRNAs and genes affected as a result of variability in 
exposure. 
2.5.2 Gene Families  
A number of gene families showed significant differential methylation as well as 
expression and may contribute to the endophenotypes of FASD. Some of these results are 
also supported by publications from independent groups. In terms of the histone genes, 
Hist1h3b also showed altered methylation in a whole embryonic culture of C57BL/6J 
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mice at early neurulation (Liu et al. 2009). The observation of altered methylation and 
expression observed from this gene family suggests transcriptional repression of histone 
protein production and, furthermore, a global deregulation of the cell cycle and epigenetic 
landscape that remains long after PAE. 
The Hox genes were also deregulated by PAE. In the T2 binge injection model 
mir-10b showed a -1.5 fold change (p=0.002) (Mantha et al. 2014). Notably, mir-10 is 
located within the Hox genes and also targets some of them (Lund 2010). Hox genes are a 
subset of homeobox genes and encode transcription factors that regulate developmental 
patterning, including in the brain (MacLean & Wilkinson 2010). The only unifying 
feature of all homeobox genes is that they encode a homeodomain, a motif that binds to 
specific DNA sequences, proteins, and even some RNAs (Shyu & Wilkinson 2000; 
Svingen & Tonissen 2006). Homeobox transcription factors have important roles in 
regulating the differentiation of cells during embryonic development by specifying the 
spatial positioning of cells and controlling cellular proliferation, apoptosis, cell adhesion, 
and cell migration (Pearson et al. 2005). Deregulation in the expression of homeobox 
genes can result in drastic alterations in development and subsequently result in profound 
changes in the identity of body segments (Duboule 2007; Krumlauf 1994).  
At the genomic level, the vertebrate Hox gene clusters show a specific 
organization (Duboule 2007). The four Hox clusters of mammals map to distinct 
chromosomes, are termed HoxA through HoxD, and contain 9 to 11 protein-coding genes 
that are transcribed from the same strand (Yekta et al. 2008). In many vertebrates the Hox 
genes are organized on chromosomes in a linear way that matches their expression order 
along the anterior-posterior axis. Furthermore, the Hox clusters are targeted by a number 
of miRNAs, some of which originate within the Hox clusters and have also been 
implicated in FASD (Yekta et al. 2008; Wang et al. 2009). Over 200 ncRNAs arise from 
around the Hox clusters, including miRNAs and the long non-coding RNA HOTAIR, 
which is transcribed from HoxC and results in repressive H3K27me3 at HoxD by 
recruiting polycomb repressive complex 2 (Rinn et al. 2007). The Rhox gene family is a 
set of homeobox genes clustered on the X chromosome (MacLean et al. 2005). The 
mouse Rhox gene cluster is the largest homeobox gene cluster. Similar to most homeobox 
genes, Rhox genes are expressed during embryonic development (MacLean et al. 2005; 
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Hogeveen & Sassone-Corsi 2005; Zhan et al. 2005; Daggag et al. 2008). However, unlike 
most homeobox genes, Rhox genes also show high gene expression levels after birth 
(MacLean et al. 2005). Thus, Rhox genes are candidates to control postnatal and adult 
developmental events, particularly those essential for male and female reproduction. 
Rhox5 is the most characterized Rhox gene and is regulated by many different stimuli, 
including differentiation signals, oncogenic signals, and hormones (Kobayashi et al. 
2006). Recently, Rhox5 was demonstrated to be regulated by histone H1 and DNA 
methylation (Maclean et al. 2011). Furthermore, alcohol dehydrogenase is critical for 
converting retinol to retinaldehyde, which is competitively inhibited by ethanol, and then 
later converted to the signaling molecule retinoic acid (Mezey & Holt 1971). As a 
developmental signaling molecule in mammals, retinoic acid is used to activate the 3’ 
Hox genes (Duester 2008). Thus, the Hox genes appear to represent a connection between 
acute alterations to developmental signaling and long-term alterations to the epigenome.  
Deregulation of the keratin-associated protein (Krtap) gene family was also 
observed. These results are similar to Marjonen et al., where a similar mouse model was 
used and a significant (p=0.04) 2.1 fold increase in the expression of Krtap6-1 and a 
significant (p=0.004) 1.7 fold decrease in the expression of Krtap27-1 was observed 
(Marjonen et al. 2015). Notably, keratinocytes constitute the vast majority of the 
epidermis (McGrath et al. 2004). It is tempting to speculate that these alterations in the 
adult brain may reflect on earlier alterations to developmental stem cell identity during 
neurulation where neural progenitor cells and the epithelium/epidermis begin to 
differentiate from each other. This observation may also alternatively or additionally 
reflect on the possibly of a premature exit from the cell cycle. 
Adam (a disintegrin and metalloproteinase) and Adamts genes were also 
deregulated by PAE. These peptidase gene families are involved in cleaving the extra-
cellular portions of trans-membrane proteins and stimulate neural crest migration 
(Prendergast et al. 2012; Kulesa & McLennan 2015). They have a role in cell adhesion 
and cell signaling as they are used to cleave and thus regulate cell surface molecules, such 
as Cadherin, Ephrin, EGF, TNF-α, and Notch (Reiss et al. 2005; Alfandari et al. 2009). 
ADAM10 also processes APP, which is involved in Alzheimer’s disease (Haass et al. 
2012). Furthermore, Adam13 has been shown to be required for 3 dimensional cranial 
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neural crest cell migration and interact with Cadherin11 (Cousin et al. 2012). Finally, 
another transmembrane protein family is the Tmem gene family, which is relatively 
uncharacterized and be may representative alterations to cellular signaling. 
2.5.3 Alterations to Cellular Signaling Genes 
The most significantly altered (p=9.01E–7) canonical pathway identified by the 
2012 analysis was Cdk5 signaling, where 60% of the genes involved showed significant 
differential methylation (Figure 2.6). Cdk5 signaling is a sensory pathway that is 
restricted to the nervous systems and plays a critical role in neuronal migration, neuronal 
differentiation, neurite outgrowth, synaptic vesicle exocytosis and neurotransmission, 
long-term potentiation, as well as the proteasome, autophagy, and apoptosis (Cheung & 
Ip 2012). Notably, Cdk5 signaling has been implicated in neurodegenerative diseases and 
circadian rhythm (Cheung & Ip 2012; Kwak et al. 2013).  
Additionally, 57% of the genes involved in the Pten signaling pathway showed 
significant (p=1.9E–06) differential methylation (Figure 2.7). Pten, was upregulated 
(1.38-fold change and p=2.5E–03) and the three miRNAs (mir-369-5p, mir-25 and mir-
495) that were predicted to target it by IPA were downregulated, with mir-369-5p 
belonging to the Dlk1-Dio3 cluster (Appendix A). This signaling pathway was also 
identified in the updated (2016) analysis as the phosphatidylinositol signaling system 
(Table 2.8). PTEN functions as a lipid phosphatase that counteracts the kinase function of 
phosphatidylinositol-3-kinase (PI3K) and suppresses AKT activation (Maehama & Dixon 
1998). Akt, which showed a gain of methylation at a predicted CTCF binding-site (Figure 
2.8A), is a major mediator of signaling pathways in response to a large spectrum of 
extracellular stimuli, which include PAE (Hard et al. 2005). Upon its activation in 
neurons, AKT phosphorylates different substrates, which in turn regulate diverse 
processes of neuronal development, including morphogenesis, dendritic development, 
synapse formation and synaptic plasticity, all of which are altered in FASD (Yoshimura et 
al. 2006). Furthermore, AKT is known to regulate autophagy/lysosome and 
ubiquitination/proteasome systems, which recycle damaged proteins (Wang et al. 2012; 
Xu et al. 2015). AKT has been shown to phosphorylate the GABAA receptor, which 
increases the number of receptors on the plasma membrane surface, and thus promotes 
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synaptic plasticity (Wang et al. 2003). Studies in mice with a targeted inactivation of Pten 
in differentiated neurons showed abnormal social interaction and exaggerated responses 
to sensory stimuli (Kwon et al. 2006). Given the integral role of Pten in 
neurodevelopment, it is no surprise that it has been implicated in the developmental basis 
of many major psychiatric disorders (Kim et al. 2009) and FASD (Green et al. 2007). 
Overall, the alterations to all of the above clusters and signaling pathways suggests that 
there may be a molecular footprint of alterations to developmentally important regions 
that is sometimes but not always reflected in adult gene expression.   
2.5.4 Considerations for Future Research 
The research presented in this chapter highlights a number of considerations for 
future experimentation. The first consideration is the confirmation of alterations to gene 
expression. Although qPCR is the gold standard for confirmation, the technology used at 
the time of experimentation contained a limitation related to experiments of this nature. 
Specifically, it may not be sensitive enough to consistently detect low, but statistically 
significant, fold changes (<2.0) (Peirson & Butler 2007; Vikalo et al. 2010) that are 
typical of the fine-tuning nature of miRNAs (Moazed 2009). The results presented in this 
chapter are similar to Marjonen et al., where a voluntary maternal consumption PAE 
paradigm revealed alterations to similar gene families. They noted that, “The expression 
levels of the differentially expressed genes observed in hippocampus were low and 
impossible to verify by quantitative PCR (TaqMan)” (Marjonen et al. 2015). More 
recently, the Singh lab has shown that digital droplet PCR (ddPCR), which is a more 
sensitive technology capable of detecting low fold changes and low copy numbers, can be 
used to confirm changes not found to be significant by standard qPCR (Chater-Diehl et al. 
2016). Therefore, future PAE experimentation would benefit from utilizing ddPCR as a 
method for confirming some alterations to gene expression.  
The second consideration for future research is cell type heterogeneity. In this 
chapter whole brain homogenate, which contains a number of cell types including 
neurons and glia, was examined. Therefore, the observed differential gene and ncRNA 
expression as well as DMRs may represent a combined epigenomic signature of depleted 
vulnerable cell types as well as specific alterations to the epigenome of surviving cells 
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(Kleiber, Diehl, et al. 2014). Future experimentation would benefit from single-cell 
sorting techniques. The third technical consideration for future research is the functional 
confirmation of predicted miRNA and target mRNA binding. This could be accomplished 
by in vitro luciferase reporter assays (Zhang et al. 2015). The fourth technical 
consideration is the utility of updating previous bioinformatic analyses. Bioinformatics is 
a rapidly advancing field and over relatively short periods of time a number of new 
annotations, algorithms, and software packages become available. Updated or new 
bioinformatic methods can offer additional insight into previous analyses and allow for a 
more direct comparison to more recent experiments utilizing the newer methods. 
However, as the results of this research suggest, a newer analysis does not necessarily 
invalidate a previous analysis as each bioinformatic method may be better suited for a 
specific application. Ultimately, with all of the above considerations in mind, there are a 
number of conclusions that can be drawn from the results of this chapter.   
2.5.5 Conclusion 
The results of this research demonstrate in vivo, long-term, and epigenome-wide 
alterations in PAE mice. Furthermore, the changes in DNA methylation and ncRNAs may 
maintain long-term alterations to gene expression following PAE, as the epigenomic 
changes appear to begin at the time of PAE, where they may then be inherited through 
successive cell proliferation and differentiation. Thus, the mouse model results presented 
in this chapter offer the hypothesis that an ontogenetic ‘footprint’ of PAE exists long after 
exposure (Kleiber et al. 2012) and provides novel evidence that was used to expand it into 
the epigenetic landscape (Kleiber, Diehl, et al. 2014; Chater-Diehl et al. 2016). The 
alterations in the epigenome and transcriptome are hypothesized to have arisen in 
developmentally and/or functionally similar genes in early stem cells (Kleiber, Diehl, et 
al. 2014; Marjonen et al. 2015). Finally, this footprint may undergo additional 
modification throughout development and by other environmental exposures.  
Ultimately, the results of this research provide a number of candidate genes and 
pathways for future functional genomics studies and also provide a foundation for human 
studies. Perhaps more importantly, the epigenomic hypothesis of FASD as proposed may 
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be applied towards understanding the effect of neurodevelopmental exposures, which 
includes insight into neurodevelopmental disorders. 
 
Footnote 
A modified version of this chapter has been published (Laufer et al. 2013).  
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Chapter 3 
Exploration of Differential DNA Methylation in 
Children with FASD 
3.1. Overview 
The results included in chapter 2 show that prenatal alcohol exposure (PAE) in 
mice involves changes to the DNA methylation of genes implicated in the manifestation 
of a number of endophenotypes related to fetal alcohol spectrum disorders (FASD). The 
results suggest that the differential DNA methylation in mice is caused by PAE. 
Furthermore, the alterations to DNA methylation may maintain changes to gene 
expression, which are present at adulthood and may result in the lifelong manifestation of 
some FASD endophenotypes. The experiments included in this chapter examine young 
children with a diagnosis of FASD whose mothers consumed alcohol during pregnancy. 
The human experiments had a restriction in that post-mortem brains were not available. 
Therefore, buccal swabs were utilized as they can be obtained non-invasively from 
individuals of any age and buccal epithelial cells represent the closest peripheral lineage 
related to cells incorporated in the brain. 
This chapter analyzes data from human samples and characterizes the altered 
genome-wide CpG methylation profile in buccal swabs from children with FASD as 
compared to age, sex, and genetic background matched controls. Most, but not all, of 
these results are published in Laufer et al. (2015). The results have revealed a set of 
candidate genes and pathways that are altered by PAE in children with FASD. Select 
CpGs from the methylomic profile of the discovery cohort (nFASD=5, ncontrol=6) were 
further examined in a larger number of children. The results show heterogeneity that is 
patient specific. As it stands, no single gene is consistently affected in all patients. 
However, the results do suggest that, as in mice, children with FASD show non-random 
changes in DNA methylation as compared to matched controls. 
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3.2.  Introduction 
The mechanisms of how PAE results in life-long FASD remains a major concern 
in the medical community. The cause of FASD, PAE, is known (Williams et al. 2015) 
and theoretically 100% preventable, yet the impact on society remains substantial. 
Current preventive and ameliorative strategies are complex and ineffective. The best 
strategy available is an early diagnosis that enables early therapeutic intervention (Paley 
& O’Connor 2009; Chokroborty-Hoque et al. 2014). A reliable method for early 
diagnosis of FASD is not yet available and will require understanding the underlying 
long-term molecular mechanisms. For a variety of reasons, the best insight into FASD has 
come from studies of animal models. Molecular results from rodent models of PAE have 
suggested that epigenetic alterations underlie FASD (Kleiber et al. 2014) and have been 
reproduced in a number of laboratories (Marjonen et al. 2015; Basavarajappa & Subbanna 
2016). Unlike mouse model research, reports on the epigenetic profiles of humans with 
FASD are rather limited.   
In 2009, Ouko et al. examined the sperm of alcohol consuming adult men and 
found hypomethylation at the two imprinted regions; H19 and DLK1-DIO3 (Ouko et al. 
2009). In 2010, Krishnamoorthy et al. examined human embryonic stem cells and 
observed that exposure to low amounts of alcohol altered a nicotinic acetylcholine 
receptor subunit (CHRNA5), which is linked to the altered expression of GABA and 
Glutamate (NMDA) receptors  (Krishnamoorthy et al. 2010). In 2011, Taléns-Visconti et 
al. examined neural differentiation in neuroepithelial progenitor cells, which were 
induced from human embryonic stem cells (hESCs), and observed that alcohol alters the 
survival, differentiation into neurons and glia, and expression of select genes related to 
these processes (Talens-Visconti et al. 2011). 
More recently, Khalid et al. examined the transcriptome and methylome of hESCs 
exposed to alcohol (Khalid et al. 2014). They observed that the expression of genes 
related to metabolic processes, oxidative stress, and neuronal properties of stem cells 
were altered. The group also examined differential methylation and observed that 
undifferentiated cells appear to be more vulnerable to alcohol than their differentiated 
counterparts, the alterations are wide-spread with distinct regions of hypermethylation, 
and that not all altered methylation corresponds to altered transcription. The top genes 
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showing altered methylation were involved in neuroactive ligand–receptor interaction, 
vascular smooth muscle contraction, calcium signaling pathways, and energy metabolism. 
Additionally, Halder et al. and Mandal et al. examined the effect of alcohol on human 
embryonic carcinoma cells that were induced to undergo neural differentiation (Halder et 
al. 2015; Mandal et al. 2016). They observed alterations in pathways related to 
neurodevelopment, cell-signaling (including PI3K/AKT/mTOR), and cell-adhesion.  
At the time of this research, two other research groups had published in vivo 
examinations of the association between FASD and DNA methylation at select loci in 
humans. Lee et al. examined a Korean cohort of families, where it was found that there 
are changes in the unsorted peripheral blood of parents and also the cord blood of FASD 
children (Lee et al. 2015). There was a significant reduction of methylation to the 
promoter of a dopamine transporter (SLC6A3) in heavy alcohol consuming fathers and 
their offspring. The SLC6A3 promoter also showed a significant decrease of promoter 
methylation in mothers who consumed both moderate and heavy amounts of alcohol. The 
methylation of a serotonin transporter (SLC6A4) promoter was significantly decreased in 
children from both heavy and moderate alcohol consuming mothers. Methyl CpG binding 
protein 2 (MECP2) showed increased promoter methylation in the offspring of mothers 
with moderate alcohol consumption. The other human report is by Masemola et al., who 
examined saliva in a South-African cohort (Masemola et al. 2015). There is elegance to 
the examination of saliva (buccal epithelial cells) in that the cells share an ontogenetic 
relationship to neuronal cell types via the ectoderm. The aforementioned study only 
focused on confirmed cases of FAS, and did not examine FASD, and the differential 
methylation examined was limited to few selected imprinting control regions (ICRs). 
Most of the pyrosequenced regions weren’t informative but there were significant 
decreases of methylation in maternal ICRs. KvDMR1 showed a 7.09% decrease in 
methylation and PEG3 showed a 1.49% decrease.  
Taken together, the examinations into human cells shows similarities in alcohol 
response to the mouse model presented in chapter 2. Also, at the time of this research, no 
published study on humans had attempted genome-wide DNA methylation scans of 
patients born with FASD. In this chapter, I will describe the results of experiments on 
cheek swab DNA methylation from young children diagnosed with FASD as compared to 
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unaffected (age, sex, and race) matched controls. The results are informative and argue 
that the effects of PAE on DNA methylation are similar but not identical between the 
mouse model and human patients. The results suggest that the mouse model used to study 
the molecular underpinning of PAE is valid. They also show that the analysis of a single 
gene cannot be used to identify FASD, which demonstrates the heterogeneity of this 
complex disorder. 
3.3. Materials & Methods 
The results are primarily based on two cohorts [discovery (nFASD=5, ncontrol=6) and 
replication (nFASD=6, ncontrol=6)] of young children clinically diagnosed with FASD by Dr. 
J. Kapalanga in Ontario, Canada. All subjects of the discovery cohort had most features 
of FASD and matched controls showed no sign of the disorders (Table 3.1A). The 
patients were recruited from the same clinic while visiting for annual check-ups or 
relatively minor non-neurodevelopmental or behavioural problems, which may include 
asthma, allergies, musculoskeletal problems, or gastrointestinal problems. Following 
ethical approval and informed consent from parents or guardians, the study subjects 
contributed cheek swabs for analysis of buccal epithelial DNA. A second cohort of FASD 
patients (replication cohort) was comprised of a different set of 6 children with FASD and 
unaffected controls. Although four (E8, E13, E18, E19) of the six patients of the 
replication cohort were 6 -10 year-old males and not on medication, two were older 7 and 
9 year-old females (E7 and E17) and on psychotropic/stimulant medication (Table 3.1B). 
Finally, a third cohort representative of the general population, and consisting in part of 
the first two cohorts, from Owen Sound, Ontario was also examined (Appendix G). This 
cohort primarily consisted of FASD patients that were much more heterogeneous. The 
FASD patients and matched controls in the general population cohort were much more 
variable in terms of age, sex ratio, ancestry, family history of mental illness, as well as 
other medical conditions and required medication. 
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Table 3.1. Clinical features of patients from the discovery (A) and replication (B) cohorts 
with the diagnosis of FASD. 
 
A Discovery Cohort             
 
Patient ID E1 E2 E3 E4 E5 E6 
 
Patient  (Age) and Sex  (6)  M 
 (6)  
M 
(5)  
M 
(4)  
M 
 (3)  
M 
(3) 
 M 
 
Clinical Features             
 
Developmental delay  x x x x x x 
 
Hyperactivity, poor impulse control  x x x x x x 
 
Learning disorders x x x       
 
Short attention span and inattention x x   x     
 
Conduct disorder x x x   x   
 
Oppositional defiant disorder x     x x   
 
Social difficulties x     x x   
 
Nervousness and anxiety   x x x     
 
Mood disorder x     x     
 
Macrocephaly/macrotia   x x       
 
Microcephaly/microtia       x x   
 
Distinctive facial features x     x x x 
 
Stimulant/Psychotrophic Meds No No No No No No 
        B Replication Cohort             
 
Patient ID E7 E8 E13 E17 E18 E19 
 
Patient (Age) and Sex  (7)  F 
(6) 
 M 
(6)  
M 
(9)  
F 
(6)  
M 
(10) 
 M 
 
Clinical Features             
 
Developmental delay  x x x   x x 
 
Hyperactivity, poor impulse control  x x x x x x 
 
Learning disorders x   x   x x 
 
Short attention span and inattention x x x x x x 
 
Conduct disorder x x x x x x 
 
Oppositional defiant disorder x x x x     
 
Social difficulties x x x       
 
Nervousness and anxiety x x x     x 
 
Mood disorder     x x   x 
 
Macrocephaly/macrotia   x         
 
Microcephaly/microtia           x 
 
Distinctive facial features x   x     x 
 
Stimulant/Psychotrophic Meds  Yes No No Yes No No 
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3.3.1. Methylation Array 
The Illumina HumanMethylation450 BeadChip (450K array) is a dual channel 
SNP genotyping microarray that utilizes sodium bisulfite conversion and a targeted array 
approach to examine DNA methylation. During sodium bisulfite treatment, cytosine is 
converted by deamination to uracil, whereas 5-methylcytosine (5mC) is protected from 
the conversion. During PCR amplification, uracil is paired with adenine and that adenine 
is later paired thymine. Thus, bisulfite conversion creates a single nucleotide variant that 
converts cytosine to thymine, whereas 5mC is detected as a cytosine. The 450K array 
interrogates 485,764 sites at single nucleotide resolution across 99% of RefSeq genes 
(Bibikova et al. 2011; Sandoval et al. 2011). There is an average of 17 CpG sites per a 
gene that represent the promoter, 5’ UTR, first exon, gene body, and 3’ UTR. The 450K 
array covers 96% of CpG islands and other features, as well as sites based on genome-
wide association studies (GWAS). Methylation levels, known as β-values, are determined 
by comparing the ratio of C to T at the CpG site. 
In order to analyze their DNA methylation, individual cheek swabs from FASD 
and matched control children were used to isolate genomic DNA using the QIAamp DNA 
Mini Kit following manufacturer’s protocol. This DNA was subject to sodium bisulfite 
modification at The Centre for Applied Genomics (Toronto, Canada). The genome-wide 
CpG methylation for each subject was assessed using the 450K array, following the 
manufacturer’s protocol. The arrays were scanned using Illumina’s GenomeStudio at The 
Centre for Applied Genomics (Toronto) that generated scan data (.idat files) for each 
subject used in this analysis.  
The .idat files were analyzed using Partek Genomics Suite® Version 6.6. A site 
based DNA methylation workflow for Illumina BeadArray Methylation was utilized. Pre-
processing using both control normalization and background subtraction was performed 
using Illumina’s algorithm to generate β-values. β-values were then normalized, 
converted to a fold-change and subjected to a one-way ANOVA analysis to identify 
regions of differential methylation using annotations from Hg18. Custom genome dot 
plots (also known as Manhattan plots) were generated from the ANOVA results. 
Different stringencies of genes list were used for hierarchical clustering (p<0.005), gene 
ontology (p<0.005) analysis using Enrichr (Chen et al. 2013), and bioinformatic pathway 
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analysis via Partek Pathways (p<0.05). Additional annotations were added to top CpGs 
using Ensembl (Flicek et al. 2014) (for novel ncRNAs) and Uniprot (UniProt-Consortium 
2014) (for protein function and localization). The subset-quantile within array 
normalization (SWAN) algorithm (Maksimovic et al. 2012; Fortin et al. 2014) from the 
minifi bioconductor package was used within Partek to allow for the multi-batch analysis 
(Pidsley et al. 2013). 
3.3.2. Pyrosequencing  
Pyrosequencing® is a sequencing by synthesis method (Tost & Gut 2007; Nyrén 
2007). When a deoxyribonucleoside triphosphate (dNTP) is incorporated a pyrophosphate 
is released. The pyrophosphate is converted to ATP and used by luciferase to produce 
light. The nucleotides are added a single base a time, and degraded by apyrase in-between 
steps. Pyrosequencing enables absolute quantification of methylation levels without 
depending on normalization to matched controls, and thus is ideal for obtaining 
methylation in individual cases. While the gold standard for DNA methylation, 
pyrosequencing is relatively limited by short reads and a high use of resources.   
In order to confirm the results of the 450K array, the same bisulfite converted 
buccal swab DNA from the discovery cohort array was pyrosequenced by EpigenDx on 
the PSQ96 HS System (Qiagen) following the manufacturer’s instructions, using custom 
assays (www.EpigenDx.com), and a gradient of controls with known methylation levels. 
This allowed for the quantification of the absolute percent methylation of each CpG using 
QCpG software (Qiagen) (Lim et al. 2014). The sequencing reads also allowed for the 
analysis of SNPs known to be within or close to the CpGs of the 450K probes.  
For the follow-up into the general population cohort, assays were developed based 
on performance from the DNA methylation arrays, primarily from the discovery cohort. 
A number of genes affected in arrays were examined by pyrosequencing. The gene 
COLEC11 was selected based on results on the 450K arrays and the NGS panel. 
PCDBH18 was selected based on performance on the human arrays and the results in the 
trimester 3 binge exposure mouse model. HTT was selected due to performance on 
previous DNA methylation arrays and pyrosequencing. Furthermore, a number of CpG 
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sites located at 12q24.31, 10q26.12, and 2q22.1 were selected based on performance from 
the NGS panel.  
3.3.3. NGS Panel 
The Ion Torrent Personal Genome Machine (PGM)TM is a next-generation 
sequencing (NGS) system that utilizes sequencing by synthesis and detects the release of 
hydrogen ions from dNTPs during polymerization (Merriman et al. 2012). dNTPs are 
added one at a time and the released hydrogen ion is detected by an ion sensor. While the 
Ion Torrent PGM is less accurate than pyrosequencing, it is more resource effective and 
thus can be used to create custom targeted bisulfite sequencing panels to screen a large 
number of loci across relatively few samples. Therefore, a subset of the 268 CpGs 
identified on the arrays were selected for further development on a next generation 
sequencing (NGS) panel using the Ion Torrent PGM. Thirty of the top performing CpGs 
from the 450K array were selected as loci for primer design based on the criteria of a 
greater than 1.5 fold change and a preference against a large number of flanking CpGs. 
Thirty gene and intragenic sequences +/- 5000 bases were acquired from the Ensembl 
database or UCSC database. Target regions of each gene were selected based on the 
methylation array results. The panel design, bisulfite conversion, sequencing, and 
calculation of methylation values was performed by EpigenDx (Hopkinton, MA). 
500 ng human genomic DNA was bisulfite treated using the EZ DNA Methylation 
Kit (Zymo Research). Multiplex PCR was performed using 0.5 units of TaKaRa EpiTaq 
HS (Takara Bio) in 2x master mix including primers (EpigenDx) in a 20 µl reaction. The 
PCRs were performed using the following protocol: 95ºC 15 min; (95ºC 30s; 63ºC (or 56 
ºC) 30 s, -1°C; 68ºC 30 s) 9x cycles; (95ºC 30s; 55ºC (or 50ºC) 30 s; 68ºC 30 s) 36x 
cycles; 68ºC 5 min; 4ºC hold. Libraries were prepared using the KAPA Library 
Preparation Kit (Cat# KK8310) for Ion Torrent and were quantified by real-time PCR 
using KAPA Library Quantification (KAPA Biosystems). 344 million library molecules 
were templated using the Ion PGM Template OT2 200 kit and sequenced using an Ion 
PGM™ Sequencing 200 Kit v2 kit with Ion 316™ and Ion 318™ Chips (Life 
Technologies) on the Ion Torrent PGM. FASTQ files from the Ion Torrent PGM were 
aligned to the local database using open source Bismark Bisulfite Read Mapper with the 
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Bowtie2 alignment algorithm. Methylation levels were calculated in Bismark by dividing 
the number of methylated reads by the number of total reads, considering all CpG sites 
covered by a minimum of 30 total reads.  
The results presented include a total of 31 target PCRs designed by PyroMark 
Assay Design Software (Qiagen, Pyrosequencing) for the assessment of the human 
samples. During design and optimization 23 loci passed quality control for assay design, 
leaving a total of 67 CpGs for analysis from the Buccal swabs of children. The CpG 
methylation level was then analyzed using a one-way ANOVA.  
3.4. Results 
The results suggest that FASD is associated with a profile of differential DNA 
methylation in buccal swabs. Using a stringent but not false discovery rate (FDR) 
corrected CpG list (p<0.005), genome-wide differential methylation of children with 
FASD was analyzed in the: (A) discovery cohort and (B) replication cohort (Figure 3.1). 
In each case, the heatmaps show that children diagnosed with FASD clearly group 
together and are distinct from matched non-FASD controls. From theses arrays a one-way 
ANOVA was created to generate a list of CpGs and corresponding genes that showed 
significant differential methylation between FASD children and matched controls (after 
pre-processing and data normalization). The results of the discovery and replication 
cohorts were analyzed separately in order to avoid any batch effects. This analysis of the 
discovery cohort that represented established maternal drinking and relatively uniform 
manifestation of FASD (developmental delays, hyperactivity/poor impulse control, and 
mental deficits) identified 268 significantly (p<0.005) differentially methylated CpG sites 
(Appendix H). Also notable is the differential methylation of genes that modify the 
epigenome, such as EHMT2 (p=0.0002), PRDM6 (p=0.004), and HDCA4 (p=0.004). 
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Figure 3.1. Differential DNA methylation in children diagnosed with FASD: A) Heatmap 
of significantly (p<0.005) differentially methylated targeted CpG sites generated using 
hierarchical clustering of standardized β-values from buccal epithelial DNA obtained via 
swabs from FASD (n=6) and matched control (n=5) children from the discovery cohort; 
B) Heatmap of significantly (p<0.005) differentially methylated targeted CpG sites 
generated using hierarchical clustering of standardized β-values from buccal epithelial 
DNA obtained via swab from FASD (n=6) and matched control (n=6) children from the 
replication sample.  
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3.4.1. Gene Network and Ontologies Associated with FASD 
Figure 3.2 shows the GeneMANIA network generated from the genes regulated 
by the 268 CpG sites that showed significantly (p<0.005) altered methylation in the 
discovery cohort. Among other genes it identified 11 sites that regulate the clustered 
protocadherins genes located on 5q31 (Figure 3.3). 
Next, the differentially methylated genes from the discovery cohort were used in 
an analysis towards identification of specific biological processes, functions, and 
pathways affected as a result of changes in methylation. The results (Table 3.2) show that 
the major biological processes affected include cell adhesion and nervous system 
development. There are alterations to relevant molecular functions including calcium ion 
binding and channel activity. The genes code for proteins localized to synaptic vesicles 
and the cytoskeleton. Notably, alterations to similar ontologies were observed in the gene 
expression data from the mouse model binge injection paradigms (Kleiber et al. 2013). 
There were also similar alterations to DNA methylation observed in the continuous 
preference drinking (CPD) paradigm presented in chapter 2 and those results are 
compared in chapter 4.  
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Figure 3.2. GeneMANIA associative network analysis of genes annotated to 
differentially methylated CpGs (p<0.005) from cheek swabs of the discovery cohort.  
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Figure 3.3. Manhattan plot of human chromosome 5 from the discovery cohort. Genomic location is plotted on the x-axis and –log10 
(p-value) of differential CpG methylation from FAE is on the y-axis (Manhattan plot). Each dot represents a single CpG site. A red dot 
indicates an increase in methylation and a blue dot indicates a decrease in methylation. A black arrow indicates the clustered 
protocadherin locus. 
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Table 3.2. Ontologies for genes with significant (p<0.005) differences in CpG 
methylation from the discovery cohort. 
Enrichr GO Biological Processes  Overlap p-value 
Homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) 25/142 5.9E-24 
Cell-cell adhesion (GO:0098609) 26/191 2.5E-22 
Cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742) 26/190 2.2E-22 
Nervous system development (GO:0007399) 12/277 1.0E-05 
Replacement ossification (GO:0036075) 4/30 2.3E-04 
Endochondral ossification (GO:0001958) 4/30 2.3E-04 
Ossification (GO:0001503) 7/116 1.1E-04 
Osteoblast development (GO:0002076) 3/19 9.4E-04 
Vesicle localization (GO:0051648) 4/51 1.4E-03 
Calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules 
(GO:0016339) 3/28 2.6E-03 
Enrichr GO Cellular Location Overlap p-value 
Cytoplasmic vesicle membrane (GO:0030659) 8/229 7.2E-04 
Cytoplasmic vesicle part (GO:0044433) 10/363 9.4E-04 
Vesicle membrane (GO:0012506) 8/249 1.2E-03 
Actin cytoskeleton (GO:0015629) 6/193 5.8E-03 
Z disc (GO:0030018) 4/87 6.5E-03 
Actin filament (GO:0005884) 3/44 6.6E-03 
Voltage-gated sodium channel complex (GO:0001518) 2/15 8.3E-03 
Sodium channel complex (GO:0034706) 2/18 1.1E-02 
Synaptic vesicle membrane (GO:0030672) 2/22 1.6E-02 
Integral component of plasma membrane (GO:0005887) 15/1066 2.9E-02 
Enrichr GO Molecular Function Overlap p-value 
Calcium ion binding (GO:0005509) 34/698 3.3E-15 
Solute:proton antiporter activity (GO:0015299) 3/17 8.4E-04 
Ion channel binding (GO:0044325) 5/80 1.3E-03 
Solute:cation antiporter activity (GO:0015298) 3/28 3.1E-03 
Monovalent cation:proton antiporter activity (GO:0005451) 2/10 5.5E-03 
3',5'-cyclic-GMP phosphodiesterase activity (GO:0047555) 2/11 6.5E-03 
Sodium ion transmembrane transporter activity (GO:0015081) 5/128 8.6E-03 
Ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374) 3/46 1.1E-02 
Activating transcription factor binding (GO:0033613) 3/53 1.6E-02 
Fibroblast growth factor binding (GO:0017134) 2/20 1.8E-02 
Monovalent inorganic cation transmembrane transporter activity (GO:0015077) 8/343 1.8E-02 
Voltage-gated sodium channel activity (GO:0005248) 2/22 2.0E-02 
Cation:cation antiporter activity (GO:0015491) 2/22 2.1E-02 
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3.4.2. The Top Canonical Pathways are Related to 
Neurodevelopment and Neurotransmission  
The top canonical pathways (Table 3.3) of the significantly (p<0.05) altered CpGs 
identified are largely related to neurodevelopment as they are involved in stem cell 
signaling, synaptic connections, metabolism, and immune processes. Hippo signaling 
(Figure 3.4) had 25 out of 120 genes affected, which was the most significant enrichment 
(p=0.0002) in the pathway analysis. The glutamatergic synapse pathway (Figure 3.5) was 
the top synaptic pathway and showed a significant (p=0.001) enrichment with 18 out of 
77 genes showing significant (less stringent list, p<0.05) alterations to CpG methylation. 
Furthermore, there was a significant (p=0.005) alteration to the calcium signaling 
pathway (Figure 3.6) with 23 out of 102 genes affected. Notably, a number of synaptic 
pathways were enriched. The retrograde endocannabinoid signaling pathway (Figure 3.7) 
was significantly (p=0.006) altered with 16 out of 60 genes affected and the serotonergic 
synapse pathway (Figure 3.8) was significantly (p=0.009) altered with 16 out of 63 genes 
affected.  
The pathways presented in detail were selected due to their similarities to results 
from the mouse model (chapter 2). Also notable is the overlap of the human methylation 
results with alterations to gene expression observed in the mouse binge injection 
paradigms (Kleiber et al. 2013). In the trimester 1 exposure paradigm calcium signaling 
was altered. In the trimester 2 exposure paradigm serotonin receptor signaling was 
altered. In the trimester 3 exposure paradigm glutamate receptor signaling, retinoic acid-
mediated apoptosis, and circadian rhythm signaling were altered. Finally, a role for 
retrograde endocannabinoid signaling was also seen in the trimester 3 exposure model, 
where a miRNA and target receptor were reciprocally deregulated (Stringer et al. 2013).  
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Table 3.3. Pathway analysis for genes with significant (p<0.05) differences in CpG 
methylation from the discovery cohort. 
Partek KEGG Pathways Overlap  p-value 
Hippo signaling pathway 25/85 2.0E-04 
Other types of O-glycan biosynthesis 8/10 2.9E-04 
Phagosome 23/85 9.7E-04 
Glutamatergic synapse 18/59 1.1E-03 
HTLV-I infection 33/152 2.3E-03 
Calcium signaling pathway 23/99 5.1E-03 
Retrograde endocannabinoid signaling 16/60 6.2E-03 
Viral myocarditis 10/29 7.0E-03 
Viral carcinogenesis 23/104 8.4E-03 
Serotonergic synapse 16/63 9.2E-03 
Axon guidance 17/71 1.2E-02 
Allograft rejection 8/22 1.2E-02 
Cell adhesion molecules (CAMs) 18/78 1.3E-02 
Endocytosis 23/109 1.3E-02 
Lysine degradation 9/28 1.5E-02 
Graft-versus-host disease 8/23 1.5E-02 
Basal cell carcinoma 10/34 1.7E-02 
Type I diabetes mellitus 8/24 1.8E-02 
Fatty acid metabolism 7/20 2.1E-02 
Circadian entrainment 13/53 2.2E-02 
Autoimmune thyroid disease 8/27 3.0E-02 
Long-term depression 8/28 3.5E-02 
Focal adhesion 21/109 3.8E-02 
ECM-receptor interaction 11/46 3.9E-02 
Dorso-ventral axis formation 5/14 4.7E-02 
Cholinergic synapse 14/68 5.5E-02 
Apoptosis 10/44 6.1E-02 
Arrhythmogenic right ventricular cardiomyopathy (ARVC) 9/38 6.1E-02 
Wnt signaling pathway 16/83 6.4E-02 
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Figure 3.4. Genes in the hippo signaling pathway affected by altered CpG methylation in children from the discovery cohort. Genes 
were identified and then assembled as protein complexes. Green marks a decrease in methylation and potentially increased gene 
expression while red indicates a increase in methylation and potentially decreased gene expression. 
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Figure 3.5. Genes in the glutamatergic synapse pathway that were affected by altered CpG methylation in children from the discovery 
cohort. 
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Figure 3.6. Genes in the calcium signaling pathway that were affected by altered CpG methylation in children from the discovery 
cohort.
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Figure 3.7. Genes in the retrograde endocannabinoid signaling pathway that were 
affected by altered CpG methylation in children from the discovery cohort. A list of 
notable CpGs as well as related genes and functions is also presented. 
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Figure 3.8. Genes in the serotonergic synapse pathway that were affected by altered CpG methylation in children from the discovery 
cohort.
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3.4.3. Confirmation of the 450K Array by Pyrosequencing  
Next, microarray results were examined using an independent technology that 
does not depend on the matched controls for modeling. For this, probes with different 
performances from the carefully matched discovery cohort were chosen. First, one of two 
CpGs to pass multiple testing at the FDR filtering level in this relatively small cohort was 
chosen. The array analysis identified the enhancer of COLEC11 (FDR p=1.93x10-7). 
Pyrosequencing analysis of the affected CpG (cg15730644) in COLEC11 revealed a 
significant increase (p=0.002) with an average methylation of 94.2% in FASD compared 
to 79.8% in matched controls (Figure 3.9A). It also shows that all children affected with 
FASD consistently have higher methylation at this CpG site compared to their matched 
controls. The sequencing run also examined SNP rs182514706 (T>G) and found that it 
was not present in any members of either the exposed or control groups and thus would 
not interfere with the confidence in the performance of this probe.  
The next probe examined did not pass a FDR cut-off and is more representative of 
the gene list used for higher level analysis, including heatmaps, ontologies, and pathways. 
HTT (Huntington) is a hub gene involve in neurological disorders and showed a 1.5 fold 
increase (p=0.003) in methylation in FASD patients. In the mouse trimester 3 binge 
injection paradigm HTT showed a significant (p=0.001) 23% decrease in gene expression 
in adult brains. Pyrosequencing analysis of the affected CpG (cg26128129) revealed that 
the CpG in the enhancer of HTT shows a significant increase (p=0.001) with an average 
methylation of 87.6% in FASD and an average of 50.7% in matched controls (Figure 
3.9B). Interestingly, there is variation among the control samples as compared to the 
FASD patients. This CpG is known to contain a SNP [rs362313 (C>T)] that causes a loss 
of the CpG, as well as another SNP near the probe [rs147422679 A>G]; however, 
pyrosequencing confirmed neither SNP was present in any of the individuals examined. 
The available results support the suggestion that CpG specific DNA methylation is altered 
in the cheek swab DNA of children affected with FASD.  
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A)  
 
 
B)  
 
 
Figure 3.9. Pyrosequencing results for (A) COLEC11 and (B) HTT in the discovery 
cohort. Patient ID represents the individuals from the discovery cohort and the metrics 
represent percent methylation of the CpG from the sample. 
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3.4.4. Examination of Select Loci in the General Population  
An average of 10 FASD and 7 Control patients were analyzed across 23 genes 
(Table 3.4 and Appendix I). Chr12q24.3 showed a significant (p=0.036) decrease in 
methylation (FASD = 2.7±1.2, Control = 7.4±1.5) at CpG 24, while CpG #26 
(cg20313522) showed a trend (p=0.098) of decreased methylation (FASD = 2.7±1.3, 
Control = 8.5±3.0). COLEC11 showed a trend (p=0.056) of decreased methylation 
(FASD = 57.5±10.9, Control = 85.3±5.0) at cg15730644. Chr2q22.1 showed a trend 
(p=0.080) of decreased (FASD = 91.5±1.0, Control = 87.5±2.0) methylation at CpG 19, 
while CpG 20 (cg23885472) showed no significant (p=0.228) alteration. Chr10q26 
showed a trend (p=0.107) of increased (FASD = 85.4±4.2, Control = 71.7±7.3) 
methylation at cg03697076. The above 4 were loci were deemed informative across all 
individuals and used for follow-up pyrosequencing in more members from the general 
population. However, pyrosequencing analysis revealed no significant alterations once 
applied to more individuals (Table 3.5 and Appendix J).  
  
 122 
Table 3.4. Summary of NGS panel results for an average of the same ten FASD and 
seven control patients from Owen Sound, Ontario that were analyzed across 23 genes.  
Gene Symbol CpG Mean FASD Mean Control p value  
ALPL 
CpG#-701 12.3±1.8 13.4±2.0 0.69 
CpG#-700 (cg10487998) 17.9±3.0 14.5±3.5 0.47 
AK3L CpG#95 (cg24049468) 19.6±2.3 21.4±2.6 0.60 
Chr1p21.3 
CpG#2 10.3±3.2 11.6±5.9 0.84 
CpG#3 49.2±6.2 59.7±7.8 0.30 
CpG#4 40.4±8.4 54.7±8.0 0.24 
CpG#5 (cg21436544) 41.0±5.6 52.8±7.3 0.21 
CpG#6 51.9±5.3 60.2±6.3 0.32 
C1orf110 
CpG#-68 (cg01450736) 66.7±5.3 71.8±1.9 0.43 
CpG#-67 11.8±6.3 16.4±6.4 0.62 
CpG#-66 83.3±4.4 86.4±1.3 0.55 
COLEC11 
CpG#602 (cg15730644) 57.5±10.9 85.3±5.0 0.06 
CpG#603 81.5±2.1 83.7±0.9 0.41 
CpG#604 (cg13811808) 90.9±2.2 93.0±0.6 0.46 
CpG#605 88.5±3.0 91.1±1.3 0.48 
Chr2q22.1 
CpG#19 91.5±1.0 87.5±2.0 0.08 
CpG#20 (cg23885472) 67.9±11.6 47.6±11.3 0.23 
LIMCH1 
CpG#79 (cg13578194) 18.6±5.1 11.3±3.1 0.26 
CpG#80 43.9±6.3 38.3±3.3 0.47 
CpG#81 61.6±4.3 62.4±3.7 0.90 
CpG#82 45.8±7.8 42.0±4.5 0.69 
Chr4q26 
CpG#6 60.8±7.4 60.1±4.9 0.94 
CpG#7 (cg04452203) 7.7±0.9 10.2±2.4 0.37 
NOTCH4  CpG #68 (cg17351927) 92.8±2.8 95.7±1.1 0.39 
RUNX2  CpG#-5 (cg05996042) 34.3±5.1 33.3±6.0 0.91 
GRB10  CpG#-322 34.7±2.3 32.0±3.5 0.51 
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CpG#-321 (cg10335798) 15.5±1.3 14.2±2.1 0.60 
ADARB2 
CpG#7041 92.4±1.3 91.3±1.0 0.54 
CpG#7042 93.3±0.9 90.5±2.0 0.18 
CpG#7043 95.2±0.9 94.4±0.5 0.48 
CpG#7044 84.2±1.4 82.9±2.0 0.59 
CpG#7045 86.8±1.1 84.4±2.6 0.40 
CpG#7046 68.0±3.2 68.4±3.0 0.94 
CpG#7047 (cg11270017) 50.7±6.4 53.2±5.6 0.78 
PHYH 
CpG#70 (cg19018267) 7.1±2.0 4.8±1.0 0.35 
CpG#71 10.2±2.4 11.0±3.4 0.84 
CpG#72 13.4±3.0 13.1±3.6 0.96 
CpG#73 7.2±1.5 5.9±2.0 0.64 
CpG#74 54.3±6.3 55.1±7.1 0.94 
Chr10q26 CpG#7 (cg03697076) 85.4±4.2 71.7±7.3 0.11 
FBXO3 
CpG #-52 (cg05237503) 48.7±11.3 59.3±8.4 0.48 
CpG #-51 90.1±2.8 93.7±0.9 0.27 
LMO2 CpG #177 (cg17408637) 18.0±4.7 26.2±5.3 0.28 
Chr12p12.3  CpG#7 (cg05694021) 14.4±2.5 16.9±2.9 0.53 
Chr12q24.31 
CpG#24 2.7±1.2 7.4±1.5 0.04 
CpG#25 0.7±0.4 1.5±1.1 0.53 
CpG#26 c(g20313522) 2.7±1.3 8.5±3.0 0.10 
CpG#27 13.7±4.6 29.5±10.0 0.18 
FAM106A 
CpG#31 87.8±5.0 85.2±2.8 0.67 
CpG#32  (cg17745575)  45.3±5.0 42.7±4.9 0.71 
KRT32  
CpG#-6 25.4±3.4 29.6±5.0 0.49 
CpG#-5 (cg25598400) 18.1±3.0 20.9±3.0 0.53 
CpG#-4 68.5±4.5 65.3±6.2 0.68 
UCKL1  
CpG#481 11.2±2.1 13.2±3.1 0.59 
CpG#482 (cg07507493) 13.9±2.2 14.9±3.7 0.82 
CpG#483 5.0±1.8 3.4±1.2 0.50 
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KRTAP27-1 
CpG#1 75.4±1.3 76.1±1.3 0.72 
CpG#2 93.8±0.9 93.4±1.3 0.82 
CpG#3 95.5±0.4 96.1±0.6 0.38 
CpG#4 (cg05809586) 62.6±10.0 58.6±14.7 0.82 
ChrXp11.4  CpG #32 (cg11868078) 11.7±2.9 18.5±4.5 0.21 
PCDHGA1  
CpG #1774 71.9±2.4 77.6±2.9 0.15 
CpG #1775 
 cg21915313 26.9±1.5 25.5±2.4 0.63 
CpG #1776 47.5±1.7 51.1±3.3 0.34 
CpG #1777 38.6±1.6 46.0±5.5 0.22 
CpG #1778 (cg01544213) 57.8±2.5 60.8±2.9 0.46 
CpG #1779 30.6±1.0 34.6±2.6 0.18 
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Table 3.5. Summary of pyrosequencing results from children representative of the 
general population of Owen Sound, Ontario.  
Gene 
and n CpG FASD Control p-value 
COLEC11 CpG#602 (cg1573064)4 87.4±3.2 88.7±1.7 0.38 
38 FASD CpG#603 60.3±2.3 57.5±2.2 0.20 
27 Control CpG#604 78.9±2.3 79.7±1.2 0.39 
  CpG#605 77.6±2.2 76.9±1.9 0.40 
PCDBH18 CpG#-5 (cg27086874) 16±2.2 19.9±5.7 0.23 
8 FASD CpG#-4 6.4±1.3 6.9±0.9 0.42 
4 Control CpG#-3 6.1±1.7 3.6±1.9 0.22 
  CpG#-2 9.4±1.6 4.3±2.5 0.06 
  CpG#-1 5.4±1.6 5.5±2.8 0.48 
HTT CpG#2310 (cg26128129) 75.6±7.7 63.3±6.1 0.12 
15 FASD CpG#2311 87±1.7 88±0.9 0.33 
12 Control CpG#2312 61±3.8 58.9±4.3 0.36 
  CpG#2313 27.9±2.6 26.9±4 0.41 
12q24.31 CpG#26 (cg20313522) 6.3±2.7 9.2±3 0.25 
11 FASD 
8 Control CpG#27 23.1±6.3 32.9±8.1 0.17 
10q26.12 
11 FASD 
8 Control 
CpG#7 (cg03697076) 80.1±4 70±7.8 0.12 
2q22.1 CpG#19 87.4±1.7 85.2±1.6 0.18 
11 FASD 
8 Control CpG#20 (cg23885472) 59.2±10.6 52.2±9.6 0.32 
Results presented overlap with those from Figure 3.9. 
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3.5. Discussion 
The results of the research in this chapter provide a methylomic profile (Figure 
3.1) of young children with FASD (Table 3.1). The genes identified are non-random as 
they have a number of interactions identified by an associative gene network analysis 
(Figure 3.2).  
3.5.1. Non-Random Genome-Wide Differential Methylation 
The ontologies (Table 3.2) and pathways (Table 3.3) identified are related to 
cellular and synaptic signaling, (neuro)development, immune processes, cell proliferation 
and differentiation, and also represent non-neuronal tissues such as the heart and kidneys. 
The analysis of human children has implicated a signaling pathway well-known to be 
altered by alcohol: the glutamatergic synapse (Figure 3.5). The results have also 
implicated the retrograde endocannabinoid signaling pathway (Figure 3.7), which is 
known to be deregulated by PAE (Basavarajappa 2015). Endocannabinoids are 
synthesized from the phospholipid membrane and are recognized by receptors that inhibit 
calcium channels and suppress the release of glutamate or GABA. The serotonergic 
synapse pathway was also deregulated (Figure 3.8). The aforementioned synaptic 
pathways all utilize calcium signaling (Figure 3.6), are specifically relevant to 
endophenotypes associated with FASD and related mental disabilities, and are an 
unexpected result of easily obtained buccal swabs.  
A novel pathway identified in the results is hippo signaling (Figure 3.4). Hippo 
signaling is known to restrain cell proliferation and promote apoptosis in differentiating 
epithelial cells (Saucedo & Edgar 2007). While hippo signaling has been primarily 
studied in Drosophila melanogaster, it has been translated to Mus musculus and Homo 
sapiens and identified as a highly conserved signaling pathway involved in the control of 
cell growth, proliferation, and migration as well as apoptosis and organ size control 
(Wang et al. 2009).  
Hippo signaling contains conserved families of signal responsive transcription co-
regulators that transduce cytoplasmic signals into a response of transcriptional regulation 
in the nucleus via kinase cascade (Wang et al. 2009). The hippo signaling components are 
expressed in many tissues and co-regulate transcriptional enhancer factors [(TEFs) or 
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transcription enhancer domain (TEAD) factors], runt-domain transcription factors 
(Runxs), peroxisome proliferator-activated receptor gamma (PPAR-γ), T-box 
transcription factor 5 (Tbx5), and several others. Notably, hippo signaling regulates the 
growth of niche stem cell precursors (Sarikaya & Extavour 2015) and has recently been 
linked to chromatin modification by recruiting a histone methyltransferase complex (Oh 
et al. 2014). It has also been shown to regulate Wnt/β-Catenin signaling (Varelas et al. 
2010).  
A transcription factor analysis was also utilized on all the identified genes (Chen 
et al. 2013). It revealed a significant (p<0.005) enrichment for CTCF insulator sites (Kim 
et al. 2007), which are involved in establishing chromatin domains and boundaries and 
result in a large-scale nuclear architecture that is specific to cell type. Another 
transcription factor enriched for was RAD21, which cooperates with pluripotency 
transcription factors, including CTCF, in the maintenance of embryonic stem cell identity 
(Nitzsche et al. 2011). CTCF is known to be the master regulator of the clustered 
protocadherins (Golan-Mashiach et al. 2012; Guo et al. 2012) where it influences 
complex DNA looping.  
The clustered protocadherins are located on 5q31 and showed a concerted increase 
in methylation (Figure 3.3). The protocadherins are trans-membrane proteins with repeats 
of the cadherin motif or the cadherin extracellular domain (Hirano & Takeichi 2012; 
Chen & Maniatis 2013). This domain contains a conserved Ca2+ binding sequence and the 
number of extracellular domains may vary across different cadherin molecules. The 
protocadherins function as cell adhesion molecules with immense isoform diversity that is 
used to create individual neuronal identities and allow for large-scale network formation 
via controlling synaptic interactions. An increase in methylation in some, most, or all 
gene promoters as observed in human FASD patients, is expected to reduce the isoform 
diversity, thus limiting brain function. The clustered protocadherins were also represented 
by many of the gene ontologies (Table 3.2). They have been implicated in a number of 
brain disorders with similar endophenotypes to FASD, such as autism spectrum disorders, 
bipolar disorder, and schizophrenia (Hirano & Takeichi 2012). The molecular functions 
of the clustered protocadherins are further discussed in chapter 4, where the human 
observations are compared to the mouse CPD PAE paradigm (chapter 2).  
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3.5.2. Comparison of Discovery and Replication Cohorts 
The replication cohort (R) included six patients (3-10 years old) and six matched 
controls (Table 3.1B) and their cheek swab DNA was used to generate genome-wide 
DNA methylation profiles (Figure 3.1B). They were recruited from the same clinic and 
diagnosed by the same Pediatrician (J. Kapalanga). However, the replication cohort was 
also much more heterogeneous compared to the discovery cohort with respect to sex, 
medication exposure, environment, and socioeconomic status. In order to compare the 
cohorts across batches a different pre-processing algorithm was selected: the subset-
quantile within array normalization (SWAN) algorithm (Maksimovic et al. 2012; Fortin et 
al. 2014) from the minifi (Aryee et al. 2014) bioconductor package. When the two cohorts 
were pre-processed separately by the Illumina algorithm or together with the SWAN 
algorithm, they produced genome-wide results that had similarities but were not identical 
to the discovery cohort. In general, there was decreased significance in the replication 
cohort and greater levels of variation. Despite these differences, the main similarities 
between the two cohorts were significant alterations in ontologies related to glutamate 
and the canonical glutamatergic synapse pathway. Additionally, there was a clustered 
protocadherin signal on the Manhattan plot, as well as replication of alterations to 
imprinted regions also seen in the mouse models and the discovery cohort.  
Next, the replication cohort was reanalyzed following removal of females and 
children on medication (Table 3.1B; R1 and R4). Also, four controls of the replication 
cohort were removed to better match age range and medical history. The selected scans 
were then pre-processed using the Illumina algorithm. Upon removal, the groups cluster 
much more closely and the signal is almost identical to what was observed in the 
discovery cohort. Glutamatergic synapses, cell-adhesion, neuroactive ligand receptor 
interactions, MAPK signaling, axon guidance, and a number of other pathways were all 
significant (p<0.005) even though the ranking of specific pathways varied slightly. The 
results argue that although DNA methylation is altered in patients with FASD, other 
factors, including sex, age, and medication history, may affect the final outcome. 
An independent group has also replicated some of this research (Laufer et al. 
2015). Portales-Casamar et al. published an examination of genome-wide DNA 
methylation patterns in the buccal epithelial cells of a Canadian cohort (Portales-Casamar 
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et al. 2016). They compared 110 children with FASD to 96 control children between the 
ages of 5 to 18. In addition to utilizing the 450K array and pyrosequencing, a genotyping 
array was used to statistically correct for genetic background. Their analysis revealed 658 
differentially methylated CpGs with 41 of those showing a >5% change in methylation. 
They observed an enrichment for genes with functions related to neurodevelopment. 
Furthermore, there was an increase of methylation in multiple probes from the clustered 
protocadherins and also alterations to genomically imprinted regions, which included 
H19. Overall, their observations confirm key findings from both the mouse and human 
results presented in this thesis and expand them to a more diverse cohort. 
3.5.3. No Single Gene Examined Identifies FASD  
The differential methylation observed was not replicated when examined at select 
loci in a different cohort more representative of the general population (Tables 3.4 & 
3.5). While it is possible that the marks examined are simply not informative of PAE, 
there are also a number alternative possibilities that may account for the lack of 
replication. First, individual sequencing is a more practical approach for clinical use as a 
substantial change in methylation level at a biomarker locus would allow for the detection 
of exposure without the need for carefully matched controls. However, individual 
sequencing does not have the advantage of normalization of signal across matched 
samples and reference genes.  
These findings highlight the difficulty of expanding from the homogeneity of a 
small carefully matched group to that of the heterogeneous general population. In the 
follow-up pyrosequencing and NGS panel, FASD patients were more variable across a 
number of factors including age, sex, drug exposure, and family history of mental health 
disorders. The control patients were also in the clinic for a more heterogeneous mixture of 
acute and chronic medical problems, which involved medication in some cases. 
Ultimately, given the potential for variation across a number of factors, it appears that 
each case of FASD may be represented in the epigenome as a complex signature that is 
altered by other environmental factors. This large amount of heterogeneity would benefit 
from future experimentation with much larger sample sizes, which would provide added 
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statistical power. Furthermore, a regression could also be used to dissect the complex 
environmental interactions that shape the general population.  
One possible approach to dissect the heterogeneity of FASD would be to mirror 
an array discovery approach and machine learning strategy used to detect prenatal 
exposure to smoking. In this example, the cord blood from 1,062 newborn Norwegian 
children prenatally exposed to maternal smoking during the second trimester was 
analyzed on the 450K array, revealing 26 significantly altered CpGs that mapped to 10 
genes (Joubert et al. 2012). The genes distinctly altered had functions related to 
detoxification and development. A separate follow-up study utilized whole blood from an 
American cohort (of 531 children) that were 3-5 years old and analyzed the same 26 
CpGs using machine learning, where they found that 81% of the time they could predict 
prenatal exposure to smoking (Ladd-Acosta et al. 2016). The above examples suggest that 
larger sample sizes from interdisciplinary collaborative efforts increase statistical power. 
However, given that 19% of cases were not identified, there are still limitations to the 
approach of epigenetic epidemiology and the statistical approaches available need further 
improvement, in terms of both loci examined and computational analysis, if they are to 
properly model the heterogeneity of the human population and be used for public health 
decisions (Ramsay 2015). To further expand on this point, a massive meta-analysis of 
prenatal exposure to maternal smoking found that even a sustained and heavy exposure 
results in a 450K profile with only nominal significance when applied to different cohorts 
of older children with the same heavy prenatal exposure (Joubert et al. 2015). In the same 
study, moderate exposure to any level of smoking, which made up a larger amount of 
children, produced a much less distinct profile that wasn’t fully explored.   
Ultimately, it appears that pyrosequencing of single loci is not suitable for use as a 
diagnostic of FASD. Methodologies that allow for accurate, rapid, and inexpensive 
quantification of DNA methylation levels across multiple loci in a single sample will 
soon emerge. These future technologies could be used to further examine the sites 
identified, as well as those identified by deeper epigenome wide screens, in a larger 
number of samples that will allow for the dissection of the interaction of other 
environmental and inherited variables. The above future improvements and a deeper 
understanding of natural variation in the methylome may one day enable the possibility of 
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diagnosing FASD from buccal swabs. Furthermore, this insight into DNA methylation 
from buccal swabs would be particularly suited for use with other modern diagnostics 
(Reynolds et al. 2011; Portales-Casamar et al. 2015), such as eye movement recordings 
(Paolozza, Rasmussen, et al. 2014a; Paolozza, Rasmussen, et al. 2014b; Paolozza et al. 
2015), diffusion tensor imaging (Paolozza, Treit, et al. 2014), and/or a robotic virtual 
reality platform (Williams et al. 2014).  
3.5.4. Select Functions of Sequenced Genes 
The genes examined by pyrosequencing and the NGS panel have a number of 
functions that are biologically relevant to PAE. COLEC11 is involved in fundamental 
developmental processes and serves as a guidance cue for neural crest cell migration 
where aberrations are known to produce spectrum disorders with similar endophenotypes 
to FASD known as 3MC syndrome (Rooryck et al. 2011). This biomarker was one of the 
strongest performing on the 450K array and was also confirmed by pyrosequencing. In a 
group of patients with intellectual disability and normal molecular karyotype COLEC11, 
BLCAP, FAM50B, SHANK2, and GLI2 were identified as showing significant alterations 
to methylation in peripheral blood by the 450K and confirmed by pyrosequencing 
(Kolarova et al. 2015). Notably, a marker could not be found for general intellectual 
disability and thus an individual based approach was taken. The hypermethylation of 
COLEC11 was observed and confirmed in a single patient with a thin upper lip 
vermillion, long flat philtrum, moderate developmental delay, generalized epilepsy, 
cerebral movement disorder with ataxia, and blepharophimosis. The aforementioned 
endophenotypes overlap with FASD.  
Chr2q22.1 (Chr2:136120695-136120697) is a few kilobases downstream from 
CXCR4 (Chr2:136114349-136118165). CXCR-4 is involved in neurogenesis, both 
developmental and adult, where it has a role in neuronal guidance and is implicated in 
epilepsy (Bagri et al. 2002). Chr10q26 is inside WDR11-AS, the antisense transcript for 
WDR11. WDR11 is also known as bromodomain and WD repeat-containing protein 2. It 
is involved in human puberty and in mouse and zebrafish models was found to have a role 
in developmental neuroepithelial cell migration (Kim et al. 2010). Bromodomains 
recognize monoacetylated lysine and the WDR domain allows for protein interaction. 
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Members of this family are typically involved in cell cycle progression, signal 
transduction, apoptosis, and gene regulation. Chr12q24.31 (Chr12:124774899-
124774989) is close to numerous novel lncRNAs and SCARB1. SCARB1 functions as a 
receptor for high density lipoprotein, its well known for its role in cholesterol 
homeostasis, and could have a role for membrane and neurosteroid synthesis in neurons 
of the eye (Provost et al. 2003). 
Also, notable is ADARB2 an RNA editing enzyme involved in the post-
transcriptional A-to-I modification and is a process. RNA editing results in the 
recognition of the modified base (Inosine) as a Guanosine by cellular machinery. RNA 
editing is enriched in the brain at 5htr2c and Glur2, which are serotonin and glutamate 
receptors that are involved in neurological disorders (Li & Church 2013). In the mouse 
models, the snoRNA gene families Snord115 and Snord116 were markers of PAE in the 
brain across different exposure dose and timing (Laufer et al. 2013). SNORD115 is 
involved in the alternative splicing of 5HTR2C (Kishore & Stamm 2006). Editing of 
Glur2 by Adar2 alters calcium permeability and is involved in synaptic activity and drug 
addiction (Lomeli et al. 1994; Schmidt et al. 2014). 
3.5.5. Considerations for Future Research 
While this research generates a number results, there are also a number of 
considerations for future studies. Unsorted peripheral tissue contains DNA methylation 
patterns from a heterogeneous population of cells and is a limitation of studies that use 
whole blood. Saliva is comprised of both buccal epithelial cells and a variable level of 
leukocytes and microbes (Aps et al. 2002) that are minimized by using swabs of the check 
pouch as opposed to mouthwashes (Thiede et al. 2000). The above mentioned variations 
in cellular composition may have the potential to lead to spurious findings in some cases, 
as alterations can reflect a shift in cell type composition as opposed to specific epigenetic 
alteration (Souren et al. 2013). However, the buccal epithelium also shares a 
developmental connection to the brain via the ectoderm and has led to novel insights into 
the brain as it is an easily accessible peripheral tissue. Interestingly, studies have 
indicated that the unsorted saliva appears to serve as a better proxy for the psychiatric 
disorders than unsorted blood (Lowe et al. 2013; Abdolmaleky et al. 2014; Wilmot et al. 
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2015). While cell type sorting is an ideal standard it is not always practical, particularly in 
cases where low amounts of DNA available and thus is a limitation to be considered 
when interpreting the results presented. Furthermore, a study using a similar approach to 
examine autism spectrum disorders noted that technical inter-array differences accounted 
for the majority of confounding variation, even after the use of stringent pre-processing 
algorithms to adjust for batch effects (Berko et al. 2014). The two arrays in this chapter 
showed a similar outcome and were analyzed separately to minimize the major source of 
confounding variation.  
3.5.6. Conclusion 
In this research, it was observed that children (3-6 year olds) with a 
comprehensive FASD diagnosis and a maternal history of PAE (termed the discovery 
cohort) have non-random differences in genome-wide DNA methylation. This effect is 
similar, but not identical, in a replication cohort collected 6 months after. The analysis 
allowed for the identification of the clustered protocadherins as well as glutamate and 
hippo signaling proteins as critical molecules. These results may also explain overlaps 
involving FASD and other neurodevelopmental disorders of unknown etiology. However, 
these associations were observed in a small sample of carefully matched children and 
next generation sodium bisulfite sequencing of a larger sample suggests that the selected 
differences may be influenced by sex, age, medication, and genetic background. 
Ultimately, the results establish that DNA methylation is affected at specific 
neurodevelopmental loci in children with FASD but may be altered by other variables.  
Thus, despite the potential caveats, the results included have a number of 
implications. First, the identification of specific loci and pathways, including the clustered 
protocadherins and hippo signaling, may serve as a foundation for functional genomics 
studies. Second, with future optimization, the methylomic profile may serve as part of a 
diagnostic suite that enables early diagnosis and proper application of any corrective 
therapies, which are most effective for FASD if applied as early as possible during 
neurodevelopment (Paley & O’Connor 2009; Chokroborty-Hoque et al. 2014). The 
identified loci may also be utilized towards the development of precision medicine by 
somatic epigenome editing (Laufer & Singh 2015). Finally, the results of this research 
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established that a complex epigenomic signature of PAE remains in the saliva of human 
children. 
 
Footnotes: A substantially modified portion of this chapter has been published (Laufer et 
al. 2015). 
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Chapter 4 
Comparison of PAE Mice and Humans 
4.1 Overview 
The results presented in this thesis represent a number of novel observations. The 
mouse model (chapter 2) revealed that long-term alterations to DNA methylation as well 
as non-coding RNA and gene expression are induced by prenatal alcohol exposure (PAE) 
in the brain. Observations of saliva (chapter 3) show that there is a heterogeneous profile 
of non-random differential DNA methylation characteristic of young children with Fetal 
Alcohol Spectrum Disorders (FASD). In this chapter, I highlight that there are some 
comparable alterations in DNA methylation between the brains of adult male mice and 
the buccal epithelium of human children. A portion of this chapter has been previously 
published in Laufer et al. 2015. Together, the results of this research suggest that while 
different genes are altered, a long-term profile exists in diverse cell types with an 
ontogenetic relationship stemming from the ectoderm. The candidate loci identified in the 
two species belong to related non-random ontologies and pathways as well as complex 
epigenetically regulated syntenic loci. The results of this research may be used to guide 
future functional genomics studies examining the development of FASD following PAE. 
The novel results are also expected to aid the future development of strategies for early 
diagnosis and protocols for amelioration. 
4.2  Introduction  
The mouse model results presented in chapter 2 are in agreement with research 
using human cells. For example, Khalid et al. examined the transcriptome and methylome 
of human embryonic stem cells (hESCs) exposed to alcohol (Khalid et al. 2014). The top 
deregulated hub genes were SCUBE3 and SLC22A5, which showed decreased gene 
expression. Notably, SLC22A5 was ranked as the 3rd gene showing the highest differential 
hyper-methylation in the mouse model presented in this thesis. The SLC22A5 gene codes 
for a solute carrier protein (OCTN2) that has a role in TGF-β signaling and transports 
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carnitine, which is involved in transporting fatty acids from the cytosol to the 
mitochondrial matrix, where they can be used for metabolism (Sonne et al. 2012). 
SCUBE3 also codes for a protein that has a number of functions, which include TGF-β 
signaling and the complement system (Yang et al. 2013). In the analysis of gene 
expression in the mouse model, the complement system was the top deregulated 
canonical pathway and also enriched in the gene ontology analysis. Finally, as noted by 
Khalid et al., the two hub genes identified are expressed in a number of non-neuronal 
tissues including the heart. These similarities highlight the translational potential of the 
PAE mouse model, which I used as a comparison point for the observations from human 
children with FASD.  
The experiments involving mice were based on a MeDIP-Chip tilling array that 
analyzes CpG islands with greater than 2 methylated cytosines per a 50-75 base pair 
probe, which are then tilled into a larger contiguous sequence to represent a differentially 
methylated region (DMR) (Figure 2.7) (Laufer et al. 2013). For the human analysis, the 
450K methylation array was used to analyze alterations to single CpG sites via sodium 
bisulfite conversion and an (epi)genotyping approach (Figure 3.1A) (Laufer et al. 2015). 
The translational comparison of results allowed for the identification of specific 
ontologies, pathways, and loci that are concordant between the independent array sets, 
which may be further developed as robust biomarkers of PAE. 
4.3 Methods 
The mouse model results are described in chapter 2. Briefly, the updated (2016) 
methylation analysis was used for the comparison of ontologies and pathways, as this 
analysis was generated using a workflow more similar to the human results and thus 
allowed for a more direct comparison. However, the updated analysis is from software 
with limited support for the array, which did not provide complete genomic location 
annotations for the tiled sequence, and thus the original (2012) methylation analysis was 
used for comparative alignment. The analysis of the human observations is described in 
chapter 3. The observations from the discovery cohort were used for the comparison to 
mice. Alignment of reference genomes for both species was carried out using the UCSC 
genome browser (www.genome.ucsc.edu). 
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4.4 Results  
Of the 190 CpGs from the human discovery cohort that were annotated to genes, 
36 (19%) overlapped with the 2898 annotated genes identified from the updated 2016 
mouse analysis. However, the ontologies and pathways identified in the human discovery 
cohort (Tables 3.2 & 3.3) are similar to those identified in adult PAE mouse brains 
(Tables 2.7 & 2.8) and related to cellular and synaptic signaling, (neuro)development, 
immune processes, cell proliferation and differentiation, and also represent non-neuronal 
tissues such as the heart and kidneys. The observations represent a number of diverse 
ontogenetic events that are altered long after their initial deregulation by PAE. The most 
common and clearly connected are cellular signaling events related to development and 
neurotransmission, which are responsive to the external environment. For instance, the 
top pathway identified in the human results was hippo signaling (Table 3.3; 25/85 
molecules and p=0.0002), which was also altered in the mouse model (Table 2.8; 40/115 
molecules and p=0.04). Calcium signaling was also altered in the children’s swabs (Table 
3.3; 99/475 molecules, p=0.005) and mouse brains (Table 2.8; 50/136 molecules, 
p=0.01). Calcium signaling has numerous diverse roles, including in neurotransmission, 
where it contributes to depolarization of the cell membrane and resulting action 
potentials. Also notable are the only two genes that passed the FDR filtering on the 450K 
array. Both showed increased methylation, and AHNAK2 was 1.7 fold (p=1.93E-07) and 
COLEC11 was 1.6 fold (p=6.61E-08) (Appendix D). AHNAK2 is a type of giant 
propeller-like protein linked to calcium channels (Komuro et al. 2004). COLEC11 
encodes a guidance cue for neural crest migration (Rooryck et al. 2011). The CL-K1 
protein encoded by COLEC11 is part of the lectin complement pathway, which functions 
in complement activation (Wallis et al. 2010), an immune process represented in the 
ontologies and as the top pathway of mouse gene expression (Table 2.2). 
The comparison of mouse and human results has enabled the identification of not 
only ontologies and pathways deregulated by PAE, but also genomic loci. Some genes 
showing differential methylation in children belonged to genes families with altered 
methylation in mice [PHOX2B (p=0.0009), ADAMTS17 (p=0.002), KRT32 (p=0.004), 
TMEM229A (p=0.004)]. As another example, complex epigenetically regulated syntenic 
loci were also identified in both mice and humans. Alterations to imprinted ncRNA from 
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the SNRPN-UBE3A locus [SNORD116 (HBII-85) (p<0.005) and SNORD115 (HBII-52) 
(p<0.01)] were also present in the human buccal DNA, which was the most ubiquitously 
expressed marker for PAE that was identified in the mouse model chapter of this thesis 
(Appendix D). SNORD115 changes the alternative splicing of the serotonin receptor 
5HTR2C (Kishore & Stamm 2006; Glatt-Deeley et al. 2010), which is a G-protein 
coupled receptor involved in calcium signaling (Nakatani et al. 2009). Calcium signaling 
was deregulated in both the mouse model and human model, and the serotonergic synapse 
pathway was altered in human children (Table 3.3).  
4.4.1   Increased Methylation at the Clustered Protocadherins 
In both humans with FASD and PAE mice, the clustered protocadherins showed a 
broad increase in methylation at select regions (Figure 4.1). An increase in methylation 
in some, most, or all gene promoters (Tables 4.1 & 4.2) is expected to reduce the isoform 
diversity, thus restraining brain function. Table 4.1 contains a list of genes, genomic 
position, and the functional CpG site that is differentially methylated in the buccal swabs 
of FASD patients from the discovery cohort as compared to their matched controls. 
Similarly, Table 4.2 contains corresponding protocadherin genes that were differentially 
methylated in adult mouse brains long after PAE. Figure 4.1A includes a plot of the raw 
Illumina β values, which correspond to percent methylation, for significant (p<0.005) 
CpGs in the differentially methylated region of the protocadherin γ cluster of humans and 
also how they align with alternate transcripts choice. The differential methylation appears 
to correspond to the first variable exon and preceding promoter of an alternative 
transcript. Protocadherins are involved in the generation of synaptic complexity in the 
developing brain and evolved primarily by tandem duplications and divergence. This 
complex locus contains three clusters (α, β, and γ) of protocadherin gene families that are 
transcriptionally complex and very similar between humans and mice (Figure 4.1B). The 
clustered protocadherin locus generates comparable transcripts in the two species and has 
relatively conserved CpG sites. More importantly, a number of the CpG sites/islands are 
specifically prone to increased methylation following PAE in both species. 
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Table 4.1. Nucleotide-specific analysis of CpGs in the protocadherin gene family clusters 
showing significant (p<0.005) alterations to CpG methylation in human buccal epithelial 
DNA from children of the discovery sample. 
Family p-value  CpG ID CpG Coordinate 
Fold 
Change Average β  
α 2.24E-03 cg03318614 140154796 1.10 0.55 
α 4.90E-03 cg16234335 140168303 1.11 0.60 
α 4.07E-03 cg25225155 140202437 1.23 0.64 
α 4.42E-04 cg15122993 140236606 1.17 0.49 
α 3.79E-03 cg13619597 140237001 1.54 0.68 
β 1.90E-03 cg27086874 140549040 1.14 0.19 
β  1.99E-03 cg05941060 140594004 1.43 0.46 
γ  1.37E-03 cg01561869 140704042 1.22 0.29 
γ  8.85E-04 cg25657261 140705331 1.34 0.33 
γ  6.14E-05 cg24922090 140720687 1.24 0.37 
γ  3.24E-03 cg02074191 140731690 1.60 0.46 
γ  1.36E-04 cg06757405 140731792 1.35 0.35 
γ  4.86E-03 cg26856475 140734108 1.38 0.42 
γ  1.08E-03 cg22087053 140734498 1.27 0.35 
γ  8.46E-04 cg18297751 140749183 1.31 0.39 
γ  4.98E-03 cg24633027 140752470 1.32 0.55 
γ  6.18E-04 cg18705909 140754610 1.58 0.45 
γ  4.41E-03 cg08854987 140759645 1.26 0.34 
γ  4.36E-04 cg21117330 140769634 1.20 0.28 
γ  8.56E-04 cg03831054 140769892 1.53 0.48 
γ  8.64E-04 cg21915313 140779155 1.50 0.39 
  
 146 
  
Table 4.2. Tiling-based analysis of promoters from the protocadherin gene clusters 
showing significant (p<0.01) increases in methylation in adult brain tissue from a mouse 
model of prenatal alcohol exposure. 
Family Peak Start Peak End Peak Length 
α 37090887 37091731 844 
α 37099823 37099982 159 
α 37100493 37101082 589 
α 37120628 37121169 541 
α 37121813 37122462 649 
α 37128647 37129396 749 
α 37148470 37149114 644 
α 37153966 37154515 549 
α 37159353 37160304 951 
α 37166096 37167215 1119 
α 37181780 37182430 650 
β 37456114 37456763 649 
β 37603162 37603321 159 
β 37645176 37646223 1047 
β 37657621 37657881 260 
β 37674825 37674994 169 
β 37678546 37679275 729 
γ 37828934 37831185 2251 
γ 37835333 37836297 964 
γ 37840948 37841597 649 
γ 37850740 37850974 234 
γ 37854441 37854897 456 
γ 37868606 37868955 349 
γ 37886555 37887889 1334 
γ 37892011 37893005 994 
γ 37922706 37922835 129 
Data based on the original 2012 analysis.  
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Figure 4.1. Broad profile of increased methylation at the clustered protocadherins in 
children with FASD and PAE mice: (A) Representative methylation patterns in 14 CpGs 
of the gamma cluster in the discovery cohort. Red represents children with FASD and 
blue represents matched controls. (B) Significantly (p<0.005) increased methylation in 
the clustered protocadherin region of patients (red dots), known CpG island (green dots) 
and potential transcripts (blue lines) along with their similarity to the mouse model 
(p<0.01). Figure is not to scale as non-informative regions have been removed for clarity.  
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4.5 Discussion 
The similarities between mice and humans are striking because the arrays are 
designed to investigate different regulatory sequences: the mouse arrays are tiled regions 
of larger change in CpG islands, whereas the human arrays are focused on single CpG 
sites that could be in a CpG island shore/shelf and up to 2 kilobases away from the 
corresponding island (Yasui et al. 2007; Irizarry et al. 2009; Doi et al. 2009). Although, 
some CpG islands are represented on the human array, as exemplified by the clustered 
protocadherins. Thus, the clustered protocadherin signal is a more direct comparison.  
While some of the results may not appear related, most can be connected 
parsimoniously. For example, the enrichment for cancer pathways is related to 
developmental events. Many cancers have been redefined as disorders of the epigenome 
that stem from epigenetic alterations related to stem-cell programming pathways used in 
development (Feinberg et al. 2006; Feinberg et al. 2016).  These results are presumably 
present due to a larger focus from the research community on cancer rather than 
development. There are also alterations to genes involved in immune events, which 
suggest that some alterations may be occurring in glia as well. For instance, microglia 
induce apoptosis in stressed-but-viable neurons by phagocytosis, which is signaled for by 
complement components (Brown & Neher 2014). The complement system was 
implicated in both mouse (Table 2.2) and human (COLEC11) results, and differential 
methylation of phagocytosis related genes was observed in both mice (Table 2.8) and 
children (Table 3.3). The above example also suggests that the long-term profile informs 
on not only past alterations to the epigenome, but also active differences in transcription. 
However, the most striking shared signature was the preferential methylation of the 
clustered protocadherins, which is similar in mice and children.   
4.5.1   Functions of the Clustered Protocadherins  
The increased methylation of protocadherin genes from the cheek swab DNA of 
FASD patients is supported by comparable results in the brains of adult mice prenatally 
exposed to alcohol (Figure 4.1B). These results have the potential to cause a down-
regulation of specific gene products depending on the specificity of methylated promoters 
in neural cells of mice as well as humans. Notably, a number of exposure paradigms in 
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the previously developed mouse model showed alterations to clustered protocadherin 
gene expression. Pcdhb2 was down-regulated (1.2 fold, p=0.02) in the voluntary maternal 
continuous preference drinking (CPD) PAE paradigm. Pcdhb3 was up-regulated (1.2 fold 
change, p=0.005) in the trimester 1 (T1) binge exposure paradigm, while Pcdhb7, 
Pcdh15, Pcdhb11, Pcdhb16, and Pcdhb18 were down-regulated (~1.3 fold, p<0.003) 
(Kleiber et al. 2013). In the trimester 3 (T3) exposure paradigm Pcdhb18 showed a 21% 
increase after acute exposure and 43% decrease in adult brain gene expression (Kleiber et 
al. 2013). Furthermore, such changes are expected to affect function because Pcdhb18 has 
been demonstrated to control axon growth and arborization in zebrafish (Biswas et al. 
2014). Finally, the clustered protocadherins also showed increased histone methylation in 
the hippocampus of adult PAE mice from the T3 binge exposure paradigm (Chater-Diehl 
et al. 2016). Both (activating) H3K4me3 and (repressive) H3K27me3 were increased. 
While the enriched histone post-translational modifications typically act in opposing 
fashions, this enrichment may also represent bivalent chromatin, which allows for genes 
silenced in embryonic stem cells to be poised for later activation during differentiation 
(Bernstein et al. 2006; Vastenhouw & Schier 2012). Finally, some of the clustered 
protocadherins are proteolytically processed by the metalloprotease ADAM10, which 
releases an extracellular fragment for signaling (Reiss et al. 2006). ADAM10 and number 
of other ADAM(S) genes showed differential methylation in the mouse model. Thus, the 
mouse models provide further support for the existence of a complex epigenetic signature 
in the clustered protocadherins that is associated with PAE.  
The protocadherins are the largest subgroup of the cadherin gene superfamily of 
homophilic cell-adhesion proteins (Hirano & Takeichi 2012; Chen & Maniatis 2013). 
They are primarily expressed in the developing nervous system where they are 
stochastically involved in a neuronal self-avoidance that allows neurons to interact with 
the same neuronal subtype but not themselves (Sano et al. 1993). Protocadherins have 
been observed mediating cell-to-cell interactions in dendrites, axons, synapses, growth 
cones, and neuronal soma (Kohmura et al. 1998; Wang et al. 2002; Kallenbach et al. 
2003; Phillips et al. 2003; Junghans et al. 2008; Lefebvre et al. 2012; Chen et al. 2013). In 
vertebrates, the majority of protocadherin genes are organized in 3 clusters: α, β, and γ. 
Intriguingly, the cell specific variation in transcripts created by this locus parallels the 
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complexity of the immune system. Unlike the immune system, which relies on genetic 
recombination, the protocadherin complexity is realized by epigenetic mechanisms that 
parallel the act of recombination via promoter choice and splicing. The transcriptional 
initiation of the α and γ families is dependent on the methylation status of numerous 
promoters in the variable regions of the families that end in shared exons. β, on the other 
hand, does not contain a shared exon and each gene appears to be under the control of its 
own promoter. The α and γ gene families contain CTCF binding sites that families form a 
DNA loop structure, which is proposed to bring the isoform specific promoters into the 
proximity of flanking enhancers and transcriptional machinery (Guo et al. 2012; Golan-
Mashiach et al. 2012; Chen & Maniatis 2013; Guo et al. 2015). This allows stochastic 
expression of several different alternative isoforms from each chromosome, while also 
enabling both chromosomes to express constitutive isoforms.  Thus, it appears that CTCF 
serves as a master transcription factor for this locus and is used to determine the isoform 
expression of protocadherins (Figure 4.2). Furthermore, stochastic isoform expression 
from the α cluster is dependent on epigenetic priming by de novo methylation patterns 
established at promoters by Dnmt3b during early embryonic stages, which goes on to 
influence isoform expression in subsequent differentiated cells (Toyoda et al. 2014). 
The isoform diversity created by the clustered protocadherins creates a molecular 
signature on the cell surface of individual neurons that is used to interact in trans (Chen et 
al. 2013). This diversity is accomplished by individual neurons expressing different 
combinations of the protocadherin isoforms on their cell surface and forms even more 
diversity by creating multimers (in cis). Ultimately, each neuron could have its own 
unique identity amongst other individuals of the same subtype (Bonn et al. 2007; 
Schreiner & Weiner 2010). This is believed to be critical for the specific and yet 
enormous network formation of precise neuronal connections required for 
neurodevelopment.  
The clustered protocadherins function in neurite self-avoidance (Lefebvre et al. 
2012), dendritic patterning (Suo et al. 2012), and axonal projection (Katori et al. 2009). 
Given their essential role underlying neurodevelopment, it comes as no surprise that the 
protocadherin gene family clusters have been implicated in a number of 
neurodevelopmental disorders (Kalmady & Venkatasubramanian 2009). Furthermore, 
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DNA methylation of the clustered protocadherins is known to be environmentally 
responsive. A broad profile of increases and decreases in DNA methylation, H3K9 
acetylation, and gene expression in the hippocampus of the rat revealed that the clustered 
protocadherins show the largest differential response in adult offspring that received 
altered maternal care (McGowan et al. 2011). A further comparison to the hippocampus 
of humans that were abused as children revealed increased methylation in promoters of 
the clustered protocadherin locus (Suderman et al. 2012). It is notable that the mouse and 
human results of this thesis displayed a profile more similar to humans who were abused 
as children, rather than the rodent model of altered maternal care that contained both 
increases and decreases in methylation. Finally, increased methylation and decreased 
expression of the γ protocadherins has been observed in fetal Down syndrome cortex 
(Hajj et al. 2016).  
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Figure 4.2. A hypothetical model of gene regulation by CTCF at the clustered 
protocadherin locus. DNA looping mediated by CTCF/Cohesin may regulate gene 
expression by bringing alternative promoters of select clustered protocadherins into the 
proximity of enhancers and transcriptional machinery. 
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4.5.2   Conclusion 
The comparison of changes to DNA methylation following PAE shows that there 
are similarities between the buccal epithelium of children with FASD and the whole 
brains of PAE adult mice. The similarities typically do not occur in the same genes but 
are evidenced by alterations to similar ontologies and pathways. These alterations to 
methylation occur in genes with functions related to cellular and synaptic signaling, 
(neuro)development, the cell cycle, immune processes, and genomic imprinting (SNORD 
115 & SNORD 116). Furthermore, there is a broad profile of increased methylation at the 
clustered protocadherins in PAE mice and human children. The similarities observed 
come from functionally diverse tissues that share a stem cell progenitor and suggest an 
ontogenetic footprint of PAE is maintained by the epigenome. Thus, the findings 
demonstrate that for translational human studies, rodent models may be used as a 
reference point to help decipher the complex signature of select life experiences amongst 
the epigenetic variation that shapes every individual.  
 
Footnote 
A modified portion of this chapter has been published (Laufer et al. 2015).  
4.6 References  
Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., 
Meissner, A., Wernig, M., Plath, K., Jaenisch, R., Wagschal, A., Feil, R., Schreiber, 
S.L. & Lander, E.S., 2006. A Bivalent Chromatin Structure Marks Key 
Developmental Genes in Embryonic Stem Cells. Cell, 125(2), 315–326. 
Biswas, S., Emond, M.R., Duy, P.Q., Hao, L.T., Beattie, C.E. & Jontes, J.D., 2014. 
Protocadherin-18b interacts with Nap1 to control motor axon growth and 
arborization in zebrafish. Molecular Biology of the Cell, 25(5), 633–42. 
Bonn, S., Seeburg, P.H. & Schwarz, M.K., 2007. Combinatorial expression of alpha- and 
gamma-protocadherins alters their presenilin-dependent processing. Molecular and 
Cellular Biology, 27(11), 4121–4132. 
Brown, G.C. & Neher, J.J., 2014. Microglial phagocytosis of live neurons. Nature 
Reviews Neuroscience, 15(4), 209–216. 
Chater-Diehl, E.J., Laufer, B.I., Castellani, C.A., Alberry, B.L. & Singh, S.M., 2016. 
Alteration of Gene Expression, DNA Methylation, and Histone Methylation in Free 
 154 
Radical Scavenging Networks in Adult Mouse Hippocampus following Fetal 
Alcohol Exposure. PloS one, 11(5), e0154836. 
Chen, W. V, Alvarez, F.J., Lefebvre, J.L., Friedman, B., Nwakeze, C., Geiman, E., Smith, 
C., Thu, C.A., Tapia, J.C., Tasic, B., Sanes, J.R., Maniatis, T. & Street, O., 2013. 
Functional Significance of Isoform Diversification in. Neuron, 75(3), 402–409. 
Chen, W. V & Maniatis, T., 2013. Clustered protocadherins. Development, 140(16), 
3297–3302. 
Doi, A., Park, I.-H., Wen, B., Murakami, P., Aryee, M.J., Irizarry, R., Herb, B., Ladd-
Acosta, C., Rho, J., Loewer, S., Miller, J., Schlaeger, T., Daley, G.Q. & Feinberg, 
A.P., 2009. Differential methylation of tissue- and cancer-specific CpG island shores 
distinguishes human induced pluripotent stem cells, embryonic stem cells and 
fibroblasts. Nature Genetics, 41(12), 1350–1353. 
Feinberg, A.P., Koldobskiy, M.A. & Göndör, A., 2016. Epigenetic modulators, modifiers 
and mediators in cancer aetiology and progression. Nature Reviews Genetics, 17(5), 
284–99. 
Feinberg, A.P., Ohlsson, R. & Henikoff, S., 2006. The epigenetic progenitor origin of 
human cancer. Nature Reviews Genetics, 7(1), 21–33. 
Glatt-Deeley, H., Bancescu, D.L. & Lalande, M., 2010. Prader-Willi syndrome, 
Snord115, and Htr2c editing. Neurogenetics, 11(1), 143–144. 
Golan-Mashiach, M., Grunspan, M., Emmanuel, R., Gibbs-Bar, L., Dikstein, R. & 
Shapiro, E., 2012. Identification of CTCF as a master regulator of the clustered 
protocadherin genes. Nucleic Acids Research, 40(8), 3378–3391. 
Guo, Y. et al., 2015. CRISPR Inversion of CTCF Sites Alters Genome Topology and 
Enhancer/Promoter Function. Cell, 162(4), 900–910. 
Guo, Y., Monahan, K., Wu, H., Gertz, J., Varley, K.E., Li, W., Myers, R.M., Maniatis, T. 
& Wu, Q., 2012. CTCF/cohesin-mediated DNA looping is required for 
protocadherin α promoter choice. Proceedings of the National Academy of Sciences 
of the United States of America, 109(51), 21081–21086. 
Hajj, N. El, Dittrich, M., Böck, J., Kraus, T.F.J., Nanda, I., Müller, T., Seidmann, L., 
Tralau, T., Galetzka, D., Schneider, E. & Haaf, T., 2016. Epigenetic dysregulation in 
the developing Down syndrome cortex. Epigenetics. 
Hirano, S. & Takeichi, M., 2012. Cadherins in Brain Morphogenesis and Wiring. 
Physiological Reviews, 92(2), 597–634. 
Irizarry, R.A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., 
Gabo, K., Rongione, M., Webster, M., Ji, H., Potash, J.B., Sabunciyan, S. & 
Feinberg, A.P., 2009. The human colon cancer methylome shows similar hypo- and 
 155 
hypermethylation at conserved tissue-specific CpG island shores. Nature Genetics, 
41(2), 178–186. 
Junghans, D., Heidenreich, M., Hack, I., Taylor, V., Frotscher, M. & Kemler, R., 2008. 
Postsynaptic and differential localization to neuronal subtypes of protocadherin 
beta16 in the mammalian central nervous system. The European Journal of 
Neuroscience, 27(3), 559–571. 
Kallenbach, S., Khantane, S., Carroll, P., Gayet, O., Alonso, S., Henderson, C.E. & 
Dudley, K., 2003. Changes in subcellular distribution of protocadherin gamma 
proteins accompany maturation of spinal neurons. Journal of Neuroscience 
Research, 72(5), 549–556. 
Kalmady, S. V. & Venkatasubramanian, G., 2009. Evidence for positive selection on 
Protocadherin Y gene in Homo sapiens: Implications for schizophrenia. 
Schizophrenia Research, 108(1-3), 299–300. 
Katori, S., Hamada, S., Noguchi, Y., Fukuda, E., Yamamoto, T., Yamamoto, H., 
Hasegawa, S. & Yagi, T., 2009. Protocadherin-alpha Family Is Required for 
Serotonergic Projections to Appropriately Innervate Target Brain Areas. Journal of 
Neuroscience, 29(29), 9137–9147. 
Khalid, O., Kim, J.J., Kim, H.S., Hoang, M., Tu, T.G., Elie, O., Lee, C., Vu, C., Horvath, 
S., Spigelman, I. & Kim, Y., 2014. Gene expression signatures affected by alcohol-
induced DNA methylomic deregulation in human embryonic stem cells. Stem Cell 
Research, 12(3), 791–806. 
Kishore, S. & Stamm, S., 2006. The snoRNA HBII-52 regulates alternative splicing of 
the serotonin receptor 2C. Science, 311(5758), 230–232. 
Kleiber, M.L., Mantha, K., Stringer, R.L. & Singh, S.M., 2013. Neurodevelopmental 
alcohol exposure elicits long-term changes to gene expression that alter distinct 
molecular pathways dependent on timing of exposure. Journal of 
Neurodevelopmental Disorders, 5(1), 6. 
Kohmura, N., Senzaki, K., Hamada, S., Nobuyuki, K., Yasuda, R., Watanabe, M., Ishii, 
H., Yasuda, M., Mishina, M. & Yagi, T., 1998. Diversity revealed by a novel family 
of cadherins expressed in neurons at a synaptic complex. Neuron, 20(6), 1137–1151. 
Komuro, A., Masuda, Y., Kobayashi, K., Babbitt, R., Gunel, M., Flavell, R.A. & 
Marchesi, V.T., 2004. The AHNAKs are a class of giant propeller-like proteins that 
associate with calcium channel proteins of cardiomyocytes and other cells. 
Proceedings of the National Academy of Sciences of the United States of America, 
101(12), 4053–4058. 
Laufer, B.I., Kapalanga, J., Castellani, C.A., Diehl, E.J., Yan, L. & Singh, S.M., 2015. 
Associative DNA methylation changes in children with prenatal alcohol exposure. 
Epigenomics, 7(8), 1259–1274. 
 156 
Laufer, B.I., Mantha, K., Kleiber, M.L., Diehl, E.J., Addison, S.M.F. & Singh, S.M., 
2013. Long-lasting alterations to DNA methylation and ncRNAs could underlie the 
effects of fetal alcohol exposure in mice. Disease Models & Mechanisms, 6(4), 977–
992. 
Lefebvre, J.L., Kostadinov, D., Chen, W. V, Maniatis, T. & Sanes, J.R., 2012. 
Protocadherins Mediate Dendritic Self-Avoidance in the Mammalian Nervous 
System. Nature, 488(7412), 517–521. 
McGowan, P.O., Suderman, M., Sasaki, A., Huang, T.C.T., Hallett, M., Meaney, M.J. & 
Szyf, M., 2011. Broad epigenetic signature of maternal care in the brain of adult rats. 
PLoS ONE, 6(2), e14739. 
Nakatani, J. et al., 2009. Abnormal Behavior in a Chromosome- Engineered Mouse 
Model for Human 15q11-13 Duplication Seen in Autism. Cell, 137(7), 1235–1246. 
Phillips, G.R., Tanaka, H., Frank, M., Elste, A., Fidler, L., Benson, D.L. & Colman, D.R., 
2003. Gamma-protocadherins are targeted to subsets of synapses and intracellular 
organelles in neurons. The Journal of Neuroscience, 23(12), 5096–5104. 
Reiss, K., Maretzky, T., Haas, I.G., Schulte, M., Ludwig, A., Frank, M. & Saftig, P., 
2006. Regulated ADAM10-dependent ectodomain shedding of γ-protocadherin C3 
modulates cell-cell adhesion. Journal of Biological Chemistry, 281(31), 21735–
21744. 
Rooryck, C. et al., 2011. Mutations in lectin complement pathway genes COLEC11 and 
MASP1 cause 3MC syndrome. Nature Genetics, 43(3), 197–203. 
Sano, K., Tanihara, H., Heimark, R.L., Obata, S., Davidson, M., St John, T., Taketani, S. 
& Suzuki, S., 1993. Protocadherins: a large family of cadherin-related molecules in 
central nervous system. The EMBO Journal, 12(6), 2249–2256. 
Schreiner, D. & Weiner, J.A., 2010. Combinatorial homophilic interaction between 
gamma-protocadherin multimers greatly expands the molecular diversity of cell 
adhesion. Proceedings of the National Academy of Sciences of the United States of 
America, 107(33), 14893–14898. 
Sonne, S., Shekhawat, P.S., Matern, D., Ganapathy, V. & Ignatowicz, L., 2012. Carnitine 
deficiency in OCTN2-/- newborn mice leads to a severe gut and immune phenotype 
with widespread atrophy, apoptosis and a pro-inflammatory response. PLoS ONE, 
7(10), e47729. 
Suderman, M., McGowan, P.O., Sasaki, A., Huang, T.C.T., Hallett, M.T., Meaney, M.J., 
Turecki, G. & Szyf, M., 2012. Conserved epigenetic sensitivity to early life 
experience in the rat and human hippocampus. Proceedings of the National Academy 
of Sciences, 109(Supplement 2), 17266–17272. 
Suo, L., Lu, H., Ying, G., Capecchi, M.R. & Wu, Q., 2012. Protocadherin clusters and 
 157 
cell adhesion kinase regulate dendrite complexity through Rho GTPase. Journal of 
Molecular Cell Biology, 4(6), 362–376. 
Toyoda, S., Kawaguchi, M., Kobayashi, T., Tarusawa, E., Toyama, T., Okano, M., Oda, 
M., Nakauchi, H., Yoshimura, Y., Sanbo, M., Hirabayashi, M., Hirayama, T., 
Hirabayashi, T. & Yagi, T., 2014. Developmental epigenetic modification regulates 
stochastic expression of clustered Protocadherin genes, generating single neuron 
diversity. Neuron, 82(1), 94–108. 
Vastenhouw, N.L. & Schier, A.F., 2012. Bivalent histone modifications in early 
embryogenesis. Current Opinion in Cell Biology, 24(3), 374–386. 
Wallis, R., Mitchell, D.A., Schmid, R., Schwaeble, W.J. & Keeble, A.H., 2010. Paths 
reunited: Initiation of the classical and lectin pathways of complement activation. 
Immunobiology, 215(1), 1–11. 
Wang, X., Weiner, J.A., Levi, S., Craig, A.M., Bradley, A. & Sanes, J.R., 2002. Gamma 
protocadherins are required for survival of spinal interneurons. Neuron, 36(5), 843–
854. 
Yang, M., Guo, M., Hu, Y. & Jiang, Y., 2013. Scube regulates synovial angiogenesis-
related signaling. Medical Hypotheses, 81(5), 948–953. 
Yasui, D.H., Peddada, S., Bieda, M.C., Vallero, R.O., Hogart, A., Nagarajan, R.P., 
Thatcher, K.N., Farnham, P.J. & Lasalle, J.M., 2007. Integrated epigenomic analyses 
of neuronal MeCP2 reveal a role for long-range interaction with active genes. 
Proceedings of the National Academy of Sciences of the United States of America, 
104(49), 19416–19421. 
  
 158 
Chapter 5 
Discussion 
5.1 Overview 
The research presented in this thesis has identified differential DNA methylation 
in prenatal alcohol exposed (PAE) mice (chapter 2) and in children with fetal alcohol 
spectrum disorders (FASD) (chapter 3). The mouse results revealed alterations to gene 
and non-coding RNA (ncRNA) expression as well as DNA methylation in adult whole 
brains. The human observations revealed alterations to DNA methylation from the buccal 
swabs of children with FASD. When the mouse and human results are compared (chapter 
4) they show that many alterations occur in genes involved in the same ontologies and 
pathways. Furthermore, the comparison of alterations has also allowed for the 
identification of increased methylation in the clustered protocadherins. In this chapter the 
results of these studies are synthesized and collectively show that the long-term 
alterations from PAE represent a ‘footprint’ of cellular signaling events altered at the time 
of exposure. The results of this thesis also offer a number of considerations for future 
epigenomic research.  
5.2 Towards an Inductive Mechanism: PAE Alters Cellular 
Signaling 
The mechanisms that initiate the altered long-term profile of PAE remain 
unknown. While the systems biology approaches used in this thesis are suited for 
discovery, they are not mechanistic and offer only an assessment of the downstream 
effect. Although the mechanism initiating the long-term profile was not directly 
examined, the results overlap with literature investigating PAE at the time of exposure.   
The pleiotropic effects of ethanol appear to be derived from its ability to alter a 
number of developmental cellular signaling pathways and a preferential effect on certain 
multipotent cell types that later undergo coordinated apoptosis (Kiecker 2016). For 
instance, cell fate and migration depends on signaling pathways with cell surface 
 159 
receptors that activate downstream transcriptional programming. Examples of these 
signaling pathways are bone morphogenic protein (BMP)/transforming growth factor-β 
(TGFβ)/, PI3K/AKT/mTOR, Wnt/β-catenin, retinoic acid/Hox genes, Delta/Notch, SHH 
signaling, and MAPK/ERK (Kandel et al. 2000; Lamouille et al. 2014). Notably, 
members from a number of these pathways have been found to show altered gene 
expression and epigenetic marks in PAE mice across development (Green et al. 2007; 
Resendiz et al. 2014). The neural crest is a stem cell population that appears to be 
particularly impacted by PAE (Smith, Garic, Flentke, et al. 2014). Apoptosis of neural 
crest cells is driven by elevated reactive oxygen species (ROS) and the binding of alcohol 
to a G-protein-coupled receptor (GPCR). The activation of GPCRs by ethanol results in 
the release of phosphoinosityl phosphate, which triggers the release of intracellular 
calcium. This calcium transient prevents β-catenin from activating transcription related to 
trophic support and cell adhesion, which ultimately results in apoptosis (Smith, Garic, 
Berres, et al. 2014). 
Ethanol acts directly on neurotransmitter system receptors including 
neuropeptides, amino acids, biogenic amines, and others (Valenzuela et al. 2011; 
Basavarajappa 2015). Ionotropic receptors are part of a channel pore whereas 
metabotropic receptors result in signal transduction by secondary messengers and are 
often GPCRs (Bear et al. 2007). PAE alters a number of neurotransmitter systems but 
appears to primarily interfere with synaptic signaling involving amino acids and biogenic 
amines (serotonin and dopamine) (Valenzuela et al. 2011). γ-aminobutyric acid (GABA) 
is the main inhibitory neurotransmitter, while the amino acid glutamate is the most 
abundant excitatory neurotransmitter. Ethanol has been shown to directly bind to an 
allosteric site on the GABAA receptor, which is an ionotropic receptor for a ligand-gated 
ion channel, and increases the inhibitory effect (Santhakumar et al. 2007). Ethanol also 
binds to an allosteric site on the N-methyl-D-aspartate receptor (NMDAR), which is a 
glutamate receptor subtype, and inhibits excitatory function (Möykkynen & Korpi 2012). 
Neurotransmitter systems are extensively utilized throughout development. Even before 
synapses are formed, both glutamate and GABA regulate the migration, proliferation, and 
differentiation of neural stem cells (Manent & Represa 2007; Valenzuela et al. 2011). 
Both GABA and glutamate encourage the migration of cortical neurons across the 
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different layers of a developing embryo’s cortex as they pattern it in an inside first, 
outside last fashion (Luhmann et al. 2015). When GABA or glutamate receptors are 
activated they trigger calcium transients that remodel the cytoskeleton and result in 
cellular migration (Luhmann et al. 2015). In neonatal rats, which are the equivalent of the 
third trimester of human pregnancy, both acute and repeated PAE inhibits the long-term 
potentiation and thus maturation of GABAA receptor synapses by temporarily inhibiting 
L-type voltage-gated calcium channels (Zucca & Valenzuela 2010; Morton & Fernando 
Valenzuela 2016). These channels result in calcium transients in response to action 
potentials and are involved in the retrograde release of BDNF (Zucca & Valenzuela 2010; 
Morton & Fernando Valenzuela 2016). Notably, GABA has an excitatory function that 
encourages neuronal growth, migration, and synaptogenesis until the end of the rodent 
equivalent of the third trimester of human pregnancy (Ben-Ari 2002; Valenzuela et al. 
2011). Furthermore, glutamate is involved in synaptogenesis and the maturation of 
neurons (Cline & Haas 2008; Valenzuela et al. 2011). Overall, PAE appears to alter the 
epigenetic remodeling of embryonic stem cells, neural progenitor cells, and maturing 
neurons by interfering with a number of cell-adhesion, synpatogenic, and 
neurotransmission systems (Resendiz et al. 2014). However, PAE also alters other 
signaling systems upon exposure.  
The oxidation of ethanol by alcohol dehydrogenase results in acetaldehyde. 
Acetaldehyde is more toxic than ethanol and creates an abundance of ROS, which induce 
oxidative stress (Brocardo et al. 2011). ROS are signaling molecules critical for proper 
neurodevelopment and a number of cell signaling pathways. One example of a redox 
sensitive pathway is phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of 
rapamycin (mTOR) signaling, where the antagonist, PTEN, can be inactivated by 
oxidation (Ostrakhovitch & Semenikhin 2013). The PI3K/AKT/mTOR pathway is an 
intracellular signaling pathway that regulates the cell cycle and thus proliferation and 
apoptosis. When activated by growth factors binding to various GPCRs and tyrosine 
kinase receptors at the cell surface, PI3K phosphorylates phosphatidylinositol on the cell 
membrane and signals for the activation of AKT. AKT then activates mTOR, inhibits 
FoxO, and regulates a number of transcription factors to ultimately prevent cell death and 
promote cell survival (Brunet et al. 2001). However, PTEN inhibits PI3K and therefore 
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promotes apoptosis. In neural stem cells PI3K/AKT/mTOR promotes cell proliferation, 
whereas PTEN promotes cell differentiation. Neural stem cells utilize PI3K/AKT/mTOR 
signaling to carefully balance maintaining a stem cell pool while also providing enough 
differentiated cells, which can no longer proliferate (Peltier et al. 2007). 
PI3K/AKT/mTOR signaling is also required for the strengthening of synaptic 
connections, which is known as long-term potentiation and is the basis for learning and 
memory (Man et al. 2003; Sui et al. 2008). Overall, the long-term profile of PAE 
observed in both mice and humans contains many members of the above signaling 
pathways and suggests that their disruption is maintained as an ‘ontogenetic footprint’.  
5.2.1    Alternative Hypotheses  
The results suggest that a shared stem cell precursor connects the observations in 
whole brains and buccal swab DNA. However, there are also a number of possible 
alternative explanations to the observed footprint. First, the differential epigenomics 
observed may represent alterations to cell populations as well as alterations to epigenetic 
marks. This would explain some of the genome-wide alterations, as they could be related 
to cellular profile; however, the cell line studies reviewed in the introduction of this thesis 
also establish that genome-wide alterations occur in homogenous populations. Second, 
not all the observed alterations are connected ontogenetically at the level of the ectoderm. 
There also appears to be a preferential disturbance of cells dependent on calcium 
signaling, such as the brain, heart, kidneys, and skeletal structures. Third, and perhaps 
most likely, is that footprint is a combination of the above possibilities.  
5.3 Considerations for Future Experimentation  
The field of epigenomics is rapidly advancing, however, as a discipline a number 
of limitations must be overcome. These challenges are highlighted by the approaches 
used in this thesis and represent important considerations for future research. They are as 
follows: 
1. Cell type heterogeneity. Both the whole brains and the saliva examined contain 
heterogeneous mixtures of cell types. Thus, the epigenomic signals analyzed 
represent a mixed profile that may be representative of alterations to a single cell 
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type or even be heterogeneous within single cells themselves. A deeper 
understanding this heterogeneity will aid in the knowledge of cell types to be 
targeted for functional studies, diagnostics, and/or therapeutics.  
2. Whole genome coverage. The mouse arrays utilized were designed to study CpG 
islands, specifically promoters, while the human arrays utilized were designed to 
study individual CpG shores. Future studies would benefit from the use of 
unbiased designs that allow for the investigation of a number of other features, 
such as enhancers and gene bodies, or preferentially the whole genome.  
3. Direct comparisons. This research made use of adult mouse whole brains and 
buccal swabs from children. To allow for a more direct comparison, future 
research would benefit from also examining buccal cells in mice and human post-
mortem brains. This additional characterization would provide a reference point to 
identify which alterations are tissue specific and which are species specific.   
4. Integrated analysis. This thesis has demonstrated the utility of genome-wide 
scans for both gene expression and DNA methylation in identifying candidate 
genes. Approaches examining a number of epigenetic marks alongside gene 
expression would help prioritize candidates.   
5. Larger sample sizes. The results of this thesis are limited by sample size and 
genetic diversity. An increase in both would increase statistical power. 
6. A developmental reference epigenome. The epigenome appears to create more 
variation than the genome alone. Therefore, an understanding of the extent of this 
variation across tissues would allow for the determination of modifications that 
are inherited, stochastic, and/or environmentally induced. 
7. Functional confirmation of candidate loci. While systems biology based 
approaches are suited for discovery, they also require functional confirmation 
experiments to show causation of a candidate in producing an endophenotype. 
Functional experiments could be carried out by epigenome editing with 
CRISPR/Cas9 biotechnology (Day 2014; Laufer & Singh 2015). First, mouse 
models without PAE would be used to establish causation by recreating key 
marks, which include differential methylation in imprinting control regions for 
Snrpn-Ube3a and Dlk1-Dio3 as well as the clustered protocadherins, Colec11, and 
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Htt. Then, a series of experiments could be carried with the opposite effector that 
targets the same regions in PAE mice. These causative confirmation experiments 
could be used to develop therapeutic interventions for FASD patients that are 
based on somatic epigenome editing of the brain (once the technology is 
developed for the clinic).  
5.4 Conclusions 
The results of this thesis present a number of conclusions, which are derived from 
observations in adult PAE mice and human children with FASD. The similarities come 
from functionally diverse tissues that are derived from a common stem cell progenitor.  
The analysis of adult PAE mice shows that: 
1. PAE results in long-term alterations to gene and ncRNA expression as well as 
DNA methylation in the adult brain. 
2. While genome-wide, the alterations to the epigenome are non-random and occur 
in: 
o Imprinted clusters of ncRNA: Snrpn-Ube3a and Dlk1-Dio3. 
o Functional sites of genes related to neurodevelopment, stem cell signaling, 
and immune processes.  
3. Chronic and moderate PAE or acute and binge PAE at any time point in 
pregnancy distinctly alters the epigenome.  
The observations in children with FASD reveal that: 
1. DNA from buccal swabs of children with FASD contains a genome-wide DNA 
methylation signature related to neurodevelopment, which distinguishes children 
with FASD from matched controls. 
2. Targeted sequencing of a select gene does not identify FASD in a random child 
from the general population. 
The comparison of adult PAE mice to human children with FASD shows that: 
1. The alterations to methylation occur in functionally related genes and pathways; 
however, the specific genes altered are generally not identical.   
2. The clustered protocadherins display a large-scale increase in methylation in both 
PAE mice and humans. 
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In conclusion, the results of this thesis provide foundational evidence for the long-
term effects of gene-by-environment interactions. They suggest that deregulation of the 
epigenome can be inherited across cell divisions and maintain long-term alterations that 
originate from developmental exposures. The results also suggest that non-invasively 
obtained buccal swab DNA contains a signature of neurodevelopmental exposure in 
humans. Furthermore, the results demonstrate that rodent models may be used as a 
reference point when analyzing the complexities of the human epigenome. Aside from the 
relevance of the results to FASD, the results also provide insight into basic biological 
principles. Chromatin is a dynamic molecule that enables a static linear sequence of DNA 
to maintain a molecular memory of developmental events and form distinct tissues. 
Disruption of this programing by adverse environmental experiences can result not only 
in immediate consequences to the exposed stem cells but may also be inherited across cell 
division and maintained in resulting differentiated cells. As the epigenome is more 
dynamic than the genome, therapeutic treatment of disorders through novel epigenetic 
avenues represents a frontier in personalized medicine.  
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Appendix A – IPA® miRNA target filter analysis of CPD PAE adult mouse brains.  
 
miRNA   Fold Change Gene  Fold Change 
let-7d* -1.5 Aak1 1.2 
mir-124* -1.3 Aak1 1.2 
mir-133b -1.4 Aak1 1.2 
mir-369-5p -1.3 Aak1 1.2 
mir-25 -1.2 Aak1 1.2 
mir-27a -1.4 Aak1 1.2 
mir-495 -1.2 Aak1 1.2 
mir-331-3p -1.2 Aak1 1.2 
mir-34b-3p -1.3 Aak1 1.2 
mir-500 -1.3 Aak1 1.2 
mir-124* -1.3 Adamts9 1.2 
mir-369-5p -1.3 Adamts9 1.2 
mir-25 -1.2 Adamts9 1.2 
mir-30a* -1.3 Adamts9 1.2 
mir-495 -1.2 Adamts9 1.2 
mir-34b-3p -1.3 Adamts9 1.2 
mir-362-5p -1.2 Adamts9 1.2 
mir-489 1.2 Ankrd49 -1.2 
mir-124* -1.3 Cspp1 1.3 
mir-369-5p -1.3 Cspp1 1.3 
mir-495 -1.2 Cspp1 1.3 
mir-340-5p 1.2 Ddit4l -1.3 
mir-200a* 1.2 Ddit4l -1.3 
mir-27a -1.4 Dnajc13 1.3 
mir-30a* -1.3 Dnajc13 1.3 
mir-200a* 1.2 Eapp -1.2 
mir-369-5p -1.3 Ephb1 1.3 
mir-495 -1.2 Ephb1 1.3 
mir-369-5p 1.3 Fam155a 1.3 
mir-30a* -1.3 Fam155a 1.3 
mir-124* -1.3 Gpatch8 1.2 
mir-15a* -1.2 Gpatch8 1.2 
mir-369-5p -1.3 Gpatch8 1.2 
mir-199b* -1.2 Gpatch8 1.2 
mir-25 -1.2 Gpatch8 1.2 
let-7d* -1.5 Hmga2 1.2 
mir-15a* -1.2 Hmga2 1.2 
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mir-369-5p -1.3 Hmga2 1.2 
mir-25 -1.2 Hmga2 1.2 
mir-146b 1.2 Nuak1 -1.3 
mir-19b 1.4 Nuak1 -1.3 
mir-151-5p 1.2 Nuak1 -1.3 
mir-152 1.2 Otx2 -1.3 
mir-369-5p -1.3 Pten 1.4 
mir-25 -1.2 Pten 1.4 
mir-495 -1.2 Pten 1.4 
mir-743a 1.3 Rps27l -1.2 
mir-15a* -1.2 Slc24a1 1.2 
mir-27a -1.4 Slc24a1 1.2 
mir-17* 1.5 Slitrk2 -1.2 
mir-17* 1.5 Tbc1d17 -1.3 
mir-146b 1.2 Tmem19 -1.2 
mir-340-5p 1.2 Tmem19 -1.2 
mir-369-5p -1.3 Trdn 1.2 
mir-30a* -1.3 Trdn 1.2 
mir-495 -1.2 Trdn 1.2 
mir-369-5p -1.3 Ypel1 1.2 
mir-199b* -1.2 Ypel1 1.2 
mir-27a -1.4 Ypel1 1.2 
Results were obtained from gene and miRNA expression arrays respectively. They are filtered based on 
confidence of interaction, brain specificity, and an inverse miRNA (p<0.3, fold change 1.15) to target 
mRNA (p<0.05, fold change 1.2) relationship. 
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Appendix B – Individual heatmaps of differential miRNA expression generated using 
hierarchical clustering of the four PAE paradigms (p<0.05 and 1.2-fold change cut-off). 
Experimental mice are labelled red and control mice are labelled blue. 
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Appendix C – Venn diagram of common and unique differentially expressed miRNAs 
identified by four PAE models (p<0.05 and 1.2-fold change cut-off). 
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Appendix D – Differentially expressed snoRNAs in the Snrpn-Ube3a region (chromosome 7) identified by miRNA and gene 
expression arrays in all PAE paradigms (p<0.05 and 1.2-fold change cut-off). 
 
Snrpn-Ube3a CPD     Trimester 1     Trimester 2     Trimester 3     
miRNA array       ID FC p ID FC p ID FC p 
  *No Significant ncRNAs* HBII-52-48 1.2 0.049 HBII-52-2 1.2 0.044 HBII-52-15 1.5 0.001 
       HBII-85-7 -1.3 0.037 HBII-85-22 -1.3 0.001 HBII-85-29 1.4 0.026 
       HBII-85-23 -1.8 0.050 HBII-85-26 -1.2 0.039      
       HBII-85-24 -1.4 0.039           
       HBII-85-28 -1.4 0.009           
Expression Array Ensembl ID FC p Ensembl ID FC p       Ensembl ID FC p 
MBII-52 ENSMUST00000101805  1.4 0.019 ENSMUST00000097244 1.4 0.009 *No Significant ncRNAs* ENSMUST00000102015 1.5 0.003 
  ENSMUST00000101980  1.2 0.003 ENSMUST00000101805 1.2 0.050      ENSMUST00000102017 1.3 0.017 
  ENSMUST00000101860  1.3 0.035 ENSMUST00000101861 1.2 0.050      ENSMUST00000102028 1.6 0.001 
  ENSMUST00000101803  1.2 0.002 ENSMUST00000101896 1.3 0.004      ENSMUST00000102037 1.4 0.025 
  ENSMUST00000097244  1.3 0.0003 ENSMUST00000101917 1.3 0.017      ENSMUST00000102046 1.3 0.022 
  ENSMUST00000101917  1.2 0.038 ENSMUST00000101935 1.3 0.017           
  ENSMUST00000101951  1.3 0.017 ENSMUST00000101935 1.5 0.029           
  ENSMUST00000101896  1.2 0.0002 ENSMUST00000101980 1.3 0.028           
  ENSMUST00000101932  1.2 0.0002 ENSMUST00000102037 1.3 0.038           
  ENSMUST00000101816  1.4 0.004                   
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Appendix E – Differentially expressed ncRNAs from Dlk1-Dio3 and Sfmbt2 (p<0.05 and 1.2-fold change cut-off). A) Dysregulated 
ncRNAs from the Dlk1-Dio3 region (chromosome 12) identified by miRNA and gene expression arrays in all PAE paradigms. B) 
Dysregulated imprinted miRNAs encoded in the Sfmbt2 region (chromosome 2) identified by miRNA expression arrays in all PAE 
paradigms. 
 
A) Dlk1-Dio3 CPD     Trimester 1     Trimester 2     Trimester 3     
 miRNA array ID FC p ID FC p ID FC p ID FC p 
   miR-679 1.2 0.03 miR-665 1.2 0.05 miR-666-5p -1.2 0.003 miR-665 -1.2 0.03 
   miR-300 -1.3 0.05      miR-369-5p 1.3 0.003 miR-434-3p 1.2 0.01 
             hp_mmu-mir-300 1.3  0.021 miR-376b -1.7 0.04 
             hp_mmu-mir-379 -1.2  0.031 miR-544 -1.3 0.02 
                  hp_mmu-mir-485 -1.3 0.04 
 Expression Array Ensembl ID FC p             Ensembl ID FC p 
 SNORD 113 ENSMUST00000082745  1.3 0.02 *No Significant ncRNAs* *No Significant ncRNAs*   ENSMUST00000082553 -1.5 0.01 
   ENSMUST00000082553  1.3 0.02           ENSMUST00000082611 -1.5 0.01 
   ENSMUST00000082611  1.3 0.02           ENSMUST00000082786 1.6 0.04 
   ENSMUST00000082786  1.2 0.04             ENSMUST00000082792 -1.3 0.00 
              
B) Sfmbt2 CPD     Trimester 1     Trimester 2     Trimester 3     
 miRNA array ID FC p ID FC p ID FC p ID FC p 
   miR-466f-3p 1.4 0.02 hp_mmu-mir-669j 1.72  0.002  miR-466b-3p -1.4 0.04 miR-467b 1.3 0.04 
   miR-467c -1.2 0.01     miR-669a -1.8 0.05 miR-467a-1* -1.3 0.04 
   miR-467a* 1.9 0.01     miR-466e-3p -1.5 0.0002 hp_mmu-mir-297c -1.3  0.037  
   miR-466c-3p 1.2 0.003     miR-466c-3p -1.9 0.03 hp_mmu-mir-466e -1.7  0.034  
   miR-669h-3p 1.6 0.01     hp_mmu-mir-297b -1.4 0.03 hp_mmu-mir-466f-2 -1.6 0.05 
   hp_mmu-mir-466h 1.3 0.03     hp_mmu-mir-297c -1.6 0.02 hp_mmu-mir-466h -1.6 0.03 
            hp_mmu-mir-466e -1.3 0.03 hp_mmu-mir-669j -1.4 0.0002 
            hp_mmu-mir-466f-2 -1.3 0.05 hp_mmu-mir-669m-1 -1.4 0.02 
               hp_mmu-mir-669d -2.1 0.03       
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Appendix F – Ingenuity Pathway Analysis Legend 
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